EOS Med Chem Impurity Stock 20201029-41

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Dieugenol, CAS: 03/08/4433, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄.

Difenacoum, CAS: 56073-07-5, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₄O₃.

Difenacoum-d4, CAS: /, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₀D₄O₃.

Difethialone, CAS: 104653-34-1, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₃BrO₂S.

Difethialone-d4, CAS: /, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₁₉D₄BrO₂S.

Diflunisal, CAS: 22494-42-4, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈F₂O₃.

Diflunisal 1-O-β-D-Glucuronide, CAS: 58446-29-0, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆F₂O₉.

Diflunisal Acyl-β-D-glucuronide, CAS: 58446-30-3, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆F₂O.

Diflunisal Phosphate, CAS: 84958-45-2, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₂O₆P.

Diflunisal Sulfate Diammonium Salt, CAS: /, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄F₂N₂O₆S.

Diflunisal-d3, CAS: /, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₅D₃F₂O₃.

Dimethyl 2-fluorobiphenyl-3,3’-dicarboxylate, CAS: 1381944-85-9, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃FO₄.

Dimethyl 3,3’-dichlorobiphenyl-4,4’-dicarboxylate, CAS: 1345472-30-1, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂Cl₂O₄.

Dimethyl 3-chloro-3’-fluorobiphenyl-4,5’-dicarboxylate, CAS: 1381944-21-3, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂ClFO₄.

Dimethyl biphenyl-3,4’-dicarboxylate, CAS: 55676-76-1, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₄.

Diphenyl Disulfide, CAS: 882-33-7, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀S₂.

Dipropofol, CAS: 2416-95-7, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₂.

Dipropofol-d32, CAS: /, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂D₃₂O₂.

Direct Blue 15 (Technical Grade), CAS: 2429-74-5, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₄N₆Na₄O₁₆S₄.

Direct Blue 2, CAS: 2429-73-4, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₁N₆Na₃O₁₁S₃.

Direct Blue 218 (Technical Grade), CAS: 28407-37-6, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₁₆Cu₂N₆Na₄O₁₆S₄.

Direct Blue 6 (Technical Grade), CAS: 2602-46-2, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₀N₆Na₄O₁₄S₄.

Direct Blue 76 (Technical Grade), CAS: 16143-79-6, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₁₆Cu₂N₆Na₄O₁₆S₄.

Direct Fast Red 3B, CAS: 6358-29-8, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₆N₄Na₂O₈S₂.

Direct Scarlet B, CAS: 3530-19-6, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₂N₄Na₂O₈S₂.

Disodium 2,2’-[Biphenyl-4,4’-diyldiethene-2,1-diyl]dibenenesulphonate, CAS: 27344-41-8, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀Na₂O₆S₂.

Dowtherm A, CAS: 8004-13-5, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O.C₁₂H₁₀.

DPC 423, CAS: 292135-59-2, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁ClF₄N₄O₃S.

Edonentan Hydrate, CAS: 264609-13-4, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄N₄O₆S.

Eltrombopag, CAS: 496775-61-2, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂N₄O₄.

Eltrombopag Amide, CAS: 1246929-02-1, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃N₅O₃.

Eltrombopag Ethyl Ester, CAS: /, stock: 6.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆N₄O₄.

Eltrombopag Glucuronide, CAS: /, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀N₄O₁₀.

Eltrombopag Methyl Ester, CAS: 1246929-01-0, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄N₄O₄.

Eltrombopag Olamine, CAS: 496775-62-3, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₆N₆O₆.

Eltrombopag-13C4, CAS: 1217230-31-3, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₄H₂₂N₄O₄.

Eltrombopag-d3, CAS: /, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₉D₃N₄O₄.

Eltrombopag-d9, CAS: /, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₃D₉N₄O₄.

EMD 66684, CAS: 1216884-39-7, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₈O₂ • HCl.

ent-Valsartan, CAS: 137862-87-4, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₅O₃.

EPZ 6438, CAS: 1403254-99-8, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₄N₄O₄.

Erismodegib, CAS: 956697-53-3, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆F₃N₃O₃.

Erismodegib-d4, CAS: /, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂D₄F₃N₃O₃.

Ethyl 2-Amino-4-(1,1’-biphenyl-4-yl)thiophene-3-carboxylate, CAS: 307343-50-6, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₂S.

Ethyl 2-[N-[(2’-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate, CAS: 136285-67-1, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉N₃O₄.

Ethyl 4-(2-Hydroxypropan-2-yl)-2-propyl-1-((2’-(1-trityl-1H-tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)-1H-imidazole-5-carboxylate, CAS: 144690-33-5, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₄N₆O₃.

Ethyl 4-Biphenylacetate, CAS: 14062-23-8, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

Ethyl 4’-methoxybiphenyl-4-carboxylate, CAS: 732-80-9, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₃.

Ethyl Olmesartan Medoxomil, CAS: 1378863-74-1, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂N₆O₆.

Ethyl Olmesartan Medoxomil-d4, CAS: /, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₈D₄N₆O₆.

Ethyl [1,1’-Biphenyl]-3-carboxylate, CAS: 19926-50-2, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Ethyl-2-ethoxy-1-[[(2’-cyanobiphenyl-4-yl) methyl] benzimidazole]-7-carboxylate, CAS: 139481-41-7, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃N₃O₃.

Felbinac, CAS: 5728-52-9, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

Fenbufen, CAS: 36330-85-5, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

Fenbufen-d9, CAS: 1189940-96-2, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₅D₉O₃.

FERb 033, CAS: 1111084-78-6, stock: 4.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉ClFNO₃.

Fexaramine, CAS: 574013-66-4, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₆N₂O₃.

Fexaramine-d4, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂D₄N₂O₃.

Fimasartan, CAS: 247257-48-3, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁N₇OS.

Fluorene, CAS: 86-73-7, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀.

Fluorene-13C6, CAS: 1189497-69-5, stock: 1.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₆H₁₀.

Flurbiprofen, CAS: 5104-49-4, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃FO₂.

Flurbiprofen Acid Chloride, CAS: 56430-63-8, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂ClFO.

Flurbiprofen Acyl-β-D-glucuronide (Mixture of Diastereomers), CAS: 91683-37-3, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁FO₈.

Flurbiprofen Acyl-β-D-glucuronide Allyl Ester(Mixture of Diastereomers), CAS: 1799830-00-4, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FO₈.

Flurbiprofen Acyl-β-D-glucuronide-d3 (Mixture of Diastereomers), CAS: /, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₃FO₈.

Flurbiprofen Axetil, CAS: 91503-79-6, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉FO₄.

Flurbiprofen Sodium, CAS: 56767-76-1, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂FNaO₂.

Flurbiprofen Sulfate, CAS: 1159977-37-3, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃FO₅S.

Flurbiprofen-d3, CAS: 1185133-81-6, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₃FO₂.

Flurbiprofen-d5, CAS: 215175-76-1, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₅FO₂.

Fluxapyroxad, CAS: 907204-31-3, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂F₅N₃O.

Fmoc-d-4,4’-biphenylalanine, CAS: 205526-38-1, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₅NO₄.

Fmoc-l-4,4’-biphenylalanine, CAS: 199110-64-0, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₅NO₄.

FTI 277, CAS: 1217447-06-7, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₃O₃S₂ • C ₂HF₃O₂.

Glyceryl Ester, CAS: 124635-84-3, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇FO₄.

GR 103691, CAS: 162408-66-4, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅N₃O₃.

GR 127935 Hydrochloride, CAS: 148642-42-6, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₅O₃ • (HCl).

GR 127935 Hydrochloride Hydrate, CAS: /, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₅O₃•HCl•x(H₂O).

GSK 1562590 Hydrochloride, CAS: 1003878-07-6, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀Cl₂N₄O₄ • HCl.

GSK 2033, CAS: 1221277-90-2, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈F₃NO₅S.

Hemicholinium-3, CAS: 312-45-8, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄Br₂N₂O₄.

Hippomanin A, CAS: 52934-78-8, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂O₁₈.

HM 50316, CAS: 1310361-52-4, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₃ClN₂O₃S.

Honokiol, CAS: 35354-74-6, stock: 6.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₂.

Hydroxy-Bifenthrin, CAS: 146726-17-2, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂ClF₃O₃.

Hydroxy-Bifenthrin-d5, CAS: /, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₅ClF₃O₃.

HZ-52, CAS: 1077626-51-7, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆ClN₃O₂S.

Iodobenzene-13C6, CAS: 104130-35-0, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₅I.

Irbesartan, CAS: 138402-11-6, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O.

Irbesartan Dimer Impurity, CAS: 1346598-52-4, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₈N₁₀O.

Irbesartan N-β-D-2,3,4-Tri-O-acetyl-glucuronide Methyl Ester, CAS: 224170-69-8, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₄N₆O₁₀.

Irbesartan N-β-D-Glucuronide, CAS: 160205-58-3, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆N₆O₇.

Irbesartan-d3, CAS: 1185120-76-6, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₃N₆O.

Irbesartan-d4, CAS: 1216883-23-6, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄D₄N₆O.

Irbesartan-d6, CAS: /, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂D₆N₆O.

Irbesartan-d7 2,2,2-Trifluoroacetate Salt, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂D₇F₃N₆O₃.

IRL-2500, CAS: 169545-27-1, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₅N₃O₄.

Isoleucine O-Benzyl N-Titryl Valsartan, CAS: /, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₅₁N₅O₃.

Isoleucine O-Benzyl N-Trityl Des-pentanal Valsartan, CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₃N₅O₂.

Isoleucine O-Benzyl Valsartan, CAS: /, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇N₅O₃.

Isoleucine Valsartan, CAS: 137862-78-3, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₅O₃.

Isopropyl 4-(((2S,4R)-1-([1,1’-biphenyl]-4-yl)-5-(carboxyoxy)-4-methylpentan-2-yl)amino)-4-oxobutanoate, CAS: /, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃NO₆.

isopropyl 4-((3R,5S)-5-([1,1’-biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl)-4-oxobutanoate, CAS: /, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₄.

ITD-1, CAS: 1099644-42-4, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉NO₃.

ω-1-Hydroxy Losartan, CAS: 141675-57-2, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClN₆O₂.

ω-3-Hydroxy Losartan, CAS: 141675-59-4, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClN₆O₂.

α-Hydroxy Flurbiprofen, CAS: 61466-95-3, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃FO₃.

αS,​γS)​-γ-​[[(1,​1-​Dimethylethoxy)​carbonyl]​amino]​-​α-​methyl-[1,​1’-​biphenyl]​-​4-​pentanoic Acid-d5, CAS: /, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₅NO₄.

KT109, CAS: 1402612-55-8, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆N₄O.

Kuwanon G, CAS: 75629-19-5, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₆O₁₁.

Kuwanon H, CAS: 76472-87-2, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₄O₁₁.

L,L-Dityrosine Dihydrochloride, CAS: 221308-01-6, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂Cl₂N₂O₆.

L,L-Dityrosine-13C12 Dihydrochloride, CAS: /, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₁₂H₂₂Cl₂N₂O₆.

L,L-Dityrosine-13C6 Dihydrochloride (3% unlabeled) (80% Pure), CAS: /, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₆H₂₂Cl₂N₂O₆.

L-161,982, CAS: 147776-06-5, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉F₃N₄O₄S₂.

L-4,4’-Biphenylalanine, CAS: 155760-02-4, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

L-692,585, CAS: 145455-35-2, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇N₇O₃.

LCZ696, CAS: 936623-90-4, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₈N₆O₈.

Lithium (S)-1-(tert-Butoxy)-2-cyano-4-(2-fluoro-[1,1’-biphenyl]-4-yl)-1,3-dioxopentan-2-ide, CAS: 215176-01-5, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁FLiNO₃.

LLY-507, CAS: 1793053-37-8, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₂N₆O.

Lombazole, CAS: 60628-98-0, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClN₂.

Lombazole-d9, CAS: /, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₈D₉ClN₂.

Lomitapide, CAS: 182431-12-5, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₇F₆N₃O₂.

Lomitapide-d8, CAS: /, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₂₉D₈F₆N₃O₂.

Losartan, CAS: 114798-26-4, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClN₆O.

Losartan Acetate N1-(3,4,5-O-Triacetyl)glucuronide Methyl Ester, CAS: /, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁ClN₆O₁₁.

Losartan Acetate N2-(3,4,5-O-Triacetyl)glucuronide Methyl Ester, CAS: /, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁ClN₆O₁₁.

Losartan Carboxaldehyde, CAS: 114798-36-6, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₆O.

Losartan Carboxaldehyde-d3, CAS: 1184999-26-5, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₃ClN₆O.

Losartan Carboxylic Acid, CAS: 124750-92-1, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₆O₂.

Losartan Isomer Impurity, Potassium Salt, CAS: 860644-28-6, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂ClKN₆O.

Losartan Isomer-d4 Potassium Salt Impurity, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₄ClKN₆O.

Losartan Isopropyl Ether, CAS: 1332713-64-0, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉ClN₆O.

Losartan N1-Glucuronide, CAS: 138584-34-6, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁ClN₆O₇.

Losartan N2-Glucuronide (90%), CAS: 138584-35-7, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁ClN₆O₇.

Losartan N2-Glucuronide-d4, CAS: /, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₄ClN₆O₇.

Losartan Potassium Salt, CAS: 124750-99-8, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂ClKN₆O.

Losartan Trityl Ether, CAS: 1006062-28-7, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₇ClN₆O.

Losartan-d3 Carboxylic Acid, CAS: 1189729-40-5, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₃ClN₆O₂.

Losartan-d4, CAS: 1030937-27-9, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₄ClN₆O.

Losartan-d4 Carboxylic Acid, CAS: 1246820-62-1, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₄ClN₆O₂.

Losartanyl-losartan Trityl (Losartan Impurity)(N1, N2 mixture), CAS: /, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₅₈Cl₂N₁₂O.

LP 12 Hydrochloride, CAS: 1185136-22-4, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₉N₃O • (HCl).

LP 533401, CAS: 945976-43-2, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₂F₄N₄O₃.

LP-211, CAS: 1052147-86-0, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₄O.

LT 175, CAS: 862901-87-9, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈O₃.

m-Aminophenyl Tosylate, CAS: 3865-15-4, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₃S.

m-Terphenyl, CAS: 92-06-8, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄.

Magnolol, CAS: 528-43-8, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₂.

MC 1742, CAS: 1776116-74-5, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₃O₃S.

Menthyl Ester, CAS: 908559-44-4, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁FO₂.

Methanesulfonato(2-dicyclohexylphosphino-2’,6’-di-i-propoxy-1,1’-biphenyl)(2’-amino-1,1’-biphenyl-2-yl)palladium(II), CAS: 1445085-77-7, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₆NO₅PPdS.

Methyl (S)-3-methyl-2-((2’-(1-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl-methyl) amino) butanoate hydrobromide, CAS: 852160-37-3, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₇N₅O₂ • H Br.

Methyl 1-(2-Iodophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, CAS: 5101-14-4, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇IN₂O₂.

Methyl 2,6-Diisopropyl-4-(4-fluorophenyl)-3-hydroxymethyl-5-methoxypyridine-3-carboxylate, CAS: 887407-03-6, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆FNO₃.

Methyl 2,6-Diisopropyl-4-(4-fluorophenyl)-5-hydroxymethyl-pyridine-3-carboxy-late, CAS: 202859-11-8, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FNO₃.

Methyl 2-(4-biphenylyl)propionate, CAS: 74647-99-7, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

Methyl 2-(4’-chloro-[1,1’-biphenyl]-2-yl)acetate, CAS: 1329489-84-0, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃O₂Cl.

Methyl 2-(p-Tolyl)benzoate, CAS: 114772-34-8, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 2-Methyl-6-(3-nitrophenyl)-4-oxo-2-cyclohexene-1-carboxylate + ~8% Ethyl 3-Methyl-3’-nitro-5-oxo-1,2,5,6-tetrahydro-[1,1’-biphenyl]-2-carboxylate, CAS: /, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₅ + C ₁₆H₁₇NO₅.

Methyl 2’-Methyl-[1,1’-biphenyl]-2-carboxylate, CAS: 188943-06-8, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 3-(3-Nitrophenyl)benzoate, CAS: 149506-24-1, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

Methyl 3-(4-Hydroxyphenyl)benzoate, CAS: 192376-76-4, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

Methyl 3-Aminobiphenyl-4-carboxylate Hydrochloride, CAS: 1187582-66-6, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂ • HCl.

Methyl 3-Methylbiphenyl-3-carboxylate, CAS: 128460-74-2, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 3’-Amino-1,1’-biphenyl-3-carboxylate, CAS: 168619-25-8, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

Methyl 3’-Amino-1,1’-biphenyl-3-carboxylate Hydrochloride, CAS: 343985-94-4, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂ •  (HCl).

Methyl 3’-Bromobiphenyl-4-carboxylate, CAS: 89900-91-4, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrO₂.

Methyl 3’-Formyl-[1,1’-biphenyl]-3-carboxylate, CAS: 386297-59-2, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₃.

Methyl 3’-Methoxy-[1,1’-biphenyl]-4-carboxylate, CAS: 81443-43-8, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

Methyl 3’-Methyl-[1,1’-biphenyl]-2-carboxylate, CAS: 116668-80-5, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 3’-Methyl-[1,1’-biphenyl]-4-carboxylate, CAS: 89900-94-7, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 4-(4-Chlorophenyl)benzoate, CAS: 89901-02-0, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClO₂.

Methyl 4-biphenylcarboxylate, CAS: 720-75-2, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

Methyl 4-fluoro-4’-hydroxybiphenyl-3-carboxylate, CAS: 1261900-28-0, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁FO₃.

Methyl 4’,4-Dimethylbiphenyl-2-carboxylate, CAS: 216442-81-8, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

Methyl 4’-aminobiphenyl-3-carboxylate, CAS: 400747-22-0, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

Methyl 4’-aminobiphenyl-4-carboxylate, CAS: 5730-76-7, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

Methyl 4’-Bromo-[1,1’-biphenyl]-4-carboxylate, CAS: 89901-03-1, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrO₂.

Methyl 4’-Methoxy-[1,1’-biphenyl]-3-carboxylate, CAS: 19617-68-6, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

Methyl 4’-Methoxy[1,1’-biphenyl]-4-carboxylate, CAS: 729-17-9, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

Methyl 4’-Methylbiphenyl-4-carboxylate, CAS: 49742-56-5, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl 4’-Nitro-[1,1’-biphenyl]-3-carboxylate, CAS: 107558-26-9, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

Methyl 4’-Nitro[1,1’-biphenyl]-4-carboxylate, CAS: 5730-75-6, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

Methyl 4’-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]methyl]biphenyl-2-carboxylate (Telmisartan Methyl Ester), CAS: 528560-93-2, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₂N₄O₂.

Methyl 4’-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]methyl]biphenyl-2-carboxylate-d3, CAS: 1189944-53-3, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₉D₃N₄O₂.

Methyl 5-(tert-Butyldimethylsilyloxymethyl-2,6-diisopropyl-4-(4-fluorophenyl)-pyridine-3-carboxylate, CAS: 334933-44-7, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈FNO₃Si.

Methyl 5-Methylbiphenyl-2-carboxylate, CAS: 191104-38-8, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

Methyl Flurbiprofen, CAS: 66202-86-6, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅FO₂.

Methyl Flurbiprofen-d3, CAS: 1189973-18-9, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₃FO₂.

Mexiletine Dimer, CAS: 2059988-38-2, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂N₂O₂.

MK-0822, CAS: 603139-19-1, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇F₄N₃O₃S.

MMP-2/MMP-9 Inhibitor I, CAS: 193807-58-8, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NO₄S.

Monoacylglycerol Lipase Inhibitor 21, CAS: 1643657-35-5, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆O₄.

Monodes(N-carboxymethyl)valine Daclatasvir, CAS: 1007884-60-7, stock: 9.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₉N₇O₃.

Monodes(N-carboxymethyl)valine Daclatasvir-d3, CAS: /, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆D₃N₇O₃.

MOZ-IN-3, CAS: 2055397-18-5, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇FN₂O₃S.

MRT-83, CAS: 1263131-92-5, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀N₄O₅.

N,N-Dimethyl-d6-formamide, CAS: 185990-36-7, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HD₆NO.

N,N-Dimethylformamide, CAS: 68-12-2, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇NO.

N,N’-(3,3’-Dimethyl-[1,1’-biphenyl]-4,4’-diyl)bis(3-oxobutanamide), CAS: 91-96-3, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₄.

N,N’-([1,1’-Biphenyl]-4,4’-diyl)bis(2-chloro-N-(2,6-dichlorophenyl)acetamide), CAS: /, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈Cl₆N₂O₂.

N,N’-Bis(3-methylphenyl)-N,N’-bis(phenyl)benzidine, CAS: 65181-78-4, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₂N₂.

N,N’-Di-(1-naphthyl)-N,N’-diphenyl-(1,1’-biphenyl)-4,4’-diamine, CAS: 123847-85-8, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₂N₂.

N,N’-Diphenylbenzidine, CAS: 531-91-9, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀N₂.

N,N’-Ditrityl Losartan α-Butyl-losartan Aldehyde Adduct, CAS: 1797121-42-6, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₂H₇₂Cl₂N₁₂O₂.

N,O-Ditrityl Losartan, CAS: 1796930-34-1, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₅₁ClN₆O.

N-((2’-(1H-Tetrazol-5-yl)-[1,1’-biphenyl]-4-yl)methyl)pentanamide, CAS: 914465-68-2, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N₅O.

N-(1,1’-biphenyl-4-yl)urea, CAS: 13262-48-1, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O.

N-(2,6-Dichlorophenyl)-4’-iodo-[1,1’-biphenyl]-4-amine, CAS: /, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂Cl₂IN.

N-(2’-Deoxyguanosin-8-yl)-4-amino(biphenyl-2’,3’,4’,5’-d5), CAS: /, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₅N₆O₄.

N-(2’-Deoxyguanosin-8-yl)-4-aminobiphenyl, CAS: 84283-08-9, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₆O₄.

N-(3-Amino[1,1’-biphenyl]-4-yl)-carbamic Acid tert-Butyl Ester, CAS: 335255-33-9, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₂.

N-(3-Nitro[1,1’-biphenyl]-4-yl)carbamic Acid tert-Butyl Ester, CAS: 335254-77-8, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₄.

N-(4-(9-Phenyl-9H-carbazol-3-yl)phenyl)-[1,1’-biphenyl]-4-amine, CAS: 1160294-96-1, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₂₆N₂.

N-(4-Amino[1,1’-biphenyl]-3-yl)-2’-deoxyguanosine, CAS: 1101132-48-2, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₆O₄.

N-(4-Biphenylyl)-1-naphthylamine, CAS: 446242-37-1, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇N.

N-(4-Biphenylyl)-2-biphenylamine, CAS: 1372775-52-4, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉N.

N-(4-Bromo-2-nitrophenyl)carbamic Acid tert-Butyl Ester, CAS: 327046-79-7, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₄.

N-(4-Bromophenyl)-[1,1-biphenyl]-4-amine, CAS: 1160294-93-8, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄BrN.

N-(4-piperazinyl)-oxide ABT 199, CAS: /, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₀ClN₇O₈S.

N-(4’,5-Bis(N-(methoxymethyl)-N-(pyridin-2-yl)sulfamoyl)-[1,1’-biphenyl]-2-yl)-N-(methoxymethyl)acetamide, CAS: /, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃N₅O₈S₂.

N-(4’,5-Bis(N-(methoxymethyl)-N-(pyridin-2-yl)sulfamoyl)-[1,1’-biphenyl]-2-yl)acetamide, CAS: /, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉N₅O₇S₂.

N-(4’,5-Bis(N-(pyridin-2-yl)sulfamoyl)-[1,1’-biphenyl]-2-yl)acetamide, CAS: /, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₅O₅S₂.

N-(4’-Cyano[1,1’-biphenyl]-4-yl)-N’-[4-(3H-imidazo[4,5-b]pyridin-7-yl)phenyl] Urea, CAS: 1361414-26-7, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₈N₆O.

N-(4’-Methoxy-5-(N-(methoxymethyl)-N-(pyridin-2-yl)sulfamoyl)-[1,1’-biphenyl]-2-yl)acetamide, CAS: /, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃N₃O₅S.

N-(Perbromo-[1,1’-biphenyl]-4-yl)acetamide, CAS: /, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₄Br₉NO.

N-(Piperidin-4-yl)-4’-(trifluoromethyl)-biphenyl-2-carboxamide, CAS: 182439-41-4, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉F₃N₂O.

N-([1,1’-Biphenyl]-2-yl)-9,9-dimethyl-9H-fluoren-2-amine, CAS: 1198395-24-2, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃N.

N-([1,1’-Biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine, CAS: 897671-69-1, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃N.

N-([1,1’-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine, CAS: 1246562-40-2, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₆NBr.

N-([1,1’-Biphenyl]-4-ylmethyl)-6-phenyl-3-(pyridin-2-yl)-1,2,4-triazin-5-amine, CAS: 1357171-62-0, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₁N₅.

N-1-Ethoxyethyl Losartan Carboxaldehyde, CAS: 165276-40-4, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉ClN₆O₂.

N-1-Ethoxyethyl Losartan Carboxylic Acid, CAS: 165276-41-5, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉ClN₆O₃.

N-2 Trityl Olmesartan Medoxomil, CAS: 1020157-01-0, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₄₄N₆O₆.

N-4-Biphenylyl-beta-alanine, CAS: 144653-45-2, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

N-4-Pyridinyl[1,1’-biphenyl]-4-acetamide, CAS: 51484-42-5, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O.

N-Acetyl Daclatasvir, CAS: 1800502-75-3, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₄N₈O₈.

N-Acetyl Daclatasvir-d6, CAS: /, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₈D₆N₈O₈.

N-Acetyl-4-aminobiphenyl, CAS: 4075-79-0, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO.

N-Acetyl-4-aminobiphenyl-d5, CAS: 1217046-73-5, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₅NO.

N-Acetyl-SB-611855 Glucuronide Disodium Salt, CAS: /, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NNa₂O₁₀.

N-​[(1R)​-​2-​[1,​1’-​Biphenyl]​-​4-​yl-​1-​(hydroxymethyl)​ethyl]​-carbamic Acid1,​1-​Dimethylethyl Ester, CAS: 1426129-50-1, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₃.

N-Biphenyl-4-yl-2-isopropylamino-acetamide, CAS: 852406-44-1, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O.

N-Boc-2-naphthylamine, CAS: 454713-45-2, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₂.

N-Boc-4-phenyl-L-phenylalanine, CAS: 147923-08-8, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

n-Butyl Olmesartan Medoxomil, CAS: 144689-78-1, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂N₆O₆.

n-Butyl Olmesartan Medoxomil-d6, CAS: /, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₆N₆O₆.

N-Cilexetil Candesartan Ethyl Ester, CAS: 1391054-45-7, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈N₆O₆.

N-Des(4’-chloro-3,3,6-trimethyl-2,3,4,5-tetrahydro-1,1’-biphenyl) Venetoclax, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃N₇O₇S.

N-Desmethyl Telmisartan, CAS: 144701-81-5, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₈N₄O₂.

N-Hydroxy Eltrombopag, CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂N₄O₅.

N-Hydroxy-4-aminobiphenyl, CAS: 6810-26-0, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

N-Methyl-2-biphenylmethylamine, CAS: 13737-31-0, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N.

N-Methylbiphenyl-2-amine, CAS: 14925-09-8, stock: 6.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N.

N-Methyldipentylamine, CAS: 76257-73-3, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₅N.

N-Phenyl-3-biphenylamine, CAS: 198275-79-5, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅N.

N-Phenyl-4-biphenylamine, CAS: 32228-99-2, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅N.

N-Phenyl-N,N-bis(biphenyl-4-yl)amine, CAS: 122215-84-3, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃N.

N-Triphenylmethyl Irbesartan, CAS: 886999-35-5, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₂N₆O.

N-Triphenylmethyl Irbesartan-d7, CAS: /, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₅D₇N₆O.

N-Triphenylmethyl-5-[4’-methylbiphenyl-2-yl]tetrazole, CAS: 133909-97-4, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₆N₄.

N-Triphenylmethyl-5-[4’-methylbiphenyl-2-yl]tetrazole-d4, CAS: /, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₂D₄N₄.

N-Trityl Candesartan, CAS: 894806-43-0, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₄N₆O₃.

N-Trityl Candesartan Cilexetil, CAS: 886999-34-4, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₈N₆O₆.

N-Trityl Candesartan Cilexetil Methoxy Analogue, CAS: 1797867-82-3, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₄₆N₆O₆.

N-Trityl Candesartan Ethyl Ester, CAS: 1797985-81-9, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₃₈N₆O₃.

N-Trityl Candesartan Methoxy Analogue, CAS: 1797918-38-7, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₂N₆O₃.

N-Trityl Candesartan Methyl Ester Methoxy Analogue, CAS: 1797136-91-4, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₃₄N₆O₃.

N-Trityl Candesartan Methyl Ester-d4, CAS: /, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₂D₄N₆O₃.

N-Trityl Candesartan Methyl Ester-d5, CAS: /, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₁D₅N₆O₃.

N-Trityl Candesartan Trityl Ester, CAS: 1797113-00-8, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₄₈N₆O₃.

N-Trityl Ethyl Olmesartan Acid, CAS: /, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₂N₆O₃.

N-Trityl Ethyl Olmesartan Medoxomil, CAS: /, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₆N₆O₆.

N-Trityl Losartan, CAS: 133909-99-6, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₇ClN₆O.

N-Trityl Losartan Carboxaldehyde, CAS: 133910-00-6, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₅ClN₆O.

N-Trityl Losartan Carboxylic Acid, CAS: 960231-60-1, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₅ClN₆O₂.

N-Trityl Losartan Isomer, CAS: 150098-04-7, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₇ClN₆O.

N-Trityl Losartan β-D-glucuronic Acid Methyl Ester(N1, N2 mixture), CAS: /, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₄₉ClN₆O₈.

N-Trityl Losartan-d3 Carboxaldehyde, CAS: /, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂D₃ClN₆O.

N-Trityl Losartan-d3 Carboxylic Acid, CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂D₃ClN₆O₂.

N-Trityl Losartan-d4, CAS: 1309283-24-6, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₃D₄ClN₆O.

N-Trityl Losartan-d4 Carboxaldehyde, CAS: /, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₁D₄ClN₆O.

N-Trityl O-Methyl Ether Olmesartan Acid, CAS: /, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₂N₆O₃.

N-Trityl O-Methyl Ether Olmesartan Acid Ethyl Ester, CAS: /, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₆N₆O₃.

N-Trityl Olmesartan Ethyl Ester, CAS: 172875-59-1, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₄N₆O₃.

N-Trityl Olmesartan Medoxomil Methyl Ether, CAS: /, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₆N₆O₆.

N-Trityl Olmesartan-d4 Ethyl Ester, CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₀D₄N₆O₃.

N-Trityl Olmesartan-d6 Ethyl Ester, CAS: /, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₃₈D₆N₆O₃.

N-Trityl-deshydroxymethyl Losartan, CAS: 1797133-13-1, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₅ClN₆.

N-[(2’-(N2-Trityltetrazol[1,1’-biphenyl]-4-yl)methyl]-N-[3-(2-methyl-1,3-dioxolan-2-yl)-1-oxopropyl]-L-valine Benzyl Ester, CAS: 1798904-60-5, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₅₁N₅O₅.

N-[(2’-Cyano[1,1’-biphenyl]-4-yl)methyl]-1-[(1-oxopentyl)amino]cyclopentanecarboxamide, CAS: 141745-71-3, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉N₃O₂.

N-[(2’-Cyano[1,1’-biphenyl]-4-yl)methyl]-L-valine Methyl Ester Hydrochloride, CAS: 482577-59-3, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₂.

N-[(2’-Cyano[1,1’-biphenyl]-4-yl)methyl]-N-(1-oxopentyl)-L-valine Methyl Ester, CAS: 137863-90-2, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂O₃.

N-[1,1’-Biphenyl]-2-yl-7-nitro-2,1,3-benzoxadiazol-4-amine, CAS: 413611-93-5, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂N₄O₃.

N-[2-(2-Hydroxyethoxy)ethyl]biphenyl-4-carboxamide, CAS: 1354940-68-3, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₃.

N-[2-Methyl-4-(1-methyl-1H-benzimidazol-2-yl)-6-nitrophenyl]butanamide, CAS: 1083158-66-0, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₄O₃.

N-[3-[[4-(Aminomethyl)benzoyl]amino][1,1’-biphenyl]-4-yl]carbamic Acid tert-Butyl Ester, CAS: 1003316-12-8, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₃O₃.

N-[3-[[4-(Chloromethyl)benzoyl]amino][1,1’-biphenyl]-4-yl]carbamic Acid tert-Butyl Ester, CAS: 1003316-10-6, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅ClN₂O₃.

N-[3-[[4-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]benzoyl]amino][1,1’-biphenyl]-4-yl]carbamic Acid tert-Butyl Ester, CAS: 1003316-11-7, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉N₃O₅.

N-[3-[[4-[(3-Methoxy[1,1’-biphenyl]-4-yl)methyl]-1-piperazinyl]carbonyl]phenyl]-2-naphthalenecarboxamide, CAS: 1560836-30-7, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₃N₃O₃.

N-[4-(1-Naphthalenyl)phenyl][1,1’-biphenyl]-4-amine, CAS: 897921-59-4, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₁N.

N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-phenylbenzoyl]methionine Trifluoroacetate Salt, CAS: 1217471-51-6, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₃O₃S₂ • C ₂HF₃O₂.

N-[[2’-(1H-Tetrazol-5-Yl)[1,1’-Biphenyl]-4-Yl]Methyl]Amine, CAS: 147225-68-1, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₅.

N-[[4-[[[4-[[tert-Butyloxycarbonyl]amino][1,1’-biphenyl]-3-yl]amino]carbonyl]phenyl]methyl]carbamic Acid Methyl Ester, CAS: 1013330-69-2, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₃O₅.

N-[[4-[[[4-[[tert-Butyloxycarbonyl]amino][1,1’-biphenyl]-3-yl]amino]carbonyl]phenyl]methyl]carbamic Acid Methyl Ester-d3, CAS: /, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆D₃N₃O₅.

N1-Losartanyl-losartan (Losartan Impurity), CAS: 230971-71-8, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₄Cl₂N₁₂O.

N2-Losartanyl-losartan (Losartan Impurity), CAS: 230971-72-9, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₄Cl₂N₁₂O.

N2-Trityl ent-Valsartan, CAS: /, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₃N₅O₃.

N2-Trityl Olmesartan Acid, CAS: 752179-89-8, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₀N₆O₃.

N2-Trityl Valsartan Benzyl Ester-d9, CAS: /, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₄₀D₉N₅O₃.

N4,N4’-Bis(2,6-dichlorophenyl)-3,3’-dimethyl-[1,1’-biphenyl]-4,4’-diamine, CAS: /, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀Cl₄N₂.

N4,N4’-Bis(2,6-dichlorophenyl)-[1,1’-biphenyl]-4,4’-diamine, CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₆Cl₄N₂.

Neo-Tetrazolium Diformazan, CAS: 21520-87-6, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₀N₈.

NFPS Hydrochloride, CAS: 200005-59-0, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅ClFNO₃.

NIBR 0213, CAS: 1233332-14-3, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉ClN₂O₃.

Nitrotetrazolium Blue Chloride, CAS: 298-83-9, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₀N₁₀O₆ • 2(Cl).

NMS-873, CAS: 1418013-75-8, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₄O₃S₂.

NMS-873-d9, CAS: /, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₁₉D₉N₄O₃S₂.

Nonabromobiphenyl, CAS: 119264-63-0, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HBr₉.

NSC 37553, CAS: 6954-49-0, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₈N₄O₂.

O-Acetyl Losartan, CAS: 1006062-27-6, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅ClN₆O₂.

O-Desetheyl Candesartan Ethyl Ester, CAS: 1225044-20-1, stock: 1.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀N₆O₃.

O-Desetheyl Candesartan Methyl Ester, CAS: 1203674-06-9, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈N₆O₃.

O-Desethyl Candesartan, CAS: 168434-02-4, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆N₆O₃.

O-Desethyl Candesartan Cilexetil, CAS: 869631-11-8, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀N₆O₆.

O-Desethyl N-Trityl Candesartan Cilexetil, CAS: 1798004-41-7, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₄₄N₆O₆.

o-Dianisidine Dihydrochloride (~90%), CAS: 20325-40-0, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈Cl₂N₂O₂.

O-Methyl Ether Olmesartan Acid, CAS: 1039762-40-7, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₃.

o-Phenylbenzyl Acrylate, CAS: 1373162-82-3, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₂.

o-Phenylphenol Glucuronide, CAS: 31016-74-7, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₇.

o-Phenylphenol-13C6 Glucuronide, CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₆H₁₈O₇.

o-Phenylphenol-d5 Glucuronide, CAS: /, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₅O₇.

O-Terphenyl, CAS: 84-15-1, stock: 2.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄.

Oenothein B, CAS: 104987-36-2, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₄₈O₄₄.

OG-L002, CAS: 1357302-64-7, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO.

OICR-9429, CAS: 1801787-56-3, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂F₃N₅O₃.

Olmesartan Acid, CAS: 144689-24-7, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₆O₃.

Olmesartan Acid 4-Methoxybenzyl Ether, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₄N₆O₄.

Olmesartan Acid 4-Methoxybenzyl Ether 5-Ethyl Ester, CAS: /, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₆O₄.

Olmesartan Acid O-β-D-Glucuronide, CAS: 369395-57-3, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₆O₉.

Olmesartan Acyl-glucuronide, CAS: /, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₆O₉.

Olmesartan Lactone Impurity, CAS: 849206-43-5, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₆O₂.

Olmesartan Medoxomil, CAS: 144689-63-4, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₆O₆.

Olmesartan Medoxomil Methyl Ether, CAS: 896419-17-3, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂N₆O₆.

Olmesartan Medoxomil-d6, CAS: 1127298-67-2, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄D₆N₆O₆.

Olmesartan Methyl Ester, CAS: 1347262-29-6, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₃.

Olmesartan Methyl Ketone, CAS: 1227626-45-0, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₆O₂.

Olmesartan-d4 Acid, CAS: 1420880-41-6, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₄N₆O₃.

Olmesartan-d4 Medoxomil, CAS: 1127298-55-8, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆D₄N₆O₆.

Olmesartan-d6 Acid, CAS: 1185144-74-4, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀D₆N₆O₃.

Oritavancin Phosphate, CAS: 192564-14-0, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₆H₉₇Cl₃N₁₀O₂₆ • 2( H₃O₄P).

p-Biphenylacetonitrile, CAS: 31603-77-7, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁N.

p-Terphenyl, CAS: 92-94-4, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄.

p-Terphenyl-d14, CAS: 1718-51-0, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈D₁₄.

PBB 103, CAS: 59080-39-6, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₅Br₅.

PBB 153, CAS: 59080-40-9, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₄.

PBB 155, CAS: 59261-08-4, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Br₆.

PBB 180, CAS: 67733-52-2, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃Br₇.

PBB 49, CAS: 60044-24-8, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₄.

PBB 52, CAS: 59080-37-4, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₄.

PBB 7, CAS: 53592-10-2, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈Br₂.

PBB 80, CAS: 16400-50-3, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₄.

PBB 9, CAS: 57422-77-2, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈Br₂.

PCB 101-13C12, CAS: 104130-39-4, stock: 2.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₅Cl₅.

PCB 105-13C12, CAS: 208263-62-1, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₅Cl₅.

PCB 138-13C12, CAS: 208263-66-5, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₄Cl₆.

PCB 209-13C12, CAS: 105600-27-9, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂Cl₁₀.

PCB 28-13C12, CAS: 208263-76-7, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₇Cl₃.

PCB 52-13C12, CAS: 208263-80-3, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₆Cl₄.

PCI-27483, CAS: 871266-63-6, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄N₆O₉S.

PD 166793, CAS: 199850-67-4, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈BrNO₄S.

Perfluoro(4,4’-diphenoxybiphenyl), CAS: 14055-56-2, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄O₂F₁₈.

PF 915275, CAS: 857290-04-1, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄N₄O₂S.

PF 9184, CAS: 1221971-47-6, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄Cl₂N₂O₄S.

Phenyl Ether, CAS: 101-84-8, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O.

Phloroglucide, CAS: 491-45-2, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₅.

PHP 501 Trifluoroacetate, CAS: 1236105-75-1, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂F₃N₃O₃.

Pigment Orange 13, CAS: 3520-72-7, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₄Cl₂N₈O₂.

Pigment Orange 34, CAS: 15793-73-4, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈Cl₂N₈O₂.

Pigment Yellow 13, CAS: 5102-83-0, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₄Cl₂N₆O₄.

Pigment Yellow 14, CAS: 5468-75-7, stock: 4.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₀Cl₂N₆O₄.

Pigment Yellow 176, CAS: 90268-24-9, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₅ClN₆O₆.

Pigment Yellow 81, CAS: 22094-93-5, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₂Cl₄N₆O₄.

Pigment Yellow 83, CAS: 5567-15-7, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₂Cl₄N₆O₈.

PK-THPP, CAS: 1332454-07-5, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂N₄O₂.

Potassium 4-Biphenylcarboxylate, CAS: 62698-50-4, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉O₂K.

Punicalagin, CAS: 65995-63-3, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₂₈O₃₀.

QS 11, CAS: 944328-88-5, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₃N₅O₂.

rac-2-(2-methoxyvinyl)-4’-methyl-1,1’-biphenyl, CAS: /, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O.

Rac-Corey Lactone, CAS: 54382-73-9, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₅.

rac-trans-4-Defluoro-4-(4-fluorophenyl) Paroxetine Hydrochloride, CAS: 1217655-87-2, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅ClFNO₃.

rac-trans-4-Defluoro-4-(4-fluorophenyl) Paroxetine-d4 Hydrochloride, CAS: /, stock: 4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁D₄ClFNO₃.

RE 201, CAS: 254740-64-2, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₀N₄O₅S.

RE-021-d9, CAS: /, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁D₉N₄O₅S.

Retigabine 3,3’-Dimer, CAS: 1588430-16-3, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  604.65.

Rimacalib, CAS: 215174-50-8, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃FN₄O₂.

Rimacalib Morpholine D8, CAS: /, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₈FN₄O₂.

RO 28-2653, CAS: 261956-22-3, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃N₅O₅.

Ro 6842262, CAS: 1396006-71-5, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆N₄O₄.

Rockpahos, CAS: 1262046-34-3, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₉OP.

RuPhos Pd G1 Methyl t­-Butyl Ether Adduct, CAS: /, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₃ClNO₂PPd · CH ₃OC₄H₉.

S,S’-([1,1’-Biphenyl]-4,4’-diylbis(methylene)) Dimethanesulfonothioate, CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₄S₄.

S-Phos, CAS: 657408-07-6, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅O₂P.

Sacubitril, CAS: 149709-62-6, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₅.

Sacubitril Calcium, CAS: 1369773-39-6, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈NO⁻₅ 1/2Ca²⁺.

Sacubitril Impurity 3, CAS: 1038925-00-6, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO.

Sacubitril-d4, CAS: /, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₄NO₅.

Sanggenone C, CAS: 80651-76-9, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₆O₁₂.

Sanggenone D, CAS: 81422-93-7, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₆O₁₂.

SB 216641 Hydrochloride, CAS: 193611-67-5, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₄O₄ •HCl.

SB 224289, CAS: 180083-23-2, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃ClN₄O₃.

SB 699551 Dihydrochloride, CAS: 864741-95-7, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₅N₃O  • 2HCl.

SB-224289 Hyrochloride, CAS: 180084-26-8, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂N₄O₃•HCl.

SDZ 285-428, CAS: 174262-13-6, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀ClN₃O.

Sodium 2’-Dicyclohexylphosphino-2,6-dimethoxy-1,1’-biphenyl-3-sulfonate Hydrate, CAS: 1049726-96-6, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆NaO₆PS.

Solabegron, CAS: 252920-94-8, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃ClN₂O₃.

Solabegron Acyl Glucuronide, CAS: 1357466-24-0, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁ClN₂O₉.

Solabegron Acyl Glucuronide-13C6, CAS: /, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃¹³C₆H₃₁ClN₂O₉.

Solabegron Acyl Glucuronide-d4, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇D₄ClN₂O₉.

Solabegron Ethylene D4, CAS: 1250986-04-9, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₄ClN₂O₃.

Solabegron Hydrochloride, CAS: 451470-34-1, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃ClN₂O₃•HCl.

Solabegron-13C6, CAS: /, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³C₆H₂₃ClN₂O₃.

SPhos Pd G3, CAS: 1445085-82-4, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₈NO₅PPdS.

SR 1664, CAS: 1338259-05-4, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉N₃O₅.

SR 1824, CAS: 1338259-06-5, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉BrN₂O₃.

SR 9238, CAS: 1416153-62-2, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃NO₇S₂.

SR-4370, CAS: 1816294-67-3, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈F₂N₂O.

SR9243, CAS: 1613028-81-1, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂BrNO₄S₂.

Tanomastat, CAS: 179545-77-8, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉ClO₃S.

Tasosartan, CAS: 145733-36-4, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁N₇O.

Tasosartan-d4, CAS: /, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₄N₇O.

TC-E 5006, CAS: 1257395-14-4, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉F₄NO₂.

TC-G 1006, CAS: 1324003-64-6, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆F₃N₃O₃.

TCS 1102, CAS: 916141-36-1, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆N₄O₂S.

TCS 2312, CAS: 838823-31-7, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄N₄O₂.

Telmisartan, CAS: 144701-48-4, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀N₄O₂.

Telmisartan Acyl-β-D-glucuronide, CAS: 250780-40-6, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₈N₄O₈.

Telmisartan Amide, CAS: 915124-86-6, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁N₅O.

Telmisartan Dimer Impurity, CAS: 884330-14-7, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₃₈N₄O₄.

Telmisartan Ethyl Ester, CAS: 528560-94-3, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄N₄O₂.

Telmisartan Impurity B, CAS: 1026438-56-1, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈N₄O₂.

Telmisartan Isopropyl Ester, CAS: /, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆N₄O₂.

Telmisartan n-Butyl Ester, CAS: /, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈N₄O₂.

Telmisartan n-Propyl Ester, CAS: /, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆N₄O₂.

Telmisartan tert-Butyl Ester, CAS: 144702-26-1, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈N₄O₂.

Telmisartan-13CD3, CAS: 1261396-33-1, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂¹³CH₂₇D₃N₄O₂.

Telmisartan-d3, CAS: 1189889-44-8, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₇D₃N₄O₂.

Telmisartan-d3 Acyl-β-D-glucuronide, CAS: /, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₅D₃N₄O₈.

Telmisartan-d3 tert-Butyl Ester, CAS: 1794940-54-7, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₅D₃N₄O₂.

Telmisartan-d4, CAS: /, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₆D₄N₄O₂.

Telmisartan-d7, CAS: 1794754-60-1, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₃D₇N₄O₂.

tert-​Butyl (R)​-​(1-​([1,​1’-Biphenyl]​-​4-​yl)​-​3-​oxopropan-​2-​yl)​carbamate, CAS: 149709-58-0, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₃.

tert-Butyl (2’-Chloro-6-((trimethylsilyl)oxy)-1,2,3,4-tetrahydro-[1,1’-biphenyl]-1-yl)carbamate, CAS: /, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀ClNO₃Si.

tert-Butyl (3-(4’-Fluorobiphenyl-4-yl)isoxazol-5-yl)methylcarbamate, CAS: 1065075-48-0, stock: 5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₂O₃F.

tert-Butyl 4-Methyl-2-biphenylcarboxylate, CAS: /, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₂.

tert-Butyl 4’-Methylbiphenyl-2-carboxylate, CAS: 114772-36-0, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₂.

tert-ButylBrettPhos, CAS: 1160861-53-9, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₉O₂P.

TGSH, CAS: 41481-66-7, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₄S.

Thymol Iodide, CAS: 552-22-7, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄I₂O₂.

TNBT Diformazan, CAS: 19333-63-2, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₀N₁₂O₁₀.

TP 003, CAS: 628690-75-5, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₆F₃N₃O.

TPE2TPy, CAS: 1239512-93-6, stock: 6.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₄₆N₆.

trans,trans-4,4’-bis-(4-Propylcyclohexyl)biphenyl, CAS: 85600-56-2, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂.

trans-Bifenthrin, CAS: 83322-02-5, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂ClF₃O₂.

trans-Bifenthrin-d5, CAS: /, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₅ClF₃O₂.

Trityl olMesartan acid, CAS: 761404-85-7, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₀N₆O₃.

Trityl Olmesartan-d6 Medoxomil, CAS: /, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₃₈D₆N₆O₆.

Trityl Valsartan, CAS: 783369-52-8, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₃N₅O₃.

Trityl Valsartan n-Propyl Impurity Benzyl Ester, CAS: /, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₇N₅O₃.

Trityllosartan, CAS: 124751-00-4, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₇ClN₆O.

Trypan Blue (Technical Grade), CAS: 72-57-1, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₄N₆Na₄O₁₄S₄.

TUG 891, CAS: 1374516-07-0, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁FO₃.

TUG-469, CAS: 1236109-67-3, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃NO₂.

UK 370106, CAS: 230961-21-4, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₆N₂O₅.

UK-356618, CAS: 230961-08-7, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₃N₃O₄.

URB 937, CAS: 1357160-72-5, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₄.

URB597, CAS: 546141-08-6, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₃.

URB602, CAS: 565460-15-3, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂.

Urolithin A, CAS: 1143-70-0, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₄.

Urolithin B, CAS: 1139-83-9, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈O₃.

Urolithin B-13C6, CAS: /, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₆H₈O₃.

Valsartan, CAS: 137862-53-4, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₅O₃.

Valsartan Benzyl Ester, CAS: 137863-20-8, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅N₅O₃.

Valsartan Ethyl Ester, CAS: 1111177-30-0, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃N₅O₃.

Valsartan Ethyl-d5 Ester, CAS: /, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈D₅N₅O₃.

Valsartan Isopropyl Ester, CAS: 1245820-09-0, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅N₅O₃.

Valsartan Isopropyl-d7 Ester, CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₇N₅O₃.

Valsartan Methyl Ester, CAS: 137863-17-3, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₅O₃.

Valsartan Methyl Ester-d9, CAS: /, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂D₉N₅O₃.

Valsartan n-Propyl Impurity, CAS: 952652-79-8, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₅O₃.

Valsartan n-Propyl Impurity Benzyl Ester, CAS: 1798904-61-6, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃N₅O₃.

Valsartan-d3, CAS: 1331908-02-1, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆D₃N₅O₃.

Valsartan-d9 (Major), CAS: 1089736-73-1, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀D₉N₅O₃.

Valsartan-d9 Ethyl Ester, CAS: /, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄D₉N₅O₃.

Valsartan-d9 Isoporpyl Ester, CAS: /, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆D₉N₅O₃.

Vapiprost, CAS: 85505-64-2, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₉NO₄.

Vidofludimus, CAS: 717824-30-1, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈FNO₄.

VU 0365114, CAS: 1208222-39-2, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄F₃NO₃.

VUF 11222, CAS: 1414376-84-3, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁BrIN.

WST-5, CAS: 178925-55-8, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₄N₁₂Na₂O₁₆S₆.

WWL 123, CAS: 1338574-83-6, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₂O₃.

WWL113, CAS: 947669-86-5, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆N₂O₄.

WWL123, CAS: 1338575-41-9, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄N₂O₃.

WWL70, CAS: 947669-91-2, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃N₃O₃.

Wye 672, CAS: 1221265-37-7, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇N₂O₂F₃S.

XPHOS, CAS: 564483-18-7, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₉P.

XY 018, CAS: 1873358-87-2, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₅F₇N₂O₄.

ZD 7155 Hydrochloride, CAS: 146709-78-6, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₆O • HCl.

[1,1’-Biphenyl]-2,2’-diyldimethanol, CAS: 3594-90-9, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₂.

[1,1’-Biphenyl]-2’-tetrazolo-4-carboxylic acid, [1,1’-biphenyl]-2’-tetrazolo-4-ylmethyl ester (Losartan Impurity), CAS: 1159977-10-2, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀N₈O₂.

[1,1’-Biphenyl]-3,3’,4,4’-tetracarboxylic Acid, CAS: 22803-05-0, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₈.

[1,1’-Biphenyl]-3-carbonitrile, CAS: 24973-50-0, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉N.

[1,1’-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS)-Hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-5-yl ester, CAS: 41639-72-9, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₈O₅.

[1,1’-Biphenyl]-4-carboxylic Acid (3aR,4R,5R,6aS)-Hexahydro-4-[(3R)-3-hydroxy-5-phenylpentyl]-2-oxo-2H-cyclopenta[b]furan-5-yl Ester, CAS: 145667-74-9, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂O₅.

[1,1’-Biphenyl]-4-carboxylic Acid (3aR,4S,5R,6aS)-4-(tert-Butyldiphenylsilyloxy)methyl)hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl Ester, CAS: 143399-99-9, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈O₅Si.

[1,1’-Biphenyl]-4-ethanimidamide, CAS: 310466-20-7, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂.

[1,1’-Biphenyl]-4-yl(1-trityl-1H-imidazol-5-yl)methanone, CAS: /, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₆N₂O.

[1,1’-Biphenyl]-4-yl(phenyl)(1-trityl-1H-imidazol-5-yl)methanol, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₂N₂O.

[1,​1’-​Biphenyl]​-​4-​yl(phenyl)​methanol, CAS: 7598-80-3, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O.

[2-(Biphenyl-4-yl-dimethyl-silanyl)-phenyl]-methanol, CAS: 1217863-72-3, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂OSi.

[2’-(Amino-κN)[1,1’-biphenyl]-2-yl-κC][[3,6-dimethoxy-2’,4’,6’-tris(1-methylethyl)[1,1’-biphenyl]-2-yl]bis(1,1-dimethylethyl)phosphine-κP](methanesulfonato-κO)palladium (tBuBrettPhos Pd G3), CAS: 1536473-72-9, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₂NO₅PPdS.

[3-(4-Chlorophenyl)phenyl]methylamine Hydrochloride, CAS: 1172338-38-3, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂ClN •HCl.

[3’-(Trifluoromethyl)[1,1’-biphenyl]-2-yl]-methanamine, CAS: 1261888-24-7, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂NF₃.

[4’-(Carbazol-9-yl)-4-biphenylyl]boronic Acid, CAS: 858131-73-4, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈BNO₂.

[4’-[3-Methyl-4-[[[((R)-1-phenylethyl)oxy]carbonyl]amino]isoxazol-5-yl]biphenyl-4-yl]acetic Acid Ethyl Ester, CAS: 1228690-38-7, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈N₂O₅.

((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine, CAS: 1400898-49-8, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

((2S,3R)-4-(Methoxymethoxy)-2,3-dimethyl-2,3-dihydrobenzofuran-3-yl)methanol, CAS: /, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₄.

(+)-β-Hydrastine, CAS: 29617-43-4, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₆.

(+)-Vitisin A, CAS: 142449-89-6, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₄₂O₁₂.

(+/-)-β-Hydrastine, CAS: 60594-55-0, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₆.

(+/-)-β-Hydrastine-d3, CAS: 1346598-42-2, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₃NO₆.

(+/-)-Nor-β-hydrastine, CAS: 66408-36-4, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₆.

(-)-Dehydro Griseofulvin, CAS: 3573-90-8, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅ClO₆.

(-)-Dihydroaflatoxin D2, CAS: 6795-22-8, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

(-)-Dihydroaflatoxin D2-d3, CAS: /, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₃O₄.

(-)-β-Hydrastine, CAS: 118-08-1, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₆.

(1R)-1-(1-Benzofuran-3-yl)ethan-1-ol, CAS: 1059698-12-2, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

(1R)-1-(3-methyl-1-benzofuran-2-yl)ethan-1-ol, CAS: 1344924-47-5, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)-cyclopropanecarboxylic Acid Ethyl Ester, CAS: 452324-74-2, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₂.

(1R,2S)-rel-2-(2,3-Dihydro-4-benzofuranyl)-cyclopropanemethanamine, CAS: 251562-77-3, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

(1S)-1-(3-methyl-1-benzofuran-2-yl)ethan-1-ol, CAS: 1344924-76-0, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

(2,2-dimethyl-2,3-dihydro-1-benzofuran-5-yl)methanamine, CAS: 132570-56-0, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.

(2,3-Dihydro-1-benzofuran-2-ylmethyl)(propyl)amine, CAS: 1094755-26-6, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

(2,3-Dihydro-benzofuran-2-ylmethyl)-methyl-amine hydrochloride, CAS: 19863-69-5, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO • HCl.

(2,3-Dihydrobenzofuran-6-yl)methanol, CAS: 1083168-69-7, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

(2,5-Dichlorophenyl)(2,3-dihydro-1-benzofuran-5-yl)methanamine, CAS: 1020989-37-0, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NOCl₂.

(2-Butyl-5-nitro-3-benzofuranyl)(4-hydroxyphenyl)methanone, CAS: 141645-16-1, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₅.

(2-Butyl-5-nitrobenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone, CAS: 141645-23-0, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀N₂O₅.

(2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone, CAS: 141627-42-1, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₅.

(2-Chlorophenyl)(2,3-dihydro-1-benzofuran-5-yl)methanamine, CAS: 1020929-58-1, stock: 4.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄NOCl.

(2-Methyl-2,3-dihydro-1-benzofuran-5-yl)boronic Acid, CAS: 1028748-11-9, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BO₃.

(2E)-3-(2,3-Dihydrobenzofuran-5-yl)propenoic Acid, CAS: 203505-84-4, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

(2S,3R)-2,3-Dihydro-4-hydroxy-2,3-dimethyl-3-benzofurancarbonitrile, CAS: /, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

(2S,3R)-4-(Acetyloxy)-2,3-dihydro-2,3-dimethyl-3-benzofurancarbonitrile, CAS: /, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₃.

(2S,3R)-4-(Methoxymethoxy)-2,3-dimethyl-2,3-dihydrobenzofuran-3-carbonitrile, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₃.

(2S,3S)-2,3-Bis[(4-methylbenzoyl)oxy]-butanedioic Acid with (1R)-1-(3-Aminopropyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile (Mixture), CAS: 928652-49-7, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₅FN₂O₉.

(2S,3S)-3-(Bromomethyl)-4-(methoxymethoxy)-2,3-dimethyl-2,3-dihydrobenzofuran, CAS: /, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇BrO₃.

(2Z)-2-(2-Chlorobenzylidene)-6-hydroxy-1-benzofuran-3(2H)-one, CAS: 1234351-74-6, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉O₃Cl.

(2Z)-2-[(4-fluorophenyl)methylidene]-6-hydroxy-2,3-dihydro-1-benzofuran-3-one, CAS: 139311-84-5, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉O₃F.

(3aR,4S,7R,7aS)-rel-3a,4,7,7a-Tetrahydro-4-methyl-4,7-epoxyisobenzofuran-1,3-dione, CAS: 941-63-9, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

(3aR,7aS)-rel-Hexahydro-1,3-isobenzofurandione, CAS: 13149-00-3, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃.

(3R,5S)-5-Hydroxymethyl-3-pyrrolidinol Hydrochloride, CAS: 478922-47-3, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.

(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetonitrile Hydrobromide, CAS: 608127-89-5, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉BrN₂O.

(3S)-3-(2-Amino-2-oxo-1,1-diphenylethyl)-1,1-bis[2-(2,3-dihydro-5-benzofuranyl)ethyl]pyrrolidinium Bromide, CAS: 1396968-57-2, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₁BrN₂O₃.

(3S)-N,N-Bis[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide Hydrobromide, CAS: /, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₁BrN₂O₃.

(3S)​-​rel-3-​[(5R)​-​6-​(2,​2-​Dimethyl-​1-​oxopropyl)​-​5,​6,​7,​8-​tetrahydro-​1,​3-​dioxolo[4,​5-​g]​isoquinolin-​5-​yl]​-​6,​7-​dimethoxy-​1(3H)​-​isobenzofuranone, CAS: 104270-85-1, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇NO₇.

(4Z)-Mycophenolate Mofetil (EP Impurity C), CAS: 1076198-64-5, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₇.

(5-Amino-2-butyl-3-benzofuranyl)[4-[3-(dibutylamino)propoxy]phenyl]methanone, CAS: 141644-91-9, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₂O₃.

(5-​Amino-​2-​butyl-​3-​benzofuranyl)​[4-​[3-​(butylamino)​propoxy]​phenyl]​methanone, CAS: 141626-26-8, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₃.

(5-Bromo-1-benzofuran-2-yl)boronic acid, CAS: 331833-99-9, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BBrO₃.

(5-bromo-2,3-dihydro-1-benzofuran-7-yl)methanamine hydrochloride, CAS: 1461704-70-0, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NOBr.HCl.

(5-bromo-7-methyl-1-benzofuran-2-yl)methanamine, CAS: 1343809-80-2, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀NOBr.

(5-chloro-2,3-dihydro-1-benzofuran-7-yl)methanamine hydrochloride, CAS: 1461714-44-2, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NOCl.HCl.

(5-chloro-2,3-dihydro-1-benzofuran-7-yl)methanol, CAS: 1461713-52-9, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉O₂Cl.

(5-Ethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-yl)methanamine Hydrochloride, CAS: 1208724-35-9, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂ • HCl.

(5-fluoro-2,3-dihydro-1-benzofuran-2-yl)methanol, CAS: 135634-27-4, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉O₂F.

(5-Fluoro-2-benzofuranyl)boronic Acid, CAS: 473416-33-0, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BFO₃.

(5-fluoro-3-methyl-1-benzofuran-2-yl)methanamine hydrochloride, CAS: 1315365-09-3, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀NOF.HCl.

(5-Methylthiazol-2-yl)boronic Acid, CAS: 1190875-34-3, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆BNO₂S.

(6-Dimethylsulfamoyl-3-oxo-1,3-dihydro-isobenzofuran-1-yl)-acetic Acid, CAS: 144402-61-9, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₆S.

(6-Hydroxy-1-benzofuran-3-yl)acetic Acid, CAS: 69716-04-7, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester, CAS: 805250-17-3, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

(6-Methoxybenzo[b]furan-2-yl)boronic Acid, CAS: 952737-54-1, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BO₄.

(6-Methyl-benzofuran-3-yl)acetic Acid, CAS: 142917-39-3, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

(7-Methoxybenzofuran-2-yl)boronic Acid, CAS: 1094417-81-8, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BO₄.

(±)-Anastrephin, CAS: 86003-24-9, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

(±)-Evodone, CAS: 30557-66-5, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

(DHQ)2PHAL, CAS: 140924-50-1, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₄N₆O₄.

(Dibenzofuran-2-yl)-2-oxobutanoic Acid, CAS: 885951-79-1, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₄.

(E)-6-(1,3-Dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid, CAS: 38877-93-9, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₆.

(E)-6-(1,3-Dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid-d6, CAS: /, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₆O₆.

(E)-6-[1,3-Dihydro-1-hydroxy-6-methoxy-4-[(2-methoxyethoxy)methoxy]-7-methyl-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoic Acid, CAS: 172608-84-3, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈O₉.

(E)-6-[1,3-Dihydro-6-methoxy-4-[(2-methoxyethoxy)methoxy]-7-methyl-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoic Acid Methyl Ester, CAS: 125198-47-2, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₈.

(E)-7-Hydroxy-5-methoxy-4-methyl-6-(2-(2-methyl-5-oxotetrahydrofuran-2-yl)vinyl)isobenzofuran-1(3H)-one, CAS: /, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₆.

(E)-Hexahydro-(Z)-4,7a-dimethyl-4-vinylbenzofuran-2(3H)-one, CAS: 87248-73-5, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

(furan-2-ylmethyl)[(5-methyl-1-benzofuran-2-yl)methyl]amine, CAS: 1272207-56-3, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

(αR)-Hydroxy-benzenebutanoic Acid tert-Butyl Ester, CAS: 138333-11-6, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₃.

(R)-(-)-TAK-875, CAS: 1234474-57-7, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂O₇S.

(R)-1-phenylethanamine (S)-2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, CAS: 1394138-46-5, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.C₈H₁₁N.

(R)-2-Hydroxy-4-phenylbutyric Acid Ethyl Ester, CAS: 90315-82-5, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

(R)-2-Hydroxy-4-phenylbutyric Acid-d5, CAS: 1286987-57-2, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₅O₃.

(R)-2-Hydroxy-4-phenylbutyric Acid-d5 Ethyl Ester, CAS: 1286413-90-8, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₅O₃.

(R)-5-Bromo-2,3-Dihydro-Benzofuran-3-Ylamine Hydrochloride, CAS: 1414960-64-7, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOBr.HCl.

(R)-Bufuralol Hydrochloride, CAS: 57704-11-7, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO₂.

(R)-Citalopram N-Oxide, CAS: 1217761-31-3, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O₂.

(R)-Citalopram Oxalate, CAS: 219861-53-7, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃FN₂O₅.

(R)-Citalopram-d6 N-Oxide, CAS: 1217669-62-9, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₆FN₂O₂.

(R)-Citalopram-d6 Oxalate, CAS: 1217768-91-6, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₆FN₂O₅.

(R)-Darifenacin Hydrobromide, CAS: 1092800-15-1, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁BrN₂O₂.

(R)-Darifenacin-d4 Hydrobromide, CAS: 1261394-25-5, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₄BrN₂O₂.

(R)-Desmethyl Citalopram Hydrochloride, CAS: /, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClFN₂O.

(R)-Didemethyl Citalopram Hydrochloride, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClFN₂O.

(R)-α-[[(Trifluoromethyl)sulfonyl]oxy]-benzenebutanoic Acid tert-Butyl Ester, CAS: 138276-17-2, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉F₃O₅S.

(R)-MOP, CAS: 145964-33-6, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₅OP.

(R)​-​Darifenacin, CAS: 133099-05-5, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₂.

(R)​-​Darifenacin-d4, CAS: 1261734-81-9, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆D₄N₂O₂.

(S)-(-)-SEGPHOS®, CAS: 210169-54-3, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₂₈O₄P₂.

(S)-(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid Methyl Ester, CAS: 1000414-38-9, stock: 1.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

(S)-2-Hydroxy-4-phenylbutyric Acid, CAS: 115016-95-0, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

(S)-2-Hydroxy-4-phenylbutyric Acid Ethyl Ester, CAS: 125639-64-7, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

(S)-3-(3-(2,3-Dihydrobenzofuran-5-yl)propoxy)-1-tosylpyrrolidine, CAS: /, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₄S.

(S)-4,4,7A-Trimethyl-5,6,7,7A-tetrahydrobenzofuran-2(4H)-one, CAS: 15356-74-8, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₂.

(S)-Bufuralol Hydrochloride, CAS: 57704-10-6, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO₂.

(S)-Citalopram, CAS: 128196-01-0, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O.

(S)-Citalopram Fluorophenylmethanone Oxalate Impurity, CAS: 1217846-85-9, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇F₂NO₆.

(S)-Citalopram N-Oxide, CAS: 917482-45-2, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O₂.

(S)-Citalopram Oxalate, CAS: 219861-08-2, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃FN₂O₅.

(S)-Citalopram-d4 Oxalate, CAS: 219861-08-2, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₄FN₂O₅.

(S)-Citalopram-d6 N-Oxide, CAS: 1217710-65-0, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₆FN₂O₂.

(S)-Citalopram-d6 Oxalate, CAS: 1217733-09-9, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₆FN₂O₅.

(S)-Darifenacin Nitrile, CAS: 252317-48-9, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₂O.

(S)-Darifenacin Nitrile-d4, CAS: /, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄D₄N₂O.

(S)-Desfluoro Citalopram Hydrobromide, CAS: /, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃BrN₂O.

(S)-Desfluoro Citalopram Oxalate, CAS: 1346617-31-9, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₅.

(S)-Desfluoro Citalopram-d6 Oxalate, CAS: 1346617-15-9, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₆N₂O₅.

(S)-Desmethyl Citalopram Ethanedioate, CAS: 852172-06-6, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁FN₂O₅.

(S)-Didemethyl Citalopram Hydrochloride, CAS: /, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClFN₂O.

(S)-Didemethyl Citalopram-d6 Hydrochloride, CAS: /, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁D₆FN₂O•HCl.

(S)-Didemethylamino Citalopram Carboxylic Acid, CAS: 766508-94-5, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄FNO₃.

(S)-N-Desmethyl Citalopram Hydrochloride, CAS: /, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClFN₂O.

(S)-N-Desmethyl Citalopram Hydrochloride-d3, CAS: /, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₃ClFN₂O.

(S)-N-[3(S)-(2-Amino-2-oxo-1,1-diphenylethyl)pyrrolidin-1-yl]methyl-2-[1[2-(2,3-dhydrobenzofuran-5-ylethyl]-3-pyrrolidinyl]-2,2-diphenylacetamide, CAS: /, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₀N₄O₃.

(Z)-Mycophenolic Acid, CAS: 483-60-3, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

1,2,3,4,6,7,8,9-Octachlorodibenzofuran, CAS: 39001-02-0, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂Cl₈O.

1,2,3,4,6,7,8-Heptachlorodibenzofuran, CAS: 67562-39-4, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HCl₇O.

1,2,3,4,7,8,9-Heptachlorodibenzofuran, CAS: 55673-89-7, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HCl₇O.

1,2,3,4,7,8-Hexachlorodibenzofuran, CAS: 70648-26-9, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂Cl₆O.

1,2,3,6,7,8-Hexachlorodibenzofuran, CAS: 57117-44-9, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂Cl₆O.

1,2,3,6-Tetrahydrophthalic Anhydride, CAS: 85-43-8, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

1,2,3,6-Tetrahydrophthalic Anhydride-3,3,4,5,6,6-d6, CAS: 89614-23-3, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂D₆O₃.

1,2,3,7,8,9-Hexachlorodibenzofuran, CAS: 72918-21-9, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂Cl₆O.

1,2,3,7,8-Pentachlorodibenzofuran, CAS: 57117-41-6, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃Cl₅O.

1,2,3-Trichloro-5-(3,4-dichlorophenoxy)benzene, CAS: 94339-59-0, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₅Cl₅O.

1,2,7,8-Tetrachlorodibenzofuran, CAS: 58802-20-3, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Cl₄O.

1,3-Bis(2-((benzyloxy)methyl)phenyl)isobenzofuran, CAS: /, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀O₃.

1,3-Bis(2-methylphenyl)isobenzofuran, CAS: 252873-65-7, stock: 5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O.

1,3-Dihydro-1,3-dioxo-5-isobenzofurancarboxylic Acid, CAS: 26597-44-4, stock: 4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₅.

1,3-Dihydro-1,3-dioxo-5-isobenzofurancarboxylic Acid Phenylmethyl Ester, CAS: 29638-13-9, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₅.

1,3-Dihydro-1-methoxyisobenzofuran, CAS: 67536-29-2, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

1,3-Dihydro-2-benzofuran-4-amine, CAS: 98475-10-6, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO.

1,3-Dihydro-2-benzofuran-5-sulfonamide, CAS: 1189378-81-1, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.

1,3-Dihydro-2-benzofuran-5-sulfonyl Chloride, CAS: 1151512-23-0, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇O₃SCl.

1,3-Diphenylisobenzofuran, CAS: 5471-63-6, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O.

1,​2,​3,​4,​6,​7,​8-​Heptachloro-dibenzofuran-​13C12, CAS: 109719-84-8, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂HCl₇O.

1-(1-Benzofuran-2-yl)-2-bromoethanone, CAS: 23489-36-3, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₂Br.

1-(1-Benzofuran-2-yl)-3-(2-hydroxyphenyl)prop-2-en-1-one, CAS: 107155-10-2, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂O₃.

1-(1-benzofuran-2-yl)-3-(4-methylpiperazin-1-yl)propan-1-one dihydrochloride, CAS: 1427380-31-1, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₂.₂[HCl].

1-(1-Benzofuran-2-yl)-3-(morpholin-4-yl)propan-1-one, CAS: 124617-33-0, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₃.

1-(1-benzofuran-2-yl)cyclopropan-1-amine, CAS: 1266172-97-7, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

1-(1-benzofuran-3-yl)ethan-1-amine, CAS: 1270473-91-0, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO.

1-(2,2-dimethyl-2,3-dihydro-1-benzofuran-5-yl)ethan-1-ol, CAS: 1250690-37-9, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

1-(2,2-dimethyl-2,3-dihydro-1-benzofuran-5-yl)propan-1-amine hydrochloride, CAS: 1311313-92-4, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO.HCl.

1-(2,3-Dihydro-1-benzofuran-2-carbonyl)piperazine, CAS: 1016733-45-1, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂.

1-(2,3-dihydro-1-benzofuran-3-yl)ethan-1-amine, CAS: 1423025-50-6, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

1-(2,3-Dihydro-1-benzofuran-5-yl)-2-methylpropan-1-one, CAS: 111038-58-5, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

1-(2,3-Dihydro-1-benzofuran-5-ylmethyl)piperazine DiHCl, CAS: 1052545-84-2, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O  •2HCl.

1-(2,3-Dihydro-7-benzofuranyl)ethanone, CAS: 170730-06-0, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

1-(2-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)ethyl)-3-(3’,6’-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthen-5-yl)thiourea, CAS: 1402745-37-2, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉N₅O₈S.

1-(3-methyl-1-benzofuran-2-yl)ethan-1-amine, CAS: 147724-88-7, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO.

1-(3-methyl-2,3-dihydro-1-benzofuran-2-yl)ethan-1-amine hydrochloride, CAS: 1376054-09-9, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.HCl.

1-(4-Fluorophenyl)-1,3-dihydro-3-oxo-5-isobenzofurancarbonitrile, CAS: 372941-48-5, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈FNO₂.

1-(4-Fluorophenyl)-1,3-dihydro-3-oxo-5-isobenzofurancarboxamide, CAS: 372941-46-3, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀FNO₃.

1-(4-Fluorophenyl)-1,3-dihydro-3-oxo-5-isobenzofurancarboxylic Acid, CAS: 372941-51-0, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉FO₄.

1-(4-Fluorophenyl)-5-bromophthalan, CAS: 64169-66-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀BrFO.

1-(4-Hydroxyphenyl)-2-(5-nitrobenzofuran-2-yl)pentan-1-one, CAS: /, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₅.

1-(5-acetyl-2-ethyl-1-benzofuran-3-yl)ethan-1-one, CAS: 1423025-29-9, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

1-(5-Benzofuranyl)-piperazine, CAS: 206347-31-1, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O.

1-(5-Bromo-1-benzofuran-2-yl)ethanone, CAS: 38220-75-6, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₂Br.

1-(5-bromo-7-methyl-1-benzofuran-2-yl)-2-methylpropan-1-one, CAS: 1432681-76-9, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃O₂Br.

1-(5-Chloro-1-benzofuran-2-yl)ethan-1-amine Hydrochloride, CAS: 117234-02-3, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀NOCl • HCl.

1-(5-Chloro-2,3-dihydro-1-benzofuran-2-carbonyl)piperidine-3-carboxylic Acid, CAS: 1098369-17-5, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆NO₄Cl.

1-(5-fluoro-1-benzofuran-2-yl)ethan-1-one, CAS: 1267138-82-8, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₂F.

1-(5-Fluoro-3-methyl-1-benzofuran-2-yl)ethan-1-amine Hydrochloride, CAS: 1240526-38-8, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂NOF  •  HCl.

1-(5-Methoxy-2-methyl-1-benzofuran-3-yl)ethanamine Hydrochloride, CAS: 1182284-36-1, stock: 5.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂ • HCl.

1-(5-Methoxy-3-methyl-1-benzofuran-2-yl)ethan-1-amine, CAS: 1152518-91-6, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

1-(6-Benzofuranyl)-2-propanone, CAS: 286836-34-8, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

1-(7-Fluoro-1-benzofuran-2-yl)ethan-1-amine, CAS: 1094485-72-9, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀NOF.

1-(7-Fluoro-1-benzofuran-2-yl)ethan-1-one, CAS: 1094640-56-8, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₂F.

1-(7-methoxy-1-benzofuran-2-yl)ethan-1-amine, CAS: 147724-85-4, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

1-(7-Methoxy-3,5-dimethyl-1-benzofuran-2-yl)ethan-1-amine, CAS: 1094254-09-7, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

1-(7-methoxy-3,5-dimethyl-1-benzofuran-2-yl)ethan-1-amine hydrochloride, CAS: 1354951-24-8, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.HCl.

1-Benzofuran-2-carbonitrile, CAS: 41717-32-2, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NO.

1-Benzofuran-2-sulfonyl Chloride, CAS: 17070-58-5, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₃SCl.

1-benzofuran-2-yl(cyclopropyl)methanamine, CAS: 1270427-41-2, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO.

1-Benzofuran-2-yl(phenyl)methanamine Hydrochloride, CAS: 109194-13-0, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO • HCl.

1-benzofuran-2-yl(pyridin-4-yl)methanamine dihydrochloride, CAS: 1311317-80-2, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O.₂[HCl].

1-benzofuran-3-ylmethanamine hydrochloride, CAS: 1306606-28-9, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.HCl.

1-Benzofuran-5-carbaldehyde, CAS: 10035-16-2, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₂.

1-Benzofuran-5-carboxylic acid, CAS: 90721-27-0, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃.

1-Bromo-2-(2-propen-1-yloxy)-benzene, CAS: 60333-75-7, stock: 4.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO.

1-Bromo-3-chlorobenzene, CAS: 108-37-2, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrCl.

1-Cyclopropane Mycophenolic Acid, CAS: 125198-40-5, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₆.

1-Hydroxy-5-ethylmethanesulfonate Cumaran, CAS: 1346603-15-3, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₅S.

1-Methyl-4-acetyl-2-phytyl-3,5,6-trimethylhydroquinone, CAS: /, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈O₃.

1-Methyl-phthalan, CAS: 38189-85-4, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

1-O-D-Sorbitol Mycophenolate, CAS: /, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂O₁₁.

1-Oxo-1,3-Dihydro-2-benzofuran-4-sulfonyl Chloride, CAS: 1114822-78-4, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₄SCl.

1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl-d4]-α,α-diphenyl-3-pyrrolidineacetonitrile, CAS: 1216586-32-1, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄D₄N₂O.

1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetic Acid, CAS: 1048979-16-3, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉NO₃.

1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarboxamide, CAS: 64372-56-1, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₂O₂.

1-[5-(Benzyloxy)-2-methyl-1-benzofuran-3-yl]ethanone, CAS: 309935-98-6, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₃.

1-{4-[(2,3-Dihydro-1-benzofuran-5-ylmethyl)amino]piperidin-1-yl}ethan-1-one Hydrochloride, CAS: 1221722-13-9, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₂ • HCl.

1’-Benzyl-5-Bromo-3h-Spiro[Isobenzofuran-1,4’-Piperidin]-3-One, CAS: 1399183-27-7, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈NO₂Br.

1’-Hydroxy Bufuralol (Mixture of Diastereomers), CAS: 57704-16-2, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₃.

1’-Hydroxy Bufuralol-d9 (Mixture of Diastereomers), CAS: 1185069-74-2, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₉NO₃.

1’-Oxobufuralol Hydrochloride, CAS: 137740-37-5, stock: 1.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClNO₃.

2(3H)-Benzofuranone, CAS: 553-86-6, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂.

2,2,4,6,7-Pentamethyl-2,3-dihydrobenzofuran-5-sulfonyl Chloride, CAS: 154445-78-0, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇ClO₃S.

2,2-Dimethyl-2,3-dihydro-1-benzofuran-5-sulfonyl Chloride, CAS: 118351-97-6, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃SCl.

2,2-Dimethyl-2,3-dihydro-1-benzofuran-5-thiol, CAS: 1248920-72-0, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂OS.

2,2-Dimethyl-2,3-dihydro-1-benzofuran-6-carboxylic Acid, CAS: 123656-36-0, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-carbaldehyde, CAS: 38002-88-9, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

2,2-Dimethyl-2,3-dihydrobenzofuran-4-carboxylic Acid, CAS: 123656-35-9, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,2’,3,3’,4,4’,5-Heptachloro-6’-methoxy-1,1’-biphenyl, CAS: /, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₅Cl₇O.

2,2’,3,4,4’,5’-Hexachloro-6-methoxy-1,1’-biphenyl, CAS: /, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆Cl₆O.

2,2’-((4-(4’,5’-Bis(1,3,2-dithiarsolan-2-yl)-3’,6’-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthen]-5-ylcarboxamido)-2-(2-morpholino-2-oxoethoxy)phenyl)azanediyl)diacetic Acid, CAS: 1030832-04-2, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₃₇As₂N₃O₁₃S₄.

2,3,4,6,7,8-Hexachlorodibenzofuran, CAS: 60851-34-5, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂Cl₆O.

2,3,4,7,8-Pentachlorodibenzofuran (~90%), CAS: 57117-31-4, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃Cl₅O.

2,3,7,8-Tetrachlorodibenzofuran, CAS: 51207-31-9, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Cl₄O.

2,3,7,8-Tetrachlorodibenzofuran-13C12, CAS: 89059-46-1, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₄Cl₄O.

2,3-Bromo-5-benzofurancarboxylic acid, CAS: 1427504-83-3, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄O₃Br₂.

2,3-Bromo-5-benzofurancarboxylic acid methyl ester, CAS: 1427503-52-3, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₃Br₂.

2,3-Dehydro Darifenacin Hydrobromide, CAS: 943034-52-4, stock: 8.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉BrN₂O₂.

2,3-Dihydro-1-benzofuran-3-ylmethanamine, CAS: 111191-88-9, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

2,3-Dihydro-1-benzofuran-5-sulfonamide, CAS: 112894-47-0, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.

2,3-Dihydro-1-benzofuran-5-sulfonyl Azide, CAS: 1152874-08-2, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₃S.

2,3-Dihydro-1-benzofuran-5-sulfonyl Chloride, CAS: 115010-11-2, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClO₃S.

2,3-Dihydro-1-benzofuran-5-yl(4-methoxyphenyl)methanamine, CAS: 1020982-14-2, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₂.

2,3-Dihydro-1-benzofuran-5-ylmethanol, CAS: 103262-35-7, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

2,3-Dihydro-1-benzofuran-7-boronic acid, CAS: 685514-61-8, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BO₃.

2,3-Dihydro-2,2,4,6,7-pentamethylbenzofuran, CAS: 142874-81-5, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O.

2,3-Dihydro-2,2-dimethyl-7-benzofuranol, CAS: 1563-38-8, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2,3-Dihydro-2,2-dimethylbenzofuran-5-carboxylic Acid, CAS: 123656-34-8, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,3-Dihydro-2,3,4,6,7-pentamethyl-2-(4,8,12-trimethyltridecyl)-5-benzofuranol, CAS: 185672-33-7, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₂.

2,3-Dihydro-2-(iodomethyl)benzofuran, CAS: 59152-49-7, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉IO.

2,3-Dihydro-2-benzofurancarboxylic Acid, CAS: 1914-60-9, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

2,3-Dihydro-4-(2S)-2-oxiranyl-benzofuran, CAS: 252577-77-8, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

2,3-Dihydro-4-benzofuranmethanol, CAS: 209256-41-7, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

2,3-Dihydro-5-benzofuranacetic Acid, CAS: 69999-16-2, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

2,3-Dihydro-5-benzofuranacetic Acid Methyl Ester, CAS: 155852-41-8, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,3-Dihydro-5-benzofuranacetic Acid-d2, CAS: 1216878-16-8, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₂O₃.

2,3-Dihydro-5-benzofuranacetic Acid-d2 Methyl Ester, CAS: 1219153-23-7, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₂O₃.

2,3-Dihydro-5-benzofuranethanol, CAS: 87776-76-9, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2,3-Dihydro-5-benzofuranethanol Methanesulfonate, CAS: 136081-60-2, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄S.

2,3-Dihydro-5-benzofuranethanol-d4, CAS: 1185079-36-0, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄O₂.

2,3-Dihydro-5-benzofuranmethanamine Hydrochloride, CAS: 635309-62-5, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO.

2,3-Dihydro-5-vinylbenzofuran, CAS: 633335-97-4, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O.

2,3-Dihydro-7-benzofuranacetic Acid, CAS: 152149-94-5, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

2,3-Dihydro-Benzofuran-5-Carboxylic Acid Ethyl Ester, CAS: 83751-12-6, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,3-Dihydro-benzofuran-7-ylamine Hydrochloride, CAS: 1414958-92-1, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO.HCl.

2,3-Dihydro-α-methyl-4-benzofuranethanamine Hydrochloride, CAS: 1203342-42-0, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO.

2,3-Dihydro-α-methyl-7-benzofuranethanamine Hydrochloride, CAS: /, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO.

2,3-Dihydrobenzofuran, CAS: 496-16-2, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O.

2,3-Dihydrobenzofuran-4-carbaldehyde, CAS: 209256-42-8, stock: 6.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂.

2,3-Dihydrobenzofuran-4-carboxylic Acid, CAS: 209256-40-6, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

2,3-Dihydrobenzofuran-5-amine, CAS: 42933-43-7, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO.

2,3-Dihydrobenzofuran-5-amine Hydrochloride, CAS: 1093403-66-7, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO •HCl.

2,3-Dihydrobenzofuran-5-boronic acid, CAS: 227305-69-3, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BO₃.

2,3-Dihydrobenzofuran-5-boronic acid pinacol ester, CAS: 937591-69-0, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BO₃.

2,3-Dihydrobenzofuran-5-carboxaldehyde, CAS: 55745-70-5, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂.

2,3-dihydrobenzofuran-6-ylboronic acid, CAS: 763120-44-1, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BO₃.

2,3-Dihydrobenzofuran-7-Amine, CAS: 13414-56-7, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO.

2,3-Dihydrobenzofuran-7-boronic acid, pinacol ester, CAS: 934586-50-2, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BO₃.

2,3-Dihydrobenzofuran-7-carboxylic Acid, CAS: 35700-40-4, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

2,3-Dimethyl-2,3-dihydro-1-benzofuran-7-carboxylic Acid, CAS: 103986-71-6, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2,3-Diphenylbenzofuran, CAS: 13054-95-0, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O.

2,6-Diphenylfuro[2,3-f][1]benzofuran, CAS: 5379-77-1, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄O₂.

2,8-Dichlorodibenzofuran, CAS: 5409-83-6, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₂O.

2,8-Diiododibenzofuran, CAS: 03/11/5943, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆I₂O.

2,​3-Dihydro-​5-​methyl-​7-​(2-​thienyl)​-2-​benzofuranmethanamin​e, CAS: 1309339-57-8, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NOS.

2-(1,3-Dihydro-2-benzofuran-5-sulfonamido)acetic Acid, CAS: 1240527-08-5, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₅S.

2-(1-Benzofuran-2-yl)-1,3-thiazole-4-carboxylic Acid, CAS: 1152604-97-1, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇NO₃S.

2-(1-benzofuran-2-yl)propanoic acid, CAS: 1249571-02-5, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

2-(2,2-dimethyl-2,3-dihydro-1-benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1416157-62-4, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃BO₃.

2-(2,3-Dihydro-1-benzofuran-5-yl)-1,3-thiazole-5-carboxylic Acid, CAS: 1157331-90-2, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃S.

2-(2,3-dihydro-1-benzofuran-5-yl)ethane-1-sulfonamide, CAS: 1484062-10-3, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃S.

2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 445303-12-8, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BO₃.

2-(2,3-Dihydrobenzofuran-7-yl)-1-morpholinoethanethione, CAS: /, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₂S.

2-(2-Chlorophenyl)-cyclohexanone, CAS: 91393-49-6, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃ClO.

2-(2H-1,3-benzodioxole-5-carbonyl)-1-benzofuran-3-amine, CAS: 1260722-59-5, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁NO₄.

2-(3,3-Dimethyl-2,3-dihydro-1-benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1154741-01-1, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃BO₃.

2-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)acetic Acid, CAS: 4743-58-2, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

2-(3-Oxo-2,3-dihydrobenzofuran-5-yl)ethyl methanesulfonate, CAS: /, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅S.

2-(3-Oxoisobenzofuran-1(3H)-ylidene)-2-phenyl-acetic Acid (E/Z Mixture), CAS: 61658-91-1, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀O₄.

2-(3-Oxoisobenzofuran-1(3H)-ylidene)-2-phenyl-d5-acetic Acid (E/Z Mixture), CAS: /, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₅D₅O₄.

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzofuran, CAS: 947770-80-1, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉BO₃.

2-(4-fluorobenzoyl)-1-benzofuran-3-amine, CAS: 128261-84-7, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀NO₂F.

2-(4-methoxy-2,3-dihydro-1-benzofuran-2-yl)acetonitrile, CAS: 1443979-63-2, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

2-(4-Methoxybenzoyl)-1-benzofuran-5-carbaldehyde, CAS: 300664-77-1, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂O₄.

2-(4-Oxo-octahydro-1-benzofuran-2-yl)acetonitrile, CAS: 1423034-97-2, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

2-(5-chloro-2,3-dihydro-1-benzofuran-7-yl)acetic acid, CAS: 1461715-07-0, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₃Cl.

2-(5-chloro-2,3-dihydro-1-benzofuran-7-yl)acetonitrile, CAS: 1461707-00-5, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NOCl.

2-(5-methyl-1-benzofuran-3-yl)acetic acid, CAS: 129354-89-8, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

2-(5-Methyl-2,3-dihydro-1-benzofuran-2-yl)acetic Acid, CAS: 1018251-36-9, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2-(6-Fluoro-1-benzofuran-3-yl)acetic Acid, CAS: 1038224-52-0, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₃F.

2-(6-Hydroxy-2,3-dihydrobenzofuran-3-yl)acetic Acid, CAS: 1000414-37-8, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

2-(6-Methoxy-1-benzofuran-3-yl)acetic Acid, CAS: 69716-05-8, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄.

2-(6-Tetramethylrhodamine)carboxylic Acid N-Hydroxysuccinimide Ester Tetrafluoroborate, CAS: /, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅N₃O₇ • (HBF ₄).

2-(7-Methoxy-1-benzofuran-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 1072811-86-9, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉BO₄.

2-(Benzofuran-2-yl)-2-imidazoline Hydrochloride, CAS: 89196-95-2, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁ClN₂O.

2-(Benzofuran-2-yl)-2-imidazoline-d4 Hydrochloride, CAS: /, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₄ClN₂O.

2-(Benzofuran-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, CAS: 796851-30-4, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇BO₃.

2-(Benzofuran-5-yl)ethanol, CAS: 1000548-28-6, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

2-(Bromomethyl)-5-fluoro-2,3-dihydrobenzofuran, CAS: 37603-11-5, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrFO.

2-(Demethoxy)ethylthio-griseofulvin, CAS: 187884-75-9, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClO₅S.

2-(Hydroxymethyl)benzofuran-5-carbaldehyde, CAS: 1253732-40-9, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

2-(R)-Hydroxy-4-oxo-4-phenylbutyric-d5 Acid (Major), CAS: 1286934-16-4, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₅O₄.

2-(S)-Hydroxy-4-oxo-4-phenylbutyric Acid, CAS: 146912-63-2, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

2-(tert-Butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic Acid, CAS: 851784-82-2, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇Cl₂NO₄.

2-(Tosyloxy)methyl-2,3-dihydrobenzofuran, CAS: 94709-25-8, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₄S.

2-acetyl-5-bromo-4,7-dihydro-1-benzofuran-4,7-dione, CAS: 1389264-29-2, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅O₄Br.

2-Acetyl-6-Bromo-Benzofuran-4,7-Dione, CAS: 1392804-26-0, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅O₄Br.

2-Acetyl-7-(2,3-epoxypropoxy)benzofuran, CAS: 39543-77-6, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₄.

2-Acetyl-7-bromobenzofuran, CAS: 460086-95-7, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇BrO₂.

2-Acetyl-7-ethylbenzofuran, CAS: 59664-03-8, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

2-Acetyl-7-hydroxybenzofuran, CAS: 40020-87-9, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

2-Acetyl-7-methoxybenzofuran, CAS: 43071-52-9, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

2-Acetylbenzofuran, CAS: 1646-26-0, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

2-Amino-5,6-dihydro-7(4H)-benzothiazolone Hydrobromide, CAS: 805250-54-8, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉BrN₂OS.

2-Aminodibenzofuran, CAS: 3693-22-9, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO.

2-Benzofurancarboxaldehyde, CAS: 4265-16-1, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₂.

2-Benzofurancarboxylic acid, 5-(1-piperazinyl)-, ethyl ester, (Hydrochloride), hydrate (1:2:1), CAS: 1422956-31-7, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₃ • 2(HCl)  • H ₂O.

2-Benzofuranethanamine Hydrochloride, CAS: 91949-94-9, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO.

2-Benzofuranylglyoxal Hydrate, CAS: 131922-15-1, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

2-Benzoyldibenzofuran, CAS: 6407-29-0, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₂O₂.

2-Bromo-1-(2,3-dihydro-1-benzofuran-5-yl)ethanone, CAS: 151427-19-9, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrO₂.

2-Bromo-1-benzofuran, CAS: 54008-77-4, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅OBr.

2-Bromo-8-iododibenzofuran, CAS: 916435-41-1, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆BrIO.

2-Bromoacetyl-7-ethylbenzofuran, CAS: 593266-85-4, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁BrO₂.

2-Bromodibenzofuran, CAS: 86-76-0, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇BrO.

2-Bromonaphtho[2,3-b]benzofuran, CAS: 1627917-16-1, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉BrO.

2-Butyl-5-benzofuranamine Hydrochloride, CAS: 526196-90-7, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO.

2-Butyl-5-nitrobenzofuran, CAS: 133238-87-6, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

2-Butyl-5-[methanesulfonamido]benzofuran, CAS: 437652-07-8, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃S.

2-Butylbenzofuran, CAS: 4265-27-4, stock: 2.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O.

2-Chloro-1-(1,3-dihydro-2-benzofuran-5-yl)ethan-1-one, CAS: 1221726-28-8, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₂Cl.

2-chloro-1-[4-(2,3-dihydro-1-benzofuran-5-ylmethyl)piperazin-1-yl]ethan-1-one hydrochloride, CAS: 1334147-69-1, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₂O₂Cl.HCl.

2-Chloro-5-(1-chloro-1,3-dihydro-3-oxo-1-isobenzofuranyl)-benzenesulfonyl Chloride, CAS: 68592-11-0, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇Cl₃O₄S.

2-Chloro-5-(1-isopropoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)benzenesulfonamide, CAS: /, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClNO₅S.

2-Chloro-5-methyl-1,4-benzoquinone, CAS: 19832-87-2, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅O₂Cl.

2-Chloro-N-(2,3-dihydro-1-benzofuran-2-ylmethyl)acetamide, CAS: 1182992-49-9, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂NO₂Cl.

2-cyclopropanecarbonyl-1-benzofuran, CAS: 1311316-29-6, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₂.

2-Ethyl-1-benzofuran-3-carbaldehyde, CAS: 10035-41-3, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

2-Ethyl-2,3-dihydro-5-acetylbenzofuran, CAS: 58741-14-3, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

2-Ethyl-2,3-dihydro-5-acetylbenzofuran-d3, CAS: /, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₃O₂.

2-Ethyl-3-methyl-1-benzofuran-5-amine, CAS: 1033693-15-0, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO.

2-Ethylbenzofuran, CAS: 3131-63-3, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O.

2-Ethylbenzothiazole, CAS: 936-77-6, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NS.

2-Ethylcoumaran-d3, CAS: /, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₃O.

2-Fluoro-5-bromopyridine, CAS: 766-11-0, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrFN.

2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile, CAS: 763114-25-6, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈FNO₂.

2-Hydroxy-4-phenylbutyric Acid Ethyl Ester-d5, CAS: 1189892-05-4, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₅O₃.

2-Hydroxy-5-methoxybenzeneethanol, CAS: 2503-23-3, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

2-Hydroxy-5-methoxybenzimidazole, CAS: 2080-75-3, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₂.

2-Hydroxymethyl-2,3-dihydrobenzofuran, CAS: 66158-96-1, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

2-MAPB Hydrochloride, CAS: 100389-74-0, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO.

2-MAPB Hydrochloride (1.0 mg/mL in Methanol), CAS: 100389-74-0, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO.

2-Methyl-1-(3-methyl-1-benzofuran-2-yl)propan-1-amine, CAS: 1092304-31-8, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO.

2-Methyl-1-benzofuran-5-carboxylic Acid, CAS: 219763-06-1, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

2-Methyl-1-benzofuran-7-amine, CAS: 26325-21-3, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.HCl.

2-Methyl-2,3-dihydro-1-benzofuran-5-carboxylic Acid, CAS: 103204-80-4, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

2-methyl-2,3-dihydro-1-benzofuran-5-sulfonamide, CAS: 1343576-63-5, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃S.

2-Methyl-4-oxo-4,5,6,7-tetrahydrobenzofuran-3-carboxylic Acid, CAS: 103204-90-6, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

2-Methyl-5-benzofuranamine, CAS: 26210-75-3, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.

2-Methylbenzofuran, CAS: 4265-25-2, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O.

2-Methylcoumaran, CAS: 1746-11-8, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

2-Nitrodibenzofuran, CAS: 20927-95-1, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇NO₃.

2-Oxodarifenacin, CAS: 133034-08-9, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₂O₃•HCl.

2-Propenyl Ester N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-L-ornithine Monohydrochloride, CAS: 257288-23-6, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅ClN₄O₅S.

2-[(3,4-Dihydroxyphenyl)methyl]-6,7-dihydroxy-3(2H)-benzofuranone, CAS: 473467-28-6, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

2-[(5-Fluoresceinyl)aminocarbonyl]ethyl Mercaptan, CAS: 887355-27-3, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇NO₆S.

2-[(5-Fluoresceinyl)aminocarbonyl]ethyl Methanethiosulfonate, CAS: 351330-42-2, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉NO₈S₂.

2-[5-Amino-3-(1-benzofuran-2-yl)-1H-pyrazol-1-yl]ethan-1-ol, CAS: 1152926-12-9, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₂.

2-{[4-amino-5-(5-methyl-1-benzofuran-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid, CAS: 1304271-30-4, stock: 5.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₄O₃S.

2’,3’,4,4’,5,5’,6-Heptachloro-[1,1’-biphenyl]-2-ol, CAS: /, stock: 4.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃Cl₇O.

2’,3’-Dihydro-7-methoxy-spiro[isobenzofuran-1(3H),1’-[1H]phenalen]-3-one, CAS: 1391052-83-7, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₃.

2’,4,4’,5,5’,6-Hexachloro-[1,1’-biphenyl]-2-ol, CAS: 159420-85-6, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Cl₆O.

2’,7’-Dichlorofluorescein diacetate, CAS: 2044-85-1, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₄Cl₂O₇.

2’,7’-Difluorofluorescein, CAS: 195136-58-4, stock: 6.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀F₂O₅.

2’-Deoxy-5-[3-[[[(3’,6’-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5-yl)amino]thioxomethyl]amino]-1-propynyl]uridine 5’-(Tetrahydrogen Triphosphate) Triethylamine Salt, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉N₄O₁₉P₃S•xC₆H₁₅N.

3,3-Bis(2-methyl-1-octyl-1H-indol-3-yl)isobenzofuran-1(3H)-one, CAS: 50292-95-0, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₂N₂O₂.

3,3-Dimethyl-2,3-dihydro-1-benzofuran-6-amine, CAS: 1135492-28-2, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

3,3-dimethyl-2,3-dihydro-1-benzofuran-7-carboxylic acid, CAS: 133609-87-7, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

3,3-Dimethyl-3H-spiro[isobenzofuran-1,4’-piperidine] Hydrochloride, CAS: 1172717-60-0, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClNO.

3,3-Dimethylspiro[isobenzofuran-1(3H),4’-piperidine], CAS: 180160-92-3, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO.

3,3’,4,4’-TetraCDE, CAS: 56348-72-2, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₄O.

3,4,5,6-Tetrahydrophthalic Anhydride, CAS: 2426-02-0, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

3,5-Dibromobenzofuran, CAS: 99660-97-6, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄Br₂O.

3,5-Dihydroxynapthalene-2-carboxylic Acid, CAS: 89-35-0, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈O₄.

3,5-Dimethyl-1-benzofuran-2-carboxylic Acid, CAS: 16817-32-6, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

3,6,6-Trimethyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-2-carboxylic Acid, CAS: 121625-80-7, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

3,6-Cyclopropylene-Δ4-tetrahydrophthalic Anhydride, CAS: 944-41-2, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

3,6-Dichlorophthalic Anhydride, CAS: 4466-59-5, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂Cl₂O₃.

3,6-Dimethyl-1-benzofuran-2-carboxylic Acid, CAS: 16820-37-4, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

3-(1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-1-yl)-N,N-dimethylpropan-1-amine Hydrobromide, CAS: 1332724-07-8, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃BrFNO.

3-(1-benzofuran-2-yl)-1,2,4-oxadiazole-5-thiol, CAS: 1343081-94-6, stock: 8.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂O₂S.

3-(1-Benzofuran-2-yl)-1-methyl-1H-pyrazole-4-carbaldehyde, CAS: 1152510-74-1, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₂.

3-(1-benzofuran-2-yl)-1H-pyrazol-5-amine, CAS: 1107061-06-2, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₃O.

3-(1-Benzofuran-2-yl)-1H-pyrazole-4-carbaldehyde, CAS: 1152541-71-3, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₂.

3-(1-Benzofuran-2-yl)-1H-pyrazole-4-carboxylic Acid, CAS: 1152543-40-2, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₃.

3-(1-Benzofuran-2-yl)-2-oxopropanoic Acid, CAS: 1156724-77-4, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈O₄.

3-(1-Benzofuran-3-yl)-1-methyl-1H-pyrazole-4-carboxylic Acid, CAS: 1197677-99-8, stock: 4.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₃.

3-(1-Nitroethyl)-2-benzofuran-1(3H)-one, CAS: 79017-08-6, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀ H₉ N O ₄.

3-(1H-Pyrazol-1-ylmethyl)-1-benzofuran-2-carboxylic Acid, CAS: 1152519-08-8, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₃.

3-(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)piperazin-2-one, CAS: 1373221-30-7, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₂.

3-(2,3-Dihydro-1-benzofuran-5-carbonyl)pyridine, CAS: 1094347-90-6, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₂.

3-(2,3-Dihydro-1-benzofuran-5-yl)-1,2-oxazole-5-carboxylic Acid, CAS: 1157546-45-6, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₄.

3-(2,3-Dihydro-1-benzofuran-5-yl)-1-[3-(hydroxymethyl)piperidin-1-yl]prop-2-en-1-one, CAS: 1158108-07-6, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

3-(2,3-Dihydro-1-benzofuran-5-yl)propanal, CAS: 1057670-88-8, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

3-(2,3-dihydro-1-benzofuran-5-yl)propanenitrile, CAS: 135634-51-4, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

3-(2,3-Dihydro-4-benzofuranyl)-2-propenoic Acid Ethyl Ester, CAS: 1431375-76-6, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₂.

3-(2,3-Dihydrobenzofuran-5-yl)propanoic Acid, CAS: 215057-28-6, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

3-(2-Chlorophenoxymethyl)-1-benzofuran-2-carboxylic Acid, CAS: 1039891-11-6, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁O₄Cl.

3-(3,3-dimethyl-2,3-dihydro-1-benzofuran-6-yl)propanal, CAS: 1440962-00-4, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₂.

3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide, CAS: 765317-72-4, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉Br₂N₃O₇S₃.

3-(4-(2-Butyl-5-methylsulfonamido)benzofuran-3-carbonyl)phenoxy)propyl Methanesulfonate, CAS: 1310430-09-1, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₈S₂.

3-(4-(Diethylamino)-2-methylphenyl)-3-(1,2-dimethyl-1H-indol-3-yl)isobenzofuran-1(3H)-one, CAS: 36499-49-7, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₂O₂.

3-(4-Methoxybenzyl)phthalide, CAS: 66374-23-0, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

3-(5-Bromo-1-methyl-1H-indol-3-yl)-4-(benzofuran-3-yl)pyrrole-2,5-dione, CAS: 941575-71-9, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃BrN₂O₃.

3-(5-Chloro-1-benzofuran-2-yl)-1H-pyrazole, CAS: 852690-99-4, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇N₂OCl.

3-(6,7-Dibromo-2,3-dihydrobenzofuran-5-yl)propanoic Acid, CAS: 196597-76-9, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀Br₂O₃.

3-(7-methoxy-1-benzofuran-2-yl)prop-2-enoic acid, CAS: 1326716-04-4, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₄.

3-(Aminomethyl)-1,3-dihydro-2,1-benzoxaborol-1-ol, CAS: 1093644-03-1, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀BNO₂.

3-(Hydroxymethyl)-4-nitro-benzonitrile, CAS: 90178-81-7, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₃.

3-(Hydroxymethyl)-4-nitroaniline, CAS: 77376-03-5, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

3-(methanesulfinylmethyl)-1-benzofuran-2-carboxylic acid, CAS: 1250163-72-4, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄S.

3-(Methanesulfonylmethyl)-1-benzofuran-2-carboxylic Acid, CAS: 1178181-16-2, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₅S.

3-(Methoxymethylene)-2(3H)-benzofuranone, CAS: 40800-90-6, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

3-(tert-Butyl-d9)-5-[7-(bromoethyl)-2-benzofuranyl]-2-oxazolidinone(Mixture of Diastereomers), CAS: 1185084-36-9, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁D₉BrNO₃.

3-(tert-Butyl-d9)-5-[7-(hydroxyethyl)-2-benzofuranyl]-2-oxazolidinone (Mixture of Diastereomers), CAS: 1189998-94-4, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₉NO₄.

3-Amino-2-benzoyl-6-nitrobenzofuran, CAS: 351003-27-5, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀N₂O₄.

3-Amino-2-methoxydibenzofuran, CAS: 5834-17-3, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

3-Amino-4-chloro-benzofuran-2-carboxylic Acid Methyl Ester, CAS: 1139838-91-7, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NO₃Cl.

3-amino-6-bromo-1-benzofuran-2-carbonitrile, CAS: 1379301-60-6, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅N₂OBr.

3-Aminobenzofuran-2-carboxamide, CAS: 54802-10-7, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂.

3-Aminomethylphthalide, Hydrochloride, CAS: 35690-69-8, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClNO₂.

3-Bromo-1-benzofuran, CAS: 59214-70-9, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO.

3-bromo-1-benzofuran-2-sulfonyl chloride, CAS: 128852-14-2, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₃SClBr.

3-Bromo-2-chloropyridine, CAS: 52200-48-3, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrClN.

3-Butylidene Phthalide(Cis Trans mixture), CAS: 551-08-6, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

3-Butylidene Phthalide-d8, CAS: 1795142-65-2, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₈O₂.

3-Butylphthalide, CAS: 6066-49-5, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

3-Butylphthalide-d3, CAS: /, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₃O₂.

3-Butylphthalide-D9, CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₅D₉O₂.

3-Ethoxymethacrolein, CAS: 42588-57-8, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₂.

3-Fluorophthalic Anhydride, CAS: 652-39-1, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃FO₃.

3-Hydroxy Carbofuran, CAS: 16655-82-6, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.

3-Hydroxy Carbofuran-d3, CAS: 1794759-59-3, stock: 6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₃NO₄.

3-Hydroxy Citalopram, CAS: 411221-53-9, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O₂.

3-Hydroxy Citalopram Oxalate, CAS: 1332724-03-4, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃FN₂O₆.

3-Hydroxy Darifenacin(Mixture of Diastereomers), CAS: 1285875-62-8, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₃.

3-Hydroxy-6-methoxyflavone, CAS: 93176-00-2, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₄.

3-Hydroxymethyl-6-Iodobenzofuran, CAS: 1255099-73-0, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₂I.

3-Hydroxyphthalic Anhydride, CAS: 37418-88-5, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₄.

3-Ketocarbofuran, CAS: 16709-30-1, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₄.

3-MAPB, CAS: /, stock: 5.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

3-MAPB Hydrochloride, CAS: /, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO(HCl).

3-Methoxy-1-benzofuran-2-carboxylic Acid, CAS: 104315-56-2, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

3-Methoxy-3-methylisobenzofuran-1(3H)-one, CAS: 1077-59-4, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

3-Methoxyisobenzofuran-1(3H)-one, CAS: 4122-57-0, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

3-Methyl-1-benzofuran-2-carbaldehyde, CAS: 1199-07-1, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

3-Methyl-1-benzofuran-2-sulfonyl Chloride, CAS: 1211512-14-9, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₃SCl.

3-methyl-2,3-dihydro-1-benzofuran-7-carboxylic acid, CAS: 133609-86-6, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

3-Methyl-3-(1-naphthyl)phthalide, CAS: 107796-84-9, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₂.

3-Methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-2-carboxylic Acid, CAS: 112579-43-8, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

3-Methylbenzofuran, CAS: 21535-97-7, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O.

3-Methylbenzofuran-2-carboxylic Acid, CAS: 24673-56-1, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

3-Methylbenzofuran-2-carboxylic Acid Methyl Ester, CAS: 2076-36-0, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

3-Methylbenzofuran-2-methanol, CAS: 55581-62-9, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

3-Methylhexahydrophthalic Anhydride, CAS: 57110-29-9, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

3-Nitromethylphthalide, CAS: 3598-68-3, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₄.

3-Nitrophthalic Anhydride, CAS: 641-70-3, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃NO₅.

3-Oxo Citalopram Hydrochloride, CAS: /, stock: 2.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉FN₂O₂ •HCl.

3-Phenylprop-2-en-1-ol, CAS: 4407-36-7, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

3-tert-Butyl-5-[7-(hydroxyethyl)-2-benzofuranyl]-2-oxazolidinone(Mixture of Diastereomers), CAS: 1076199-70-6, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄.

3-[(Dimethylamino)methyl]-1-benzofuran-2-carboxylic Acid Hydrochloride, CAS: 1163245-85-9, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃ • HCl.

3-[(Methylamino)methyl]phenol, CAS: 123926-62-5, stock: 1.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

3-[(Pyrimidin-2-ylsulfanyl)methyl]-1-benzofuran-2-carboxylic Acid, CAS: 1039812-24-2, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O₃S.

3-[(Thiophen-2-ylsulfanyl)methyl]-1-benzofuran-2-carboxylic Acid, CAS: 1039891-26-3, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₃S₂.

3-[5-(1-Benzofuran-2-yl)-1,3,4-oxadiazol-2-yl]propanoic Acid, CAS: 1179074-45-3, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₄.

3-{[(1-Methyl-1H-imidazol-2-yl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1039820-41-1, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₃S.

3-{[(2-Chlorophenyl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1039967-31-1, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁O₃SCl.

3-{[(2-Fluorophenyl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1040042-28-1, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁O₃FS.

3-{[(4-Fluorophenyl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1040084-06-7, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁O₃FS.

3-{[(4-Hydroxypyrimidin-2-yl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1039922-41-2, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O₄S.

3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-1-benzofuran-2-carboxylic Acid, CAS: 1050043-22-5, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₃S₂.

3’,3’’,5’,5’’-Tetraiodophenolphthalein, CAS: 386-17-4, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀I₄O₄.

3’,6’-Bis(2,2-dimethyl-1-oxopropoxy)-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthene]-6-carboxylic Acid, CAS: 192374-17-7, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₈O₉.

3’-hydroxy-3-oxo-6’-[[(trifluoromethyl)sulfonyl]oxy]-Spiro[isobenzofuran-1(3H),9’-[9H]xanthene]-6-carboxylic acid, CAS: 1268491-68-4, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₁O₉F₃S.

3’-O-Methylfluorescein, CAS: 70672-05-8, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄O₅.

4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one, CAS: 17092-92-1, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₂.

4,4’,6-Trimethoxy-6’-methyl-3’-grisen-2’,3-dione, CAS: 56783-97-2, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₆.

4,5,6,7-Tetrabromophenolphthalein, CAS: 13027-28-6, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀Br₄O₄.

4,5,6,7-tetrahydro-2-benzofuran-1-carboxylic acid, CAS: 1378818-17-7, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

4,5,6,7-Tetrahydrobenzofuran-6-Carboxylic Acid, CAS: 1481114-96-8, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

4,5-Dichlorophthalic Anhydride, CAS: 942-06-3, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂Cl₂O₃.

4,6-Bis(diphenylphosphino)dibenzofuran, CAS: 133850-81-4, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₂₆OP₂.

4,6-Dibromodibenzofuran, CAS: 201138-91-2, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₂O.

4,6-difluoro-2,3-dihydro-1-benzofuran-3-amine hydrochloride, CAS: 1461713-34-7, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NOF₂.HCl.

4,6-Dihydroxy-2-[(3-hydroxy-4-methoxyphenyl)methylene]-3(2H)-benzofuranone-d3, CAS: /, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉D₃O₆.

4,6-Dihydroxy-3(2H)-benzofuranone, CAS: 3260-49-9, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₄.

4,6-Dimethoxy-2’-methyl-3,4’,6’-grisantrione, CAS: 2855-92-7, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₆.

4,7-Difluoro-1,3-isobenzofurandione (Technical Grade, ~90%), CAS: 652-40-4, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂F₂O₃.

4-((1,3-Dioxo-1,3-dihydroisobenzofuran-5-yl)oxy)isobenzofuran-1,3-dione, CAS: 50662-95-8, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₆O₇.

4-(2,3-Dihydro-1-benzofuran-5-yl)-5-methyl-1,3-thiazol-2-amine, CAS: 1094394-71-4, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂OS.

4-(3,3’-dioxo-3H,3’H-spiro[furan-2,1’-isobenzofuran]-4-yl)benzonitrile, CAS: /, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₉NO₄.

4-(3-Formylphenoxy)benzonitrile, CAS: 90178-72-6, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₂.

4-(4-Bromophenyl)dibenzofuran, CAS: 955959-84-9, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁BrO.

4-(5-allyl-3-methyl-2,3-dihydrobenzofuran-2-yl)-2-Methoxyphenol, CAS: /, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₃.

4-(Chloromethyl)-phenol, CAS: 35421-08-0, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClO.

4-(Chloromethyl)meconin, CAS: 6518-91-8, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁ClO₄.

4-amino-5-(5-methyl-1-benzofuran-2-yl)-4H-1,2,4-triazole-3-thiol, CAS: 1270869-72-1, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₄OS.

4-Amino-5-chloro-2,3-dihydro-7-benzofurancarboxylic Acid, CAS: 123654-26-2, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈ClNO₃.

4-Aminoisobenzofuran-1,3-dione, CAS: 17395-99-2, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NO₃.

4-Aminophthalide, CAS: 59434-19-4, stock: 1.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₂.

4-​Bromo-​7-​fluoro-​2,​3-​dihydroinden-​1-​one, CAS: 1003048-72-3, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrFO.

4-Benzofurancarboxylic Acid, CAS: 166599-84-4, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃.

4-Bromo-1,3-dihydro-2-benzofuran, CAS: 1402667-16-6, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrO.

4-Bromo-1-benzofuran-2-carboxylic acid, CAS: 1369143-28-1, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrO₃.

4-Bromo-2,3-dihydrobenzofuran, CAS: 774220-36-9, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrO.

4-Bromo-2-benzofuran-1[3H]-one, CAS: 102308-43-0, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO₂.

4-Bromo-7-fluorobenzofuran, CAS: 1194376-46-9, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄OFBr.

4-Bromobenzofuran, CAS: 128868-60-0, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO.

4-Bromobenzofuran-3(2H)-one, CAS: 1020966-78-2, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂Br.

4-Bromodibenzofuran, CAS: 89827-45-2, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇OBr.

4-chloro-1-benzofuran-7-amine, CAS: 1260869-40-6, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆NOCl.

4-Chloro-2,3-dihydrobenzofuran-3-amine Hydrochloride, CAS: 1384265-47-7, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOCl.HCl.

4-Chloro-3-cyano-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline, CAS: 492444-39-0, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₄O₂.

4-chloro-7-methyl-1-benzofuran-3-carboxylic acid, CAS: 1483815-00-4, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₃Cl.

4-Cyclopropylmethyl-O-(3,4,5-triacetoxy-6-(methoxycarbonyl))glucuronide Mycophenolic Acid, CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₀O₁₅.

4-Cyclopropylmethyl-O-glucuronide Mycophenolic Acid, CAS: /, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₁₂.

4-Cyclopropylmethyl-O-methyl Mycophenolic Acid, CAS: /, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₆.

4-Desacetyl-2-debenzoyl-[2,4]-oxol Paclitaxel, CAS: 159500-49-9, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₇NO₁₃.

4-Fluoro-2,3-dihydrobenzofuran-3-amine Hydrochloride, CAS: 1384265-54-6, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOF.HCl.

4-Fluoro-2-methylaniline, CAS: 452-71-1, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈FN.

4-fluorobenzofuran-2-ylboronic acid, CAS: 1423791-86-9, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BO₃F.

4-Fluorobenzofuran-7-carbaldehyde, CAS: 555155-07-2, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅FO₂.

4-Fluorobenzofuran-7-yl-7-boronic Acid, CAS: 1204580-77-7, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BFO₃.

4-Hydroxy-1-benzofuran-2-carboxylic acid, CAS: 113511-42-5, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₄.

4-Hydroxy-1-benzofuran-3-carboxylic Acid, CAS: 112678-09-8, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₄.

4-Hydroxy-1-benzofuran-6-carbaldehyde, CAS: 1021916-93-7, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃.

4-Methoxy-3-methylbenzenesulfonyl Chloride, CAS: 84910-98-5, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉O₃SCl.

4-Methyl-7-(propan-2-yl)-2,3-dihydro-1-benzofuran-3-one, CAS: 100121-58-2, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

4-Nitrophthalic Anhydride, CAS: 5466-84-2, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃NO₅.

4-O-Demethyl Griseofulvin, CAS: 5128-41-6, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClO₆.

4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic Acid, CAS: 56671-28-4, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

4-Oxo-4,5,6,7-tetrahydrobenzofuran-2-carboxylic Acid, CAS: 108249-48-5, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

4-tert-Butylphthalic Anhydride, CAS: 32703-79-0, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₃.

4-Vinyl-2,3-dihydrobenzofuran, CAS: 230642-84-9, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O.

4-[(2,2-Dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]piperidine Hydrochloride, CAS: 1181458-55-8, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂ • HCl.

4-[(5-Chloro-2,3-dihydro-2,2-dimethyl-7-benzofuranyl)methoxy]-2,3-dimethylbenzenepropanoic Acid, CAS: 1234844-11-1, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅ClO₄.

4-[2-(Aminocarbonyl)-5-benzofuranyl]-1-piperazinecarboxylic Acid tert-Butyl Ester, CAS: 183288-44-0, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₄.

4-[2-di-[2-(2,3-Dihydrobenzofuran-4-yl)ethyl]aminoethyl)-3,3-diphenylpyrolidine-2-one, CAS: 1797983-04-0, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₀N₂O₃.

4’,5’-Bis(1,3,2-dithiarsolan-2-yl)-2’,7’-difluoro-3’,6’-dihydroxyspiro[isobenzofuran-1(3H),9’-[9H]xanthen]-3-one, CAS: 912934-89-5, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₆As₂F₂O₅S₄.

4’,5’-Bis(1,3,2-dithiarsolan-2-yl)-3’,6’-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthene]-5-carboxylic Acid, CAS: 439791-28-3, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈As₂O₇S₄.

4’,5’-Bis(1,3,2-dithiarsolan-2-yl)-3’,6’-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthene]-6-carboxylic Acid, CAS: 1042084-20-7, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈As₂O₇S₄.

4’,5’-Dibromofluorescein, CAS: 596-03-2, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀Br₂O₅.

4’-Desmethyl-6’-tosylmycophenolic Acid, CAS: 171808-03-0, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₈S.

4’-O-Demethyl Griseofulvin, CAS: 1158186-19-6, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClO₆.

4’-tert-Butyldimethylsilylmycophenolic Acid, CAS: 1076199-63-7, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₆S.

4’-Tosyl Mycophenolic Acid-d3, CAS: 1185242-13-0, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₃O₈S.

5(6)-Carboxy-2’,7’-dichlorofluorescein, CAS: 111843-78-8, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₀Cl₂O₇.

5(6)-Carboxy-2’,7’-dichlorofluorescein 3’,6’-Diacetate, CAS: 127770-45-0, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₄Cl₂O₉.

5(6)-Carboxy-2’,7’-Dichlorofluorescein Diacetate Succinimidyl Ester, CAS: 147265-60-9, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₇Cl₂NO₁₁.

5(6)-Carboxy-X-rhodamine N-succinimidyl ester, CAS: 114616-32-9, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₃N₃O₇.

5(6)-Carboxyfluorescein, CAS: 72088-94-9, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₂O₇.

5(6)-Carboxyfluorescein 3’,6’-Diacetate N-Succinimidyl Ester, CAS: 150347-59-4, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₉NO₁₁.

5(6)-Carboxyfluorescein Diacetate, CAS: 124387-19-5, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₆O₉.

5(6)-Carboxyfluorescein Diisobutyrate, CAS: 287111-44-8, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄O₉.

5(6)-Carboxyfluorescein N-hydroxysuccinimide ester, CAS: 117548-22-8, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅NO₉.

5(6)-Carboxynaphthofluorescein, CAS: 128724-35-6, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₆O₇.

5,5’-Oxybis(isobenzofuran-1,3-dione), CAS: 1823-59-2, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₆O₇.

5,6-Dihydrobenzofuran-7(4H)-one, CAS: 108153-93-1, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

5,6-dimethyl-1-benzofuran-2-carbaldehyde, CAS: 1384427-32-0, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

5,6-dimethyl-1-benzofuran-3-carboxylic acid, CAS: 1334305-03-1, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

5,6-dimethyl-2,3-dihydro-1-benzofuran-2-carboxylic acid, CAS: 1354950-79-0, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

5,7-Di-tert-butyl-3-(3,4-dimethylphenyl)benzofuran-2(3H)-one, CAS: 164391-52-0, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₂.

5,7-Dibromo-2,3-dihydrobenzofuran, CAS: 123266-59-1, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆Br₂O.

5,7-dichloro-1-benzofuran-3-carboxylic acid, CAS: 1487607-63-5, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄O₃Cl₂.

5,7-Dihydroxy-4-methylphthalide, CAS: 27979-57-3, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

5,8-Epoxy-13-cis Retinoic Acid(Mixture of Diastereomers), CAS: 112018-12-9, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

5,8-Monoepoxyretinoic Acid, CAS: /, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

5-(1,1-Dimethylethyl)-3,3-dimethyl-6-nitro-2(3H)-benzofuranone, CAS: 1246213-39-7, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₄.

5-(1-Benzofuran-2-yl)-1,3,4-oxadiazole-2-thiol, CAS: 112521-75-2, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂O₂S.

5-(1-Benzofuran-2-yl)-2H-1,2,3,4-tetrazole, CAS: 1240526-31-1, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆N₄O.

5-(1-Benzofuran-2-yl)-4H-1,2,4-triazol-3-amine, CAS: 1016701-37-3, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₄O.

5-(1-Piperazinyl)-2-benzofurancarboxylic Acid Ethyl Ester, CAS: 163521-20-8, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₃.

5-(1-Piperazinyl)-2-benzofurancarboxylic Acid Ethyl Ester Hydrochloride, CAS: 765935-67-9, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉ClN₂O₃.

5-(1-Piperazinyl)-2-benzofurancarboxylic Acid Ethyl Ester-d4 Hydrochloride, CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₄ClN₂O₃.

5-(1-Piperazinyl)-2-benzofurancarboxylic Acid Methyl Ester, CAS: 1186225-86-4, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₃.

5-(1-Piperazinyl)benzofuran-2-carboxylic Acid, CAS: 183288-47-3, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₃.

5-(1-Piperazinyl)benzofuran-2-carboxylic Acid-d8, CAS: /, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆D₈N₂O₃.

5-(2,3-Dihydro-1-benzofuran-2-yl)-1,3,4-oxadiazol-2-amine, CAS: 1016504-22-5, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₂.

5-(2,3-dihydro-1-benzofuran-5-yl)-1H-pyrazole-3-carboxylic acid, CAS: 1491131-49-7, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₃.

5-(2,3-Dihydro-1-benzofuran-5-yl)imidazolidine-2,4-dione, CAS: 1338949-31-7, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₃.

5-(2,3-Dihydro-1-benzofuran-5-yl)pyridine-3-carboxylic Acid, CAS: 1272838-47-7, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₃.

5-(2,5-Dichlorobenzoyl)-2,3-dihydro-1-benzofuran, CAS: 1096942-33-4, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₂Cl₂.

5-(2-Bromoethyl)-2,3-dihydrobenzofuran, CAS: 127264-14-6, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

5-(2-Bromoethyl)benzofuran, CAS: 133034-06-7, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrO.

5-(2-Bromoethyl-d4)-2,3-dihydrobenzofuran, CAS: 1189652-25-2, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₄BrO.

5-(2-Chlorobenzoyl)-2,3-dihydro-1-benzofuran, CAS: 1096942-27-6, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁O₂Cl.

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-2-benzofuran-1-one, CAS: 862081-37-6, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇BO₄.

5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein Hydrochloride, CAS: 21811-74-5, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₂Cl₂N₄O₅ • HCl.

5-(4-Nitrosopiperazin-1-yl)benzofuran-2-carboxylic Acid Ethyl Ester, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₄.

5-(4-Nitrosopiperazin-1-yl)benzofuran-2-carboxylic Acid Ethyl Ester-d4, CAS: /, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₄N₃O₄.

5-(5-methyl-1-benzofuran-2-yl)-1,3,4-thiadiazol-2-amine, CAS: 1248595-17-6, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₃OS.

5-(6)-Carboxynaphthofluoroscein N-Succinimidyl Ester, CAS: 150347-58-3, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₁₉NO₉.

5-(7-Acetyl-2-benzofuranyl)-3-(1,1-dimethylethyl)-2-oxazolidinone, CAS: 1246819-44-2, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₄.

5-(7-Methoxy-1-benzofuran-2-yl)-1,3,4-oxadiazol-2-amine, CAS: 1105193-69-8, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₃O₃.

5-(Acetoxymethyl) Fluorescein Diacetate, CAS: 147963-24-4, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀O₉.

5-(Aminomethyl)-2,3-dihydrobenzo[b]furan, CAS: 55745-74-9, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

5-(Bromomethyl)fluorescein, CAS: 148942-72-7, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃BrO₅.

5-(Hexadecanoylamino)fluorescein, CAS: 73024-80-3, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃NO₆.

5-(Iodoacetamido)fluorescein, CAS: 63368-54-7, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄INO₆.

5-(Piperazin-1-yl)benzofuran-2-carboxamide, CAS: 183288-46-2, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₂.

5-Amino-1-benzofuran-2-carboxamide Hydrochloride, CAS: 1171762-91-6, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂ • HCl.

5-Amino-2-(4-aminophenyl)benzofuran, CAS: 84102-58-9, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O.

5-Aminotetramethyl Rhodamine, CAS: 167095-10-5, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃O₃.

5-​Benzofuranmethanamin​e, CAS: 37798-08-6, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.

5-Benzofuranacetic Acid, CAS: 142935-60-2, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

5-Benzofuranamine, CAS: 58546-89-7, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO.

5-bromo-2,2-dimethyl-2,3-dihydro-1-benzofuran-3-one, CAS: 127049-22-3, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₂Br.

5-Bromo-2,3-dihydrobenzofuran, CAS: 66826-78-6, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrO.

5-Bromo-2,3-dihydrobenzofuran-7-carboxylic Acid, CAS: 41177-72-4, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₃Br.

5-Bromo-2-benzofuranmethanol, CAS: 38220-77-8, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BrO₂.

5-Bromo-2-methyl-2,3-dihydro-1-benzofuran, CAS: 102292-30-8, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉OBr.

5-bromo-3,7-dimethyl-1-benzofuran-2-carboxylic acid, CAS: 1343238-39-0, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉O₃Br.

5-Bromo-3-hydroxy-2-benzofuran-1(3H)-one, CAS: 102126-71-6, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO₃.

5-Bromo-3-methyl-benzofuran-2-carboxylic acid, CAS: 50638-08-9, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇BrO₃.

5-Bromo-3-methylbenzofuran, CAS: 33118-85-3, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BrO.

5-Bromo-3h-Spiro[Isobenzofuran-1,4-Piperidin]-3-One Hydrochloride, CAS: 1414959-11-7, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂NO₂Br.HCl.

5-Bromo-4,6-dimethylpyrimidine, CAS: 157335-97-2, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇BrN₂.

5-Bromo-4-fluoro-2-methylaniline, CAS: 627871-16-3, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇BrFN.

5-Bromo-4-methylisobenzofuran-1(3H)-one, CAS: 1255206-67-7, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₂Br.

5-Bromo-6-fluoro-2,3-dihydro-1-benzofuran-3-one, CAS: 1260007-95-1, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂FBr.

5-Bromo-7-chloro-3-methyl-1-benzofuran-2-carboxylic Acid, CAS: 1094288-67-1, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₃ClBr.

5-Bromo-7-chlorobenzofuran, CAS: 1194375-29-5, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄OClBr.

5-Bromo-7-ethyl-2-formyl-benzofuran, CAS: 137206-73-6, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉BrO₂.

5-Bromo-7-fluoro-2,3-dihydro-1-benzofuran-3-one, CAS: 1156601-36-3, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂FBr.

5-Bromo-7-Fluoroisobenzofuran-1(3h)-One, CAS: 1255208-34-4, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂FBr.

5-Bromo-7-iodo-2,3-dihydro-1-benzofuran, CAS: 1566912-44-4, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BrIO.

5-bromo-7-methyl-1-benzofuran-3-carboxylic acid, CAS: 1492450-22-2, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₃Br.

5-Bromo-7-[(4-piperidinylmethyl)amino]-2-benzofurancarboxylic Acid, CAS: 1310356-06-9, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇BrN₂O₃.

5-Bromobenzofuran, CAS: 23145-07-5, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO.

5-Bromobenzofuran-2-carboxamide, CAS: 35351-21-4, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNO₂.

5-Bromobenzofuran-2-carboxylic acid, CAS: 10242-11-2, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrO₃.

5-Bromobenzofuran-2-carboxylic Acid Methyl Ester, CAS: 26028-36-4, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇BrO₃.

5-Bromobenzofuran-3(2H)-one, CAS: 54450-20-3, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂Br.

5-Bromobenzo[b]furan-2-carbaldehyde, CAS: 23145-16-6, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrO₂.

5-Bromobenzo[b]thiophene-2-carbaldehyde, CAS: 7312-18-7, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrOS.

5-Bromobufuralol Hydrochloride, CAS: 137740-36-4, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BrClNO₂.

5-Bromodescyano Citalopram, CAS: 64169-39-7, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁BrFNO.

5-Bromodescyano Citalopram Hydrobromide, CAS: 479065-02-6, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂Br₂FNO.

5-Bromodescyano Citalopram-d4, CAS: /, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₄BrFNO.

5-Bromophthalide, CAS: 64169-34-2, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO₂.

5-Bromospiro[isobenzofuran-1(3H),4’-piperidin]-3-one, CAS: 920023-36-5, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂BrNO₂.

5-Carboxy-fluorescein Diacetate N-Succinimidyl Ester, CAS: 150206-05-6, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₉NO₁₁.

5-Carboxy-X-rhodamine N-succinimidyl ester, CAS: 344402-35-3, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₃N₃O₇.

5-Carboxyfluorescein, CAS: 76823-03-5, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₂O₇.

5-Carboxyfluorescein Diacetate, CAS: 79955-27-4, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₆O₉.

5-Carboxyfluorescein Dipivalate N-Hydroxysuccinimide Ester, CAS: 186032-65-5, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₁NO₁₁.

5-Carboxyfluorescein-N-hydroxysuccinimide Ester, CAS: 92557-80-7, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅NO₉.

5-Chloro-1(3H)-isobenzofuranone, CAS: 54109-03-4, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅ClO₂.

5-Chloro-2,3-dihydro-1-benzofuran-7-carboxylic Acid, CAS: 108551-58-2, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₃Cl.

5-chloro-2,3-dihydro-1-benzofuran-7-sulfonamide, CAS: 1461707-90-3, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₃SCl.

5-chloro-2,3-dihydro-1-benzofuran-7-sulfonyl chloride, CAS: 1461708-46-2, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃SCl₂.

5-Chloro-2,3-dihydro-benzofuran-2-carboxylic acid, CAS: 34385-94-9, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇ClO₃.

5-Chloro-2-(4-methylbenzoyl)-1-benzofuran, CAS: 220526-76-1, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁ClO₃.

5-Chloro-3-methyl-benzofuran-2-carboxylic Acid, CAS: 1134-00-5, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₃Cl.

5-chloro-7-(chloromethyl)-2,3-dihydro-1-benzofuran, CAS: 1461705-84-9, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈OCl₂.

5-Chloro-7-(chloromethyl)-3,3-dimethyl-2,3-dihydrobenzofuran, CAS: 1234847-20-1, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂OCl₂.

5-chloro-7-methyl-1-benzofuran-2-carbonitrile, CAS: 1250393-56-6, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NOCl.

5-Chloro-benzofuran-3-one, CAS: 3261-05-0, stock: 6.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂Cl.

5-Chlorobenzofuran-2-boronic Acid, CAS: 223576-64-5, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BClO₃.

5-Chlorobenzofuran-2-carboxylic Acid, CAS: 10242-10-1, stock: 4.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅O₃Cl.

5-Chlorodescyano Citalopram Hydrobromide, CAS: 1332724-08-9, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂BrClFNO.

5-Chlorodescyano Citalopram Oxalate, CAS: 64169-46-6, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClFNO•xC₂H₂O₄.

5-Chlorospiro[isobenzofuran-1(3H),4’-piperidin]-3-one, CAS: 180160-47-8, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂ClNO₂.

5-Cyanobenzofuran-2-ylboronic Acid, CAS: 331833-83-1, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BNO₃.

5-Cyanophthalide, CAS: 82104-74-3, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NO₂.

5-EAPB Hydrochloride, CAS: 1823776-22-2, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClNO.

5-Ethynylisobenzofuran-1,3-dione, CAS: 73819-76-8, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄O₃.

5-Fluoro-1(3h)-isobenzofuranone, CAS: 700-85-6, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅FO₂.

5-Fluoro-1-benzofuran-2-carboxylic Acid, CAS: 89197-62-6, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅O₃F.

5-Fluoro-2,3-dihydrobenzofuran, CAS: 245762-35-0, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇OF.

5-Fluoro-2-benzofurancarboxylic Acid Ethyl Ester, CAS: 93849-31-1, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉FO₃.

5-Fluoro-2-benzofuranmethanol, CAS: 276235-91-7, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇FO₂.

5-fluoro-3-methyl-1-benzofuran-2-sulfonyl chloride, CAS: 1369140-00-0, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃FSCl.

5-Fluorobenzofuran, CAS: 24410-59-1, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅FO.

5-Fluorobenzofuran-2-carboxaldehyde, CAS: 140382-35-0, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅FO₂.

5-Fluorobenzofuran-3-one, CAS: 60770-49-2, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅FO₂.

5-Formyl-1-benzofuran-2-carboxylic Acid, CAS: 10035-38-8, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₄.

5-Hexyl-1-benzofuran, CAS: 1400644-42-9, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O.

5-Hydroxy-2,3-dihydrobenzofuran-2-carboxylic Acid, CAS: 1163729-43-8, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

5-Iodo-2,3-dihydro-1-benzofuran, CAS: 132464-84-7, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇OI.

5-Methoxy-2-benzofuranboronic Acid, CAS: 551001-79-7, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BO₄.

5-Methoxybenzofuran, CAS: 13391-28-1, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂.

5-Methoxybenzofuran-2-carboxylic Acid, CAS: 10242-08-7, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

5-Methoxybenzofuran-2-carboxylic Acid Ethyl Ester, CAS: 50551-56-9, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₄.

5-Methoxyisobenzofuran-1,3-dione, CAS: 28281-76-7, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₄.

5-Methyl-1,3-cyclohexanedione, CAS: 4341-24-6, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₂.

5-Methyl-1,3-dihydroisobenzofuran-1-one, CAS: 54120-64-8, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂.

5-Methyl-1-benzofuran-2-carboxylic Acid, CAS: 10242-09-8, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

5-Nitro-1-benzofuran, CAS: 18761-31-4, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NO₃.

5-nitro-2,3-dihydro-1-benzofuran-3-carboxylic acid, CAS: 1343497-45-9, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₅.

5-Nitro-3H-benzofuran-2-one, CAS: 21997-23-9, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NO₄.

5-Nitro-benzofuran-2-carboxylic Acid, CAS: 10242-12-3, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NO₅.

5-Nitrofluorescein Diacetate, CAS: 14926-29-5, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅NO₉.

5-Prop-1-ynyl-2-benzofuran-1,3-dione, CAS: 1240685-26-0, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆O₃.

5-sulfamoyl-2,3-dihydro-1-benzofuran-2-carboxamide, CAS: 1423024-33-2, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄S.

5-[2-(1,3-dioxo-2-benzofuran-5-yl)ethynyl]-2-benzofuran-1,3-dione, CAS: 129808-00-0, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₆O₆.

5-[4’-[3-[[[3’,6’-Bis(dimethylamino)-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5-yl]carbonyl]amino]propyl][1,1’-biphenyl]-4-yl]-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide, CAS: 1186195-59-4, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₅₃Cl₂N₇O₅.

5-[Bromoacetamido]tetramethyl Rhodamine, CAS: 166442-38-2, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄BrN₃O₄.

5’-Acetylspiro[azetidine-3,1’(3’H)-isobenzofuran]-1-carboxylic Acid, 1,1-Dimethylethyl Ester, CAS: 1398609-81-8, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄.

6,6-Dimethyl-4-oxo-4,5,6,7-tetrahydro-benzofuran-3-carboxylic Acid, CAS: 121625-78-3, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

6,7,8,9-Tetrahydro-dibenzofuran-2-ol, CAS: 1133-79-5, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

6,7-dichloro-2,3-dihydro-1-benzofuran-3-amine hydrochloride, CAS: 1258639-72-3, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NOCl₂.HCl.

6,7-Dichloro-2,3-dihydro-1-benzofuran-3-one, CAS: 1153450-05-5, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂Cl₂.

6,7-dichloro-2-methyl-2,3-dihydro-1-benzofuran-3-one, CAS: 1247582-99-5, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₂Cl₂.

6,7-difluoro-2,3-dihydro-1-benzofuran-3-one, CAS: 1260013-24-8, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂F₂.

6,7-Dihydro-4(5H)-benzofuranone, CAS: 16806-93-2, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

6,7-dimethyl-2,3-dihydro-1-benzofuran-3-amine hydrochloride, CAS: 1258649-70-5, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.HCl.

6-(2,3-Dihydro-1-benzofuran-5-yl)pyridin-2-amine, CAS: 1184129-25-6, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O.

6-(benzyloxy)-2,3-dihydro-1-benzofuran-3-one, CAS: 139149-21-6, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₃.

6-(Ethyl(isopentyl)amino)-3-methyl-2-(phenylamino)-3H-spiro[isobenzofuran-1,9-xanthen]-3-one, CAS: 70516-41-5, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄N₂O₃.

6-(Fluorescein-5-carboxamido)hexanoic Acid, CAS: 194661-60-4, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃NO₈.

6-(Fluorescein-5-carboxamido)hexanoic Acid Succinimidyl Ester (>90%), CAS: 148356-00-7, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₆N₂O₁₀.

6-([4,6-Dichlorotriazin-2-yl]amino)fluorescein Hydrochloride, CAS: 118357-32-7, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₂Cl₂N₄O₅ • HCl.

6-Amino-5-(1,1-dimethylethyl)-3,3-dimethyl-2(3H)-benzofuranone, CAS: 1246213-40-0, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂.

6-Aminophthalide, CAS: 57319-65-0, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₂.

6-Aminotetramethyl Rhodamine, CAS: 159435-10-6, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃N₃O₃.

6-​Chloro-​3H-​spiro[isobenzofuran-​1,​4’-​piperidine] hydrochloride, CAS: 1359703-79-9, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO  •  (HCl).

6-Bromo-1H-pyrrolo[3,2-b]pyridine, CAS: 944937-53-5, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BrN₂.

6-Bromo-3-hydroxy-1,3-dihydro-2-benzofuran-1-one, CAS: 1225206-60-9, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₃Br.

6-Bromo-3H-isobenzofuran-1-one, CAS: 19477-73-7, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO₂.

6-Bromo-benzofuran, CAS: 128851-73-0, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO.

6-Bromobenzofuran-2-carboxylic acid, CAS: 439107-94-5, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrO₃.

6-Bromobenzofuran-3(2H)-one, CAS: 201809-69-0, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂Br.

6-Bromobenzo[b]thiophene-2-carbaldehyde, CAS: 19075-45-7, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrOS.

6-Carboxy-2’,7’-dichlorofluorescein 3’,6’-Diacetate Succinimidyl Ester, CAS: 852299-81-1, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₇Cl₂NO₁₁.

6-Carboxyfluorescein, CAS: 3301-79-9, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₂O₇.

6-Carboxyfluorescein 3’,6’-Diacetate N-Succinimidyl Ester, CAS: 150206-15-8, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₉NO₁₁.

6-Carboxyfluorescein 3’,6’-Dipivaloyl N-(1-Methylethyl)-2-propanamine, CAS: 847569-43-1, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃NO₉.

6-Carboxyfluorescein Diacetate, CAS: 06/03/3348, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₆O₉.

6-Carboxyfluorescein Dipivalate N-Hydroxysuccinimide Ester, CAS: 197850-75-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₁NO₁₁.

6-Carboxyfluorescein-N-hydroxysuccinimide Ester, CAS: 92557-81-8, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅NO₉.

6-Chloro-1-benzofuran-2-carboxylic Acid, CAS: 442125-04-4, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅ClO₃.

6-Chloro-2,3-dihydro-1-benzofuran-3-ol, CAS: 1154740-97-2, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇O₂Cl.

6-Chloro-2,3-dihydrobenzofuran-3-amine HCL, CAS: 1384265-38-6, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOCl.HCl.

6-Chloro-3-phenyl-1-benzofuran-2-carboxylic Acid, CAS: 1208402-13-4, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉O₃Cl.

6-Chloroacetamidotetramethyl Rhodamine, CAS: 159435-08-2, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄ClN₃O₄.

6-Chlorobenzofuran-3(2H)-one, CAS: 3260-78-4, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂Cl.

6-Cyanophthalide, CAS: 89877-62-3, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NO₂.

6-EAPB, CAS: 1632539-47-9, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO.

6-EAPB Hydrochloride, CAS: 1823318-37-1, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈ClNO.

6-FAM-Azide, CAS: /, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀N₄O₆.

6-fluoro-1-benzofuran-3-carboxylic acid, CAS: 1393561-25-5, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅O₃F.

6-Fluoro-3-methyl-1-benzofuran-2-carbaldehyde, CAS: 1186541-44-5, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₂F.

6-Fluoro-4-nitro-1(3H)-isobenzofuranone, CAS: 1207453-90-4, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄FNO₄.

6-HEX dipivaloate, CAS: 1166837-63-3, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₂Cl₆O₉.

6-Hydroxy-2H-benzofuran-3-one, CAS: 6272-26-0, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃.

6-IAF, CAS: 73264-12-7, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄INO₆.

6-JOE SE, CAS: 113394-23-3, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₁₇Cl₂NO₁₁.

6-MAPB Hydrochloride (1.0 mg/mL in Methanol), CAS: /, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO.

6-Methoxy-3-methyl-1-benzofuran-2-carboxylic Acid, CAS: 10410-29-4, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄.

6-Methoxybenzofuran-2-carboxylic acid, CAS: 50551-61-6, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

6-Methylbenzofuran-2-carbonitrile, CAS: 1049129-12-5, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

6-Nitrofluorescein Diacetate, CAS: 53299-21-1, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅NO₉.

6-O-Demethyl Griseofulvin, CAS: 20168-88-1, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClO₆.

6-O-Methyl Mycophenolic Acid Methyl Ester, CAS: 60435-90-7, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₆.

6-O-Methyl Mycophenolic Acid Methyl Ester-d9, CAS: 1331666-77-3, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅D₉O₆.

6-O-Methyl-d3 Mycophenolic Acid Methyl Ester (d3 Major), CAS: /, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₃O₆.

6-TET dipivaloate, CAS: 314734-87-7, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₄Cl₄O₉.

6-[Bis(methylsulfonyl)amino]-5-cyclopropyl-2-(4-fluorophenyl)-3-benzofurancarboxylic Acid Ethyl Ester, CAS: 1185313-40-9, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂NO₇FS₂.

6-[Bromoacetamido]tetramethyl Rhodamine, CAS: 166442-39-3, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄BrN₃O₄.

6-[Fluorescein-5(6)-carboxamido]hexanoic Acid, CAS: 265981-56-4, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃NO₈.

6’-(Diethylamino)-1’,3’-dimethylspiro[2-benzofuran-3,9’-xanthene]-1-one, CAS: 21934-68-9, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₃.

7-(2-Aminoethoxy)-2,2-dimethyl-2,3-dihydro-1-benzofuran Hydrochloride, CAS: 1171482-06-6, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.HCl.

7-(2-Bromoethyl)-2,3-dihydro-1-benzofuran, CAS: 1598271-92-1, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

7-(2-Bromoethyl)benzofuran, CAS: /, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉BrO.

7-(Chloromethyl)-2,2-dimethyl-2,3-dihydro-1-benzofuran, CAS: 115070-62-7, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃OCl.

7-​Aminobenzofuran, CAS: 67830-55-1, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO.

7-Bromo Darifenacin, CAS: 1391080-43-5, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉BrN₂O₂.

7-Bromo-1-benzofuran, CAS: 133720-60-2, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO.

7-bromo-1-benzofuran-3-carboxylic acid, CAS: 1374574-88-5, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅O₃Br.

7-Bromo-2,2-dimethyl-2,3-dihydro-1-benzofuran, CAS: 10178-57-1, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁OBr.

7-Bromo-2,3-dihydro-1-benzofuran-5-carbaldehyde, CAS: 875551-14-7, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₂Br.

7-Bromo-2,3-dihydro-benzofuran-2-carboxylic Acid, CAS: 1211597-12-4, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₃Br.

7-Bromo-2,3-dihydrobenzofuran, CAS: 206347-30-0, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrO.

7-Bromo-3-benzofuranone, CAS: 519018-52-1, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrO₂.

7-Bromo-3-methyl-1-benzofuran-2-carboxylic Acid, CAS: 1019115-67-3, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇O₃Br.

7-Bromo-4-fluorobenzofuran, CAS: 253429-31-1, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄BrFO.

7-Bromo-5-(chloromethyl)-2,2-dimethyl-2,3-dihydro-1-benzofuran, CAS: 1146290-40-5, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂OClBr.

7-Bromo-5-chloro-2,3-dihydro-1-benzofuran-3-one, CAS: 1153445-36-3, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂ClBr.

7-Bromo-5-chloro-3-methyl-1-benzofuran-2-carboxylic Acid, CAS: 1019111-85-3, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₃ClBr.

7-Bromo-5-methyl-2,3-dihydro-1-benzofuran-3-one, CAS: 1153450-24-8, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₂Br.

7-Bromobenzofuran-2-carboxylic acid, CAS: 550998-59-9, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrO₃.

7-Chloro-2,2-dimethyl-2,3-dihydro-1-benzofuran, CAS: 10178-55-9, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁OCl.

7-Chloro-2,3-dihydrobenzofuran-3-amine Hydrochloride, CAS: 1384265-56-8, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NOCl.HCl.

7-chloro-2-methyl-2,3-dihydro-1-benzofuran-5-sulfonamide, CAS: 1311317-50-6, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₃SCl.

7-chloro-2-methyl-2,3-dihydro-1-benzofuran-5-sulfonyl chloride, CAS: 1334146-20-1, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃SCl₂.

7-Chlorobenzofuran-5-carbonitrile, CAS: 1427420-85-6, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄NOCl.

7-Dechloro Griseofulvin, CAS: 3680-32-8, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₆.

7-Ethoxybenzofuran-2-carboxylic Acid, CAS: 206559-61-7, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄.

7-Ethyl-2-oxiranyl-benzofuran, CAS: 69543-76-6, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

7-fluoro-2,3-dihydro-1-benzofuran-2-carboxylic acid, CAS: 1354951-91-9, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇O₃F.

7-fluoro-2-methyl-2,3-dihydro-1-benzofuran-3-amine hydrochloride, CAS: 1394731-33-9, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NOF.HCl.

7-Hydroxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-6-carboxylic Acid, CAS: 1038374-76-3, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

7-Hydroxy-5-methoxy-4-methyl-6-[2-(tetrahydro-2-methyl-5-oxo-2-furanyl)ethyl]-1(3H)-isobenzofuranone, CAS: 26675-76-3, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

7-Methoxy-2,3-dihydro-benzofuran-3-ylamine Hydrochloride, CAS: 1199782-75-6, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.HCl.

7-Methoxy-3(2H)-benzofuranone, CAS: 7169-37-1, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

7-Methoxy-3,5-dimethyl-1-benzofuran-2-carboxylic Acid, CAS: 1094253-79-8, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₄.

7-Methoxy-3-phenylsulfonyl-1(3H)-isobenzofuranone, CAS: 65131-09-1, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₅S.

7-Methoxybenzofuran, CAS: 7168-85-6, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂.

7-Methoxybenzofuran-2-carboxylic Acid, CAS: 4790-79-8, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

7-Methylbenzofuran, CAS: 17059-52-8, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O.

7-Methylbenzofuran-d6, CAS: /, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₆O.

7-O-(Triethylsilyl)-2’-O-tert-butyl(dimethyl)silyl-4-desacetyl-2-debenzoyl-[2,4]oxol Paclitaxel, CAS: /, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₇₃NO₁₂Si₂.

7-O-Demethyl α-Narcotine, CAS: 68353-55-9, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₇.

7-tert-Butyl-5-methoxy-3-methyl-1-benzofuran-2-carboxylic Acid, CAS: 1097095-73-2, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₄.

9-[3-(Dibenzofuran-2-yl)phenyl]-9H-carbazole, CAS: 1338446-77-7, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₉NO.

9’-(Diethylamino)spiro[2-benzofuran-3,12’-benzo[a]xanthene]-1-one, CAS: 26628-47-7, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃NO₃.

A 80426 Mesylate, CAS: 152148-64-6, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₂ • CH ₃SO₃H.

A 987306, CAS: 1082954-71-9, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₅O.

Acetyl Citalopram Oxalate, CAS: 637026-02-9, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆FNO₆.

Acetyl Citalopram-d6 Oxalate, CAS: /, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀D₆FNO₆.

Acid Red 91, CAS: 548-24-3, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₆Br₂N₂Na₂O₉.

all-rac-cis-2,3,4,6,7-Pentamethyl-2-(4,8,12-trimethyltridecyl)-2,3-dihydrobenzofuran-5-ol, CAS: /, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₂.

all-rac-trans-2,3,4,6,7-Pentamethyl-2-(4,8,12-trimethyltridecyl)-2,3-dihydrobenzofuran-5-ol, CAS: /, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₂.

all-trans 5,8-Epoxy Retinoic Acid(Mixture of Diastereomers), CAS: 3012-76-8, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

Aureusidin, CAS: 38216-54-5, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀O₆.

BAN ORL 24 Dihydrochloride, CAS: 1401463-54-4, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅N₃O₂ • 2(HCl).

BCECF, CAS: 85138-49-4, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₀O₁₁.

BCECF/AM, CAS: 117464-70-7, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀₉H₉₈O₄₄.

Becliconazole, CAS: 112893-26-2, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂Cl₂N₂O.

Befunolol, CAS: 39552-01-7, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₄.

Befunolol-d7, CAS: /, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₇NO₄.

Benfuracarb, 90%, CAS: 82560-54-1, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₅S.

Benzarone, CAS: 1477-19-6, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₃.

Benziodarone, CAS: 68-90-6, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂I₂O₃.

Benzofuran, CAS: 271-89-6, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O.

Benzofuran (1mg/mL In Dichloromethane), CAS: 271-89-6, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O.

Benzofuran-2,5-diboronic acid, CAS: 913835-69-5, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈B₂O₅.

Benzofuran-2-boronic Acid, CAS: 98437-24-2, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BO₃.

Benzofuran-2-boronic acid, pinacol ester, CAS: 402503-13-3, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇BO₃.

Benzofuran-2-carboxylic acid, CAS: 496-41-3, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃.

Benzofuran-2-yl(pyridin-3-yl)methanamine Bis Hydrochloride, CAS: 1303889-76-0, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O • 2(HCl).

Benzofuran-3(2H)-one, CAS: 7169-34-8, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂.

Benzofuran-3-boronic Acid, CAS: 317830-83-4, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BO₃.

Benzofuran-3-carbaldehyde, CAS: 4687-25-6, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₂.

Benzofuran-5-boronic acid, CAS: 331834-13-0, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BO₃.

Benzofuran-5-boronic acid pinacol ester, CAS: 519054-55-8, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇BO₃.

Benzofuran-5-carbonitrile, CAS: 79002-39-4, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NO.

Benzofuran-5-ol, CAS: 13196-10-6, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂.

Benzofuran-6-amine, CAS: 110677-54-8, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO.

Benzofuran-6-carbaldehyde, CAS: 123297-88-1, stock: 10g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₂.

Benzofuran-6-carboxylic Acid, CAS: 77095-51-3, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₃.

Benzofuran-6-Ol, CAS: 13196-11-7, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂.

Benzofuran-6-sulfonyl Chloride, CAS: 1314920-96-1, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₃SCl.

Benzofuran-7-boronic Acid, CAS: 1432610-21-3, stock: 1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BO₃.

Benzofuran-7-boronic Acid Pinacol Ester, CAS: 1192755-14-8, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇BO₃.

Benzofuran-7-sulfonyl Chloride, CAS: 1191030-88-2, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₃SCl.

Benzofuran-d4, CAS: 1571080-49-3, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂D₄O.

Benzofuran-d4 (1mg/mL In Dichloromethane), CAS: 1571080-49-3, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂D₄O.

Beraprost Sodium Salt, CAS: 88475-69-8, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NaO₅.

Beraprost-d3, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃O₅.

Biotin-4-Fluorescein, CAS: 1032732-74-3, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂N₄O₈S.

Bis(2,2,2-trifluoroacetato-κO)di-mercury Fluorescein, CAS: 943517-73-5, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₀F₆Hg₂O₉.

Bis(2-cyanoethyl) (3’-methoxy-3-oxo-3H-spiro[isobenzofuran-1,9’-xanthen]-6’-yl) Phosphinylidenephosphite, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₁N₂O₈P.

Bis(3,4-dichlorophenyl)iodonium Chloride, CAS: 50848-00-5, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₅I.

Boc-Arg(Pbf)-OH, CAS: 200124-22-7, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈N₄O₇S.

Bufuralol Hydrochloride, CAS: 60398-91-6, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO₂.

Bufuralol-d9 Hydrochloride, CAS: 1173023-51-2, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₉ClNO₂.

C-(1,3-Dihydro-isobenzofuran-5-yl)-methylamine Hydrochloride, CAS: 1235439-82-3, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO • HCl.

Calcein (Mixture of Structural Isomers), CAS: /, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆N₂O₁₃.

Calcein AM, CAS: 890090-35-4, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₆N₂O₂₃.

Calcein AM (Mixture of Structural Isomers), CAS: /, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₄₆N₂O₂₃.

Cannabielsoin, CAS: 52025-76-0, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₃.

Cantharidin, CAS: 56-25-7, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

Carbofuran, CAS: 1563-66-2, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

Carbofuran-13C6, CAS: /, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₅NO₃.

Carbofuran-d3, CAS: 1007459-98-4, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₃NO₃.

Carbofuranphenol-3-keto, CAS: 17781-16-7, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

Carbosulfan, CAS: 55285-14-8, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₂O₃S.

Carbosulfan-d18, CAS: 1189903-75-0, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄D₁₈N₂O₃S.

Cercosporamide, CAS: 131436-22-1, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₇.

Cesium fluoride, CAS: 13400-13-0, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CsF.

CGS 35066, CAS: 261619-50-5, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆NO₆P.

Chlorendic Anhydride, CAS: 115-27-5, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂Cl₆O₃.

Chlorocitalopram, CAS: 64169-57-9, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁ClN₂O.

Chlorocitalopram, Hydrobromide, CAS: 64169-58-0, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂BrClN₂O.

cis-1,2,3,6-Tetrahydrophthalic Anhydride, CAS: 935-79-5, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

cis-Ligustilide, CAS: 81944-09-4, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

cis-Norbornene-exo-2,3-dicarboxylic Anhydride, CAS: 2746-19-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₃.

Citalopram - d4 hydrobromide, CAS: 1219803-58-3, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₄FN₂O • HBr.

Citalopram Alkene Dimer Chloride, CAS: 1370643-27-8, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₁ClF₂N₄O⁻.

Citalopram Carboxaldehyde, CAS: 227954-87-2, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂FNO₂.

Citalopram Carboxylic Acid Hydrobromide (Impurity), CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃BrFNO₃.

Citalopram Carboxylic Acid Hydrobromide-d6 (Impurity), CAS: /, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₆BrFNO₃.

Citalopram Dimethylaminobutanone Dihydrochloride Salt, CAS: /, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅Cl₂FN₂O₂.

Citalopram Hydrobromide Salt (1.0 mg/mL in Methanol), CAS: 59729-32-7, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂BrFN₂O.

Citalopram Hydrochloride, CAS: 85118-27-0, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O • (HCl).

Citalopram N-Oxide, CAS: 63284-72-0, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O₂.

Citalopram N-Oxide Hydrochloride, CAS: 62498-71-9, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClFN₂O₂.

Citalopram Nitrile Oxide, CAS: 1346601-93-1, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₂O₂.

Citalopram, Hydrobromide Salt, CAS: 59729-32-7, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂BrFN₂O.

Citalopram-d4, CAS: 1219908-84-5, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₄FN₂O.

Citalopram-d4 Hydrobromide Salt, CAS: 1219803-58-3, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₄BrFN₂O.

Citalopram-d6, CAS: 1190003-26-9, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₆FN₂O.

Citalopram-d6 N-Oxide, CAS: 1189652-54-7, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₆FN₂O₂.

Citalopram-d6 Oxalate, CAS: 1246819-94-2, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₆FN₂O₅.

CL 82198 Hydrochloride, CAS: 1188890-36-9, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃N₂O₃ • HCl.

CL-82198, CAS: 307002-71-7, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₃.

CMP-9-fluoresceinyl-NeuAc, CAS: 118720-35-7, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₃N₆O₂₀PS.

Coumestrol, CAS: 479-13-0, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈O₅.

Coumestrol dimethyl ether, CAS: 3172-99-4, stock: 7.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂O₅.

DAF-2, CAS: 205391-01-1, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄N₂O₅.

DAF-2 DA, CAS: 205391-02-2, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈N₂O₇.

DAF-FM DA (cell permeable), CAS: 254109-22-3, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈F₂N₂O₇.

Darifenacin Hydrobromide, CAS: 133099-07-7, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁BrN₂O₂.

Darifenacin(acetic Acid) Des-(5-Ethyl-2,3-dihydrobenzofuran) (Darifenacin Impurity), CAS: 1050646-75-7, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₂.

Darifenacin(benzofuran) Des-[(3S)-α,α-diphenyl-3-pyrrolidineacetamide] (Darifenacin Impurity), CAS: 633335-98-5, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O.

Dechlorane 602, CAS: 31107-44-5, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₄Cl₁₂O.

Dehydrodiisoeugenol, CAS: 2680-81-1, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄.

Demethylchloro Citalopram Hydrochloride, CAS: 1216512-47-8, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀Cl₂N₂O.

Des(methylsulfonyl) Dronedarone Oxalate, CAS: 500791-70-8, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₆N₂O₁₁.

Des-(dibutylpropylamine) Methanesulfonyl Dronedarone, CAS: 1448297-16-2, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₇S₂.

Desaminocarbonyl Vilazodone Dihydrochloride, CAS: 765936-02-5, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆N₄O•2(HCl).

Desbutyl Dronedarone Hydrochloride, CAS: 197431-02-0, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClN₂O₅S.

Desbutyl Dronedarone-d4 Hydrochloride, CAS: /, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃D₄ClN₂O₅S.

Descyano Citalopram-d4, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₄FNO.

Desmethylnarcotine, CAS: 521-40-4, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₇.

Dibenzofuran, CAS: 132-64-9, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈O.

Dibenzofuran 2-Oxoacetic Acid, CAS: 859745-04-3, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₄.

Dibenzofuran-4-boronic acid, CAS: 100124-06-9, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉BO₃.

Dibenzo[b,d]furan-3-amine, CAS: 4106-66-5, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO.

Didemethyl Chloro Citalopram Hydrochloride, CAS: 1217033-50-5, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈Cl₂N₂O.

Didemethyl Citalopram Hydrobromide, CAS: 1260887-85-1, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈BrFN₂O.

Didemethyl Citalopram-d6 Hydrobromide, CAS: 1286427-93-7, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₆BrFN₂O.

Dimethyl (3-oxo-1,3-dihydroisobenzofuran-1-yl)phosphonate, CAS: 61260-15-9, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₅P.

Dodecahydro-[5,5’-biisobenzofuran]-1,1’,3,3’-tetraone, CAS: 122640-83-9, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₆.

Dodecahydrodibenzofuran, CAS: 13054-98-3, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O.

Dronedarone Hydrochloride, CAS: 141625-93-6, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₅ClN₂O₅S.

Dronedarone N-Oxide, CAS: 1638586-56-7, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₄N₂O₆S.

Dronedarone-d6 Hydrochloride, CAS: 1329809-23-5, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₉D₆ClN₂O₅S.

DWK-1339, CAS: 1018946-38-7, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄.

E-Butylidenephthalide, CAS: 76681-73-7, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

Efaroxan Hydrochloride, CAS: 89197-00-2, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O • (HCl).

Enadoline, CAS: 124378-77-4, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₂O₃.

Endosulfan Lactone-d2, CAS: /, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₂Cl₆O₂.

Eosin Acid C.I. No. 45380, CAS: 15086-94-9, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₈Br₄O₅.

Eosine-5-isothiocyanate, CAS: 60520-47-0, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₇Br₄NO₅S.

epi-Isotetracycline, CAS: /, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₈.

Epigriseofulvin, CAS: 469-49-8, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClO₆.

Erythrosin B, CAS: 15905-32-5, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₈I₄O₅.

Erythrosin Yellowish, CAS: 33239-19-9, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀I₂O₅ • 2Na.

Erythrosine B Disodium Salt, CAS: 16423-68-0, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₈I₄Na₂O₅.

Ethane-1,2-diyl bis(1,3-Dioxo-1,3-dihydroisobenzofuran-5-carboxylate), CAS: 1732-96-3, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀O₁₀.

Ethofumesate, CAS: 26225-79-6, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₅S.

Ethofumesate Ethyl-d5, CAS: 160858-11-7, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₅O₅S.

Ethofumesate-2-keto, CAS: 26244-33-7, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅S.

Ethyl (5-Bromo-2-(6-Fluoronicotinoyl)Benzofuran-3-Yl)(3-Methoxypropyl)Carbamate, CAS: 1431434-22-8, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂O₅FBr.

Ethyl 2-(5-bromobenzofuran-3-yl)acetate, CAS: 200204-85-9, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁BrO₃.

Ethyl 2-(Chloromethyl)oxazole-5-carboxylate, CAS: 96315-26-3, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClNO₃.

Ethyl 2-Hydroxybutyrate, CAS: 52089-54-0, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

Ethyl 2-Hydroxybutyrate-d5, CAS: /, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₅O₃.

Ethyl 3-(2,3-Dihydrobenzofuran-5-yl)propanoate, CAS: 196597-66-7, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₃.

Ethyl 3-(2,3-Dihydrobenzofuran-5-yl)propenoate, CAS: 196597-65-6, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₃.

Ethyl 3-(6,7-Dibromo-2,3-dihydro-1-benzofuran-5-yl)propanoate, CAS: 196597-75-8, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄Br₂O₃.

Ethyl 3-(7-Bromo-2,3-dihydro-1-benzofuran-5-yl)propanoate, CAS: 196597-67-8, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅BrO₃.

Ethyl 3-(Aminomethyl)-1-benzofuran-2-carboxylate Hydrochloride, CAS: 1135105-75-7, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃ • HCl.

Ethyl 3-Aminobenzofuran-2-carboxylate, CAS: 39786-35-1, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Ethyl 3-Methyl-1-benzofuran-2-carboxylate, CAS: 22367-82-4, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₃.

Ethyl 3-Methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-2-carboxylate, CAS: 108993-84-6, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

Ethyl 3-Oxo-2,3-dihydrobenzofuran-2-carboxylate, CAS: 13099-95-1, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄.

Ethyl 4-bromo-1-benzofuran-2-carboxylate, CAS: 177735-22-7, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉BrO₃.

Ethyl 4-Chloro-5-formyl-3-methyl-6,7-dihydro-1-benzofuran-2-carboxylate, CAS: 137987-76-9, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃O₄Cl.

Ethyl 4-Chloronicotinate, CAS: 37831-62-2, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

Ethyl 4-[(Dimethylamino)methyl]-5-hydroxy-2-phenyl-1-benzofuran-3-carboxylate Hydrochloride, CAS: 51771-50-7, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄ • HCl.

Ethyl 5-(bromomethyl)benzofuran-2-carboxylate, CAS: 137997-18-3, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁O₃Br.

Ethyl 5-(Chlorosulfonyl)-3-methyl-1-benzofuran-2-carboxylate, CAS: 1173083-97-0, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁O₅SCl.

Ethyl 5-amino-1-benzofuran-2-carboxylate, CAS: 174775-48-5, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Ethyl 5-Aminobenzofuran-2-carboxylate Hydrochloride, CAS: 183288-42-8, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃ • HCl.

Ethyl 5-Bromo-3-((Ethoxycarbonyl)Amino)Benzofuran-2-Carboxylate, CAS: 1251582-36-1, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄NO₅Br.

Ethyl 5-bromobenzofuran-2-carboxylate, CAS: 84102-69-2, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉BrO₃.

Ethyl 5-hydroxy-2-phenylbenzofuran-3-carboxylate, CAS: 4610-75-7, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₄.

Ethyl 5-Nitro-1-benzofuran-2-carboxylate, CAS: 69404-00-8, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₅.

Ethyl 5-Nitrobenzofuran-2-carboxylate, CAS: 69604-00-8, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₅.

Ethyl 6-aminobenzofuran-3-carboxylate, CAS: 1260788-13-3, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Ethyl 6-Bromobenzofuran-3-carboxylate, CAS: 1260799-56-1, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉BrO₃.

Ethyl 6-Cyano-1H-indole-2-carboxylate, CAS: 104291-81-8, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

Ethyl 7-Aminobenzofuran 2-Carboxylate, CAS: /, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Ethyl 7-Bromo-2,3-dihydrobenzofuran-2-carboxylate, CAS: 113730-57-7, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₃Br.

Ethyl 7-bromobenzofuran-2-carboxylate, CAS: 1033201-65-8, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉BrO₃.

Ethyl Coumarilate, CAS: 3199-61-9, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

Ethyl Mycophenolate, CAS: 32483-51-5, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₆.

Ethyl-2-butynoate, CAS: 4341-76-8, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₂.

exo-Norbornane-2,3-dicarboxylic Anhydride, CAS: 14166-28-0, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

FDS, CAS: 197777-72-3, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O₁₁S₂ • 2NH ₃.

FlAsH-EDT2, CAS: 212118-77-9, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈As₂O₅S₄.

Fluorescamine, CAS: 38183-12-9, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀O₄.

Fluorescein 5-Maleimide (90%), CAS: 75350-46-8, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₃NO₇.

Fluorescein 6-Maleimide, CAS: 161598-40-9, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₃NO₇.

Fluorescein Alkynylamino-ATP, CAS: 185971-89-5, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₁N₆O₂₀P₃.

Fluorescein beta-D-galactopyranoside, CAS: 102286-67-9, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂O₁₀.

Fluorescein Biotin, CAS: 134759-22-1, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₀N₆O₈S₂.

Fluorescein Bis(methylene)]bis[N-(carboxymethyl)glycine], CAS: 207124-64-9, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆N₂O₁₃.

Fluorescein Di(β-D-galactopyranoside), CAS: 17817-20-8, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂O₁₅.

Fluorescein Di-(β-D-glucopyranoside), CAS: 129787-66-2, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂O₁₅.

Fluorescein Diacetate 5(6)-isothiocyanate, CAS: 871487-69-3, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO.

Fluorescein Dibutyrate, CAS: 7298-65-9, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄O₇.

Fluorescein Isothiocyanate (>85%), CAS: 27072-45-3, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₁NO₅S.

Fluorescein-5-thiosemicarbazide Hydrochloride, CAS: /, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₅N₃O₅S•HCl.

Fluorescein-Cadaverine Dihydrochloride, CAS: /, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇Cl₂N₃O₅S.

Fluorescein-diacetate-5-isothiocyanate, CAS: 118378-76-0, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅NO₇S.

Fluorescein-Dipalmitoylphosphatidylethanolamine, CAS: 87706-98-7, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₈₅N₂O₁₃PS.

Fluorescein-dUTP, CAS: 214154-36-6, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₁N₄O₂₁P₃.

Fluorescein-O’-acetic Acid, CAS: 233759-98-3, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄O₇.

Fluoresceinamine, CAS: 27599-63-9, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃NO₅.

Fluoresceinamine Hydrochloride Isomer 1, CAS: 53360-53-5, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄ClNO₅.

Fluoresceinamine Maleic Acid Monoamide, CAS: 75900-74-2, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅NO₈.

Fluoresceinamine, Isomer 2,, CAS: 51649-83-3, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃NO₅.

Flutax 1, CAS: 191930-58-2, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₁H₆₆N₂O₂₁.

Fmoc-Arg(Pbf)-OH, CAS: 154445-77-9, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₄O₇S.

Fmoc-​Arg(Me,​pbf)​-​OH, CAS: 1135616-49-7, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂N₄O₇S.

Fmoc-L-HomoArg(Pbf)-OH, CAS: 1159680-21-3, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂N₄O₇S.

Fmoc-N-Me-Arg(pbf)-OH, CAS: 913733-27-4, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂N₄O₇S.

FMP, CAS: 197777-68-7, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆NO₈P.

FMS, CAS: 197777-71-2, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O₈S.

Fraxinellone, CAS: 28808-62-0, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₃.

Fura PE-3 Potassium Salt, CAS: 172890-83-4, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₉N₅O₁₇ • 4K.

Fura RedTM Tetrapotassium Salt, CAS: /, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄K₄N₄O₁₂S.

FURA-2 Pentapotassium Salt, CAS: 113694-64-7, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₂N₃O₁₄K₅.

Fura-2, Pentasodium Salt, CAS: /, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇N₃O₁₄ • 5Na.

FURA-PE3/AM, CAS: 172890-84-5, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₆₃N₅O₂₉.

Furametpyr, CAS: 123572-88-3, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClN₃O₂.

Furaptra Tetrapotassium Salt, CAS: 132319-57-4, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀K₄N₂O₁₁.

Furathiocarb, CAS: 65907-30-4, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₅S.

Furofenac, CAS: 56983-13-2, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

Furofenac Ethyl Ester, CAS: 58741-20-1, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆BrNO₃.

Furofenac Methyl Ester, CAS: 76733-61-4, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄BrNO₃.

Furofenac-d3, CAS: 1794754-03-2, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₃O₃.

Gallein, CAS: 2103-64-2, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O₇.

Green CMFDA, CAS: 136832-63-8, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₇ClO₇.

Griffonilide, CAS: 61371-55-9, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

Griseofulvic Acid, CAS: 469-54-5, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClO₆.

Griseofulvin, CAS: 126-07-8, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClO₆.

Griseofulvin-13C,d3, CAS: 1329612-29-4, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₄D₃ClO₆.

Griseofulvin-d3, CAS: 1279033-22-5, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₃ClO₆.

Grossamide, CAS: 80510-06-1, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆N₂O₈.

GSK 2194069, CAS: 1332331-08-4, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄N₄O₃.

Hexahydro-1,3-isobenzofurandione, CAS: 85-42-7, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃.

Hexahydro-1,3-isobenzofurandione-d8, CAS: /, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂D₈O₃.

Hexahydro-3a-methyl-1,3-isobenzofurandione, CAS: 48122-14-1, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

Homo Egonol β-D-Glucoside, CAS: 325791-19-3, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₁₀.

Homoegonol, CAS: 17375-66-5, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₅.

Homogentisic Acid γ-Lactone, CAS: 2688-48-4, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃.

Isochlortetracycline, CAS: 514-53-4, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClN₂O₈.

Isotetracycline, CAS: 3811-31-2, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₈.

Isotetracycline-d6, CAS: /, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₆N₂O₈.

Ivacaftor Carboxylic Acid Lactone, CAS: 1246213-41-1, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₄.

α-(Bromomethyl)-7-ethyl-2-benzofuranmethanol, CAS: 593266-92-3, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃BrO₂.

α-Amino-2-Benzofuranacetic Acid Methyl Ester, CAS: 1822542-50-6, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

α-Μethyl-6-benzofuran Ethanamine-d6 Ηydrochloride (6-APB-d6 Hydrochloride), CAS: 1346600-35-8, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₆ClNO.

α1-[3-(Dimethylamino)propyl]-α1-(4-fluorophenyl)-1,2-benzenedimethanol, CAS: 1206729-90-9, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄FNO₂.

μ-(2’,7’-Difluoro-3’,6’-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthene]-4’,5’-diyl)]bis(2,2,2-trifluoroacetato-κO)di-mercury, CAS: 912934-87-3, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₈F₈Hg₂O₉.

Kadsurenone, CAS: 95851-37-9, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄O₅.

Kadsurenone-d6, CAS: /, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₆O₅.

KU14R, CAS: 189224-48-4, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O.

Lifitegrast, CAS: 1025967-78-5, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄Cl₂N₂O₇S.

Lifitegrast-d4, CAS: /, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₀D₄Cl₂N₂O₇S.

Ligustilide, CAS: 4431-01-0, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂.

m-Meconin, CAS: 531-88-4, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

MAK-683, CAS: 1951408-58-4, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇FN₆O.

Meconin, CAS: 569-31-3, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

Meconin (1.0 mg/mL in Chloroform), CAS: 569-31-3, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

Meconin-d3, CAS: 29809-15-2, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₃O₄.

Menthofuran, CAS: 494-90-6, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O.

Methyl 1-Benzofuran-2-carboxylate, CAS: 1646-27-1, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

Methyl 2,3-Dihydrobenzofuran-5-carboxylate, CAS: 588702-80-1, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

Methyl 2-(Benzofuran-5-yl)acetate, CAS: 121638-36-6, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

Methyl 2-Methyl-1-benzofuran-5-carboxylate, CAS: 117379-97-2, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

Methyl 3-(2,3-Dihydro-1-benzofuran-5-yl)propanoate, CAS: 1219101-96-8, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

Methyl 4-amino-4,5,6,7-tetrahydrobenzofuran-3-carboxylate hydrochloride, CAS: 1172813-04-5, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₃.

Methyl 4-Amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate, CAS: 182808-04-4, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClNO₃.

methyl 4-bromo-2-methyl-1-benzofuran-7-carboxylate, CAS: 1312610-36-8, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉O₃Br.

methyl 4-hydroxy-1-benzofuran-6-carboxylate, CAS: 1279218-51-7, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

Methyl 4’-Tosyl Mycophenoate-6-methyl-d3, CAS: 1185240-84-9, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₃O₈S.

Methyl 4’-Tosylmycophenolate, CAS: 171808-02-9, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈O₈S.

Methyl 5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxylate, CAS: 1234844-87-1, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃O₃Cl.

Methyl 6-[Methyl-2,3,4-tri-O-acetyl-β-D-glucuronato]mycophenolate, CAS: 39938-00-6, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈O₁₅.

Methyl 6’-Desmethyl-4’-tosylmycophenolate, CAS: 171808-04-1, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆O₈S.

methyl 7-(trifluoromethyl)-1-benzofuran-2-carboxylate, CAS: 1407521-92-9, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇O₃F₃.

Methyl 7-Ethoxy-1-benzofuran-2-carboxylate, CAS: 1407521-98-5, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₄.

Methyl benzofuran-5-carboxylate, CAS: 108763-47-9, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₃.

Methyl Mycophenolate (EP Impurity E), CAS: 31858-66-9, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₆.

Methyl Mycophenolate-d6 (EP Impurity E), CAS: 1331643-25-4, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₆O₆.

Methyl-2-bromopentanoate, CAS: 19129-92-1, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

Methylhexahydroisobenzofuran-1,3-Dione, CAS: 25550-51-0, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

MitoPY1, CAS: 1041634-69-8, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₅₃BIN₂O₅P.

Mixture of Hexahydromethylphthalic Anhydride [1],  3a-Methylhexahydroisobenzofuran-1,3-dione [2],  Hexahydro-1-methylphthalic Anhydride [3], 4-Methylcyclohexane-1,2-dicarboxylic Anhydride, mixture of isomers [4], CAS: /, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

MSN-50, CAS: 1592908-75-2, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₈BrN₃O₆.

Mycophenolate Mofetil, CAS: 128794-94-5, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₇.

Mycophenolate Mofetil β-D-O-Glucuronide, CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉NO₁₃.

Mycophenolate Mofetil N-Oxide (EP Impurity G), CAS: 224052-51-1, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₈.

Mycophenolate Mofetil-d4, CAS: 1132748-21-0, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₄NO₇.

Mycophenolic Acid, CAS: 24280-93-1, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

Mycophenolic Acid Acyl-β-D-glucoside, CAS: 344562-78-3, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₁₁.

Mycophenolic Acid Acyl-β-D-glucuronide, CAS: 99043-04-6, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₁₂.

Mycophenolic Acid Acyl-β-D-glucuronide Allyl Ester, CAS: 860615-39-0, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₁₂.

Mycophenolic Acid Carboxybutoxy Ether, CAS: 931407-27-1, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₈.

Mycophenolic Acid β-D-Glucuronide, CAS: 31528-44-6, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₁₂.

Mycophenolic Acid β-D-Glucuronide Disodium Salt, CAS: /, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆Na₂O₁₂.

Mycophenolic Acid Lactone (EP Impurity H), CAS: 79081-87-1, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

Mycophenolic Acid Methyl Ester Phenolic 6-(2,3,4,6-tetra-O-Acetyl-β-D-glucoside), CAS: 1186295-42-0, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₀O₁₅.

Mycophenolic Acid Monosodium Salt, CAS: 37415-62-6, stock: 7.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NaO₆.

Mycophenolic Acid Phenolic β-D-Glucoside, CAS: 55533-52-3, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₁₁.

Mycophenolic Acid-d3, CAS: 1185242-90-3, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃O₆.

Mycophenolic Acid-d3 Acyl-β-D-glucuronide, CAS: /, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₃O₁₂.

Mycophenolic Acid-d3 Acyl-β-D-glucuronide Allyl Ester, CAS: /, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉D₃O₁₂.

Mycophenolic Acid-d3 β-D-Glucuronide, CAS: /, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₃O₁₂.

N-(2,3-Dihydro-1-benzofuran-2-ylmethyl)cyclopropanamine, CAS: 1094481-01-2, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

N-(2,3-dihydro-1-benzofuran-5-yl)piperidine-2-carboxamide hydrochloride, CAS: 1333644-29-3, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₂.HCl.

N-(2,3-Dihydro-1-benzofuran-5-ylmethyl)cyclopentanamine, CAS: 1157544-58-5, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO.

N-(3’,6’-Dihydroxy-3-oxospiro[isobenzofuran-1(3H),9’-[9H]xanthen]-5-yl)-N’-[3-(triethoxysilyl)propyl]thiourea, CAS: 847674-22-0, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄N₂O₈SSi.

N-(5-(tert-Butyl)-2-hydroxy-3,3-dimethyl-2,3-dihydrobenzofuran-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide, CAS: /, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₄.

N-(5-Fluoresceinyl)-L-carnitine-O-thiocarbamate Chloride, CAS: /, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇ClN₂O₈S.

N-(6-Hydroxyhexyl)-6-carboxamidofluorescein Dipivalate, CAS: 467455-27-2, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁NO₉.

N-5-(2-Carbamoyl) Benzofuranyl Vilazodone (Vilazodone Impurity), CAS: /, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₂N₆O₄.

N-​(3-​Dibenzofuranyl)-​(3,4-dideutero)-5-​nitro-2-​furancarboxamide, CAS: /, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₈D₂N₂O₅.

N-​(3-​Dibenzofuranyl)-​5-​nitro-2-​furancarboxamide, CAS: 329198-87-0, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀N₂O₅.

N-Butylfluorescein, CAS: 335193-91-4, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃O₈.

N-Chloromethyl (S)-Citalopram Chloride, CAS: /, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃Cl₂FN₂O.

N-Chloromethyl Citalopram-d6 Chloride, CAS: /, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₆Cl₂FN₂O.

N-Desmethoxypropyl N-Carbethoxy Plucalopride, CAS: 137211-63-3, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClN₃O₄.

N-Desmethoxypropyl Prucalopride, CAS: 137211-64-4, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClN₃O₂.

N-Desmethyl β-Hydrastine, CAS: 1574555-20-6, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₆.

N-Des[1-(3-methoxypropyl)-4-piperidinyl] Prucalopride, CAS: 182808-16-8, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClN₂O₂.

N-Mesyldronedarone, CAS: 141626-57-5, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆N₂O₇S₂.

N-methyl-2,3-dihydro-1-benzofuran-5-amine, CAS: 1343659-78-8, stock: 9.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

N-Oxo Prucalopride, CAS: 1900715-98-1, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₄.

N-Trifluoroacetodidemethyl Citalopram, CAS: 1076199-47-7, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₄N₂O₂.

N-[(2-Aminophenyl)methyl]-N-methyl-1-benzofuran-2-carboxamide, CAS: 1153887-12-7, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₂.

N-[1-(1-Benzofuran-2-yl)ethyl]-2-chloro-N-methylacetamide, CAS: 1184567-77-8, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄NO₂Cl.

N-[1-(1-Benzofuran-2-yl)ethyl]-2-chloropropanamide, CAS: 1154010-39-5, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄NO₂Cl.

N-[1-(2,3-Dihydro-1-benzofuran-5-yl)ethylidene]hydroxylamine, CAS: 146321-88-2, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

N-[2-(2,3-Dihydro-5-benzofuranyl)ethyl] Darifenacin Hydrobromide, CAS: /, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₁BrN₂O₃.

N-[2-Butyl-3-(4-methoxybenzoyl)-5-benzofuranyl]-methanesulfonamide, CAS: 1384513-86-3, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₅S.

N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]formamide, CAS: 1309381-32-5, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₂N₂O₄.

N-[[(1R,2S)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]-rel-propanamide, CAS: 251562-65-9, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₂.

N2-[(2R)-4-[(1,1-Dimethylethoxy)amino]-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl]sulfonyl]amino]iminoethyl-L-ornithine, CAS: 1093740-20-5, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₁N₅O₈S.

N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-L-ornithine Methyl Ester Hydrochloride, CAS: 257288-19-0, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃ClN₄O₅S.

Naphthofluorescein Di-(β-D-galactopyranoside), CAS: 133551-98-1, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₆O₁₅.

NHS-5(6)Carboxyrhodamine, CAS: 150408-83-6, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₅N₃O₇.

Nitrofluorescein, Isomer 1, CAS: 3326-35-0, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₁NO₇.

Norcantharidin, CAS: 29745-04-8, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

Norgnoscopine, CAS: 36017-64-8, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₇.

Norgnoscopine Hydrochloride, CAS: /, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClNO₇.

Noscapine, CAS: 128-62-1, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₇.

Noscapine Hydrochloride, CAS: 912-60-7, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₇ •HCl.

Noscapine N-Oxide, CAS: 54383-36-7, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₈.

Noscapine-13C,d3, CAS: 1217680-57-3, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₂₀D₃NO₇.

o-​Cresolphthalein Complexone, CAS: 2411-89-4, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂N₂O₁₂.

O-Desmethyl Mycophenolic Acid, CAS: 31858-65-8, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₆.

O-Desmethyl Mycophenolic Acid Methyl Ester, CAS: 33431-38-8, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

O-Desmethyl Mycophenolic Acid Methyl Ester-d3, CAS: 1331670-20-2, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃O₆.

O-Methyl Mycophenolate Mofetil (EP Impurity D), CAS: 1322681-37-7, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃NO₇.

O-Methyl-d3 Mycophenolate Mofetil (d3 Major)(EP Impurity D), CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀D₃NO₇.

O-Methyl-O-(N-Butylfluorescein)-O-{3-[6-O-(D,L-1-ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene)-D,L-myo-inositol]}phosphate, CAS: 335630-21-2, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₉O₁₄P.

O-TBS Methyl Mycophenolate, CAS: /, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₆Si.

octahydro-1-benzofuran-4-amine, CAS: 1394040-97-1, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO.

Oregon Green 488 Carboxylic Acid, CAS: 195136-52-8, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₀F₂O₇.

Oregon Green 488 Succinimidyl Ester, CAS: 198139-51-4, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₃F₂NO₉.

p-Anisylidenephthalide, CAS: 4767-61-7, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₃.

PBFI-AM, CAS: 124549-23-1, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₆₂N₂O₂₄.

PCI-24781, CAS: 783355-60-2, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₅.

Peroxy Orange 1, CAS: 1199576-10-7, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂BNO₅.

PF 04937319, CAS: 1245603-92-2, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₆O₄.

Phenolphthalein, CAS: 77-09-8, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₄.

Phenolphthalein (0.04% Solution in Ethanol), CAS: 77-09-8, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₄.

Phenolphthalein Diphosphate Tetrasodium Salt, CAS: 68807-90-9, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₂₀H₁₂Na₄O₁₀P₂)  •  2(H₂O).

Phenolphthalein Glucuronide, Sodium Salt, CAS: 6820-54-8, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂O₁₀ • Na.

Phenolphthalein β-D-Glucuronide, CAS: 15265-26-6, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂O₁₀.

Phthalan, CAS: 496-14-0, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O.

Phthalic Acid Anhydride-13C2, CAS: 1239918-30-9, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₄O₃.

Phthalic Acid Anhydride-d4, CAS: 75935-32-9, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈D₄O₃.

Phthalic Anhydride, CAS: 85-44-9, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₃.

Phthalic Anhydride (Phenyl-13C6, D4), CAS: /, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆D₄O₃.

Phthalic Anhydride-13C, CAS: 344327-05-5, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₄O₃.

Phthalic-13C6 Anhydride, CAS: 1173019-01-6, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₄O₃.

Potassium Benzofuran-2-yltrifluoroborate, CAS: 929626-27-7, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BF₃KO.

Prucalopride Succinate, CAS: 179474-85-2, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂ClN₃O₇.

Prucalopride Succinate-13CD3, CAS: /, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₂₉D₃ClN₃O₇.

Prucalopride-N-Galactopyranoside, CAS: /, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆ClN₃O₈.

Psoralen, CAS: 66-97-7, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆O₃.

rac BHFF, CAS: 123557-91-5, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁F₃O₃.

rac Darifenacin-d4, CAS: 1189701-43-6, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₆D₄N₂O₂.

rac Demethyl Citalopram-d3 Hydrochloride, CAS: 1189650-18-7, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₃ClFN₂O.

rac Desfluoro Citalopram Acetamide, CAS: /, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₂.

rac Desfluoro Citalopram Hydrobromide, CAS: 1332724-04-5, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃BrN₂O.

rac Desmethyl Citalopram Hydrobromide, CAS: 1188264-72-3, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀BrFN₂O.

rac Desmethyl Citalopram Hydrochloride, CAS: 97743-99-2, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClFN₂O.

rac Desmethyl Citalopram-d4 Hydrobromide, CAS: /, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₄BrFN₂O.

rac Didemethyl Citalopram Hydrochloride, CAS: 1189694-81-2, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClFN₂O.

rac Didemethyl Citalopram-d6 Hydrochloride, CAS: 1189865-88-0, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₆ClFN₂O.

rac-(4aα)-4a,5,9,10,11,12-Hexahydro-1-bromo-3-methoxy]-11-formyl-6H-benzofuran[3a,3,2-e,f][2]benzazepin-6-one, CAS: 1391047-97-4, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆BrNO₄.

rac-1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile, CAS: 64169-67-1, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀FNO.

rac-3-(tert-Butyl-d9)-5-(7-ethyl-2-benzofuranyl)-2-oxazolidinone, CAS: 1189870-01-6, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₉NO₃.

rac-3-tert-Butyl-5-(7-ethyl-2-benzofuranyl)-2-oxazolidinone, CAS: 1076199-68-2, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

rac-N-Trifluoroacetodesmethyl Citalopram, CAS: 1076199-46-6, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈F₄N₂O₂.

rac-TAK-875, CAS: 1390641-84-5, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂O₇S.

Ramelteon Metabolite M-II  (mixture of R and S at the hydroxy position), CAS: 896736-21-3, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

Ramelteon Metabolite M-II-d3  (mixture of R and S at the hydroxy position), CAS: 1246812-22-5, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₃NO₃.

Rhodamine B base, CAS: 509-34-2, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₃.

Rhodamine Phenylglyoxal Hydrate, CAS: /, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₇N₇O₈.

Rocaglamide, CAS: 84573-16-0, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁NO₇.

Rocaglamide AL, CAS: 201212-33-1, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄O₇.

Rocaglamide J, CAS: 147059-47-0, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈O₈.

Rocaglaol, CAS: 147059-46-9, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆O₆.

ROS Probe, HPF, CAS: 359010-69-8, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₆O₆.

S 07662, CAS: 883226-64-0, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₂S.

S-(+)-N-Trifluoroacetodesmethyl Citalopram, CAS: 1217697-83-0, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈F₄N₂O₂.

S-(+)-N-Trifluoroacetodidemethyl Citalopram, CAS: 1217811-50-1, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆F₄N₂O₂.

S-Desmethyl S-Chloromethyl Dronedarone, CAS: 1520080-11-8, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₃ClN₂O₅S.

Salvianolic Acid B, CAS: 121521-90-2, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀O₁₆.

Salvianolic Acid C, CAS: 115841-09-3, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀O₁₀.

Saprisartan, CAS: 146623-69-0, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂BrF₃N₄O₄S.

SBFI-AM, CAS: 129423-53-6, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₅₈N₂O₂₃.

Sedanolide, CAS: 6415-59-4, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

Silychristin, CAS: 33889-69-9, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂O₁₀.

Silydianin, CAS: 29782-68-1, stock: 3.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂O₁₀.

SiR-NHS Ester, CAS: /, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁N₃O₆Si.

Sodium 1-(((7S)-1-(4-Azidophenyl)-7-(3’,6’-dihydroxy-3-oxo-4a’,9a’-dihydro-3H-spiro[isobenzofuran-1,9’-xanthen]-5-ylcarboxamido)-1,8,16-trioxo-12,13-dithia-2,9,17-triazatricosan-23-oyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate, CAS: /, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₅₁N₈NaO₁₆S₃.

Spirolaxine, CAS: 126382-01-2, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂O₆.

Spiro[benzofuran-3(2H),4’-piperidine] Hydrochloride, CAS: 167484-72-2, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO • 1(HCl).

Spiro[isobenzofuran-1(3H),4’-piperidine] Hydrochloride, CAS: 37663-44-8, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO.

Spiro[isobenzofuran-1(3H),4’-piperidin]-3-one Hydrochloride, CAS: 172733-79-8, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO₂.

Sulfidefluor 7 AM, CAS: 1416872-50-8, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₃N₇O₁₂.

TAK-875, CAS: 1000413-72-8, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂O₇S.

Talopram Hydrochloride, CAS: 7013-41-4, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO • HCl.

Tasimelteon, CAS: 609799-22-6, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₂.

Tasimelteon-D5, CAS: 1962124-51-1, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₅NO₂.

TC-F 2, CAS: 1304778-15-1, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅N₅O₂.

TCS 2002, CAS: 1005201-24-0, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄N₂O₃S.

tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate, CAS: 183288-43-9, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O₅.

Tert-Butyl 5’-Bromo-3’H-Spiro[Azetidine-3,1’-Isobenzofuran]-1-Carboxylate, CAS: 1398609-80-7, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈NO₃Br.

Tetrabenzyl 3,6-Diacetoxy Fluorescein Bis(methylene)bis(azanetriyl)tetraacetate, CAS: /, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₅₄N₂O₁₅.

Tetrabenzyl Fluorescein Bis(methylene)bis(azanetriyl)tetraacetate, CAS: /, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₅₀N₂O₁₃.

Tetrabromofluorescein Potassium Salt, CAS: 56897-54-2, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₆Br₄K₂O₅.

Tetrabromophthalic Anhydride, CAS: 632-79-1, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈Br₄O₃.

Tetrachlorophthalic Anhydride, CAS: 117-08-8, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈Cl₄O₃.

Tetraethyl Fluorescein Bis(methylene)bis(azanetriyl)tetraacetate, CAS: 1170856-93-5, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₂N₂O₁₃.

Thymolphthalein Monophosphoric Acid Disodium Salt (~90%), CAS: 123359-43-3, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉Na₂O₇P   •xH₂O.

Thymolphthalexon tetrasodium salt, CAS: 62698-55-9, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₀N₂Na₄O₁₂.

Tofogliflozin, CAS: 903565-83-3, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O₆.

Tofogliflozin-d5, CAS: /, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₅O₆.

Trans-1,2-cyclohexanedicarboxylic Anhydride, CAS: 14166-21-3, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₃.

Tremetone, CAS: 4976-25-4, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₂.

Trimellitic Anhydride, CAS: 552-30-7, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄O₅.

Trimellitic Anhydride Chloride, CAS: 1204-28-0, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₃ClO₄.

Tritoqualine, CAS: 14504-73-5, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂N₂O₈.

Tritoqualine-d15, CAS: /, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₇D₁₅N₂O₈.

True Blue Chloride, CAS: 71431-30-6, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₄O₂ • 2HCl.

True Blue Diaceturate Salt, CAS: 108321-12-6, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₄O₂ •2(C₄H₇NO₃).

Usnic Acid, CAS: 125-46-2, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₇.

Usnic Acid Sodium, CAS: 34769-44-3, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NaO₇.

Vilazodone, CAS: 163521-12-8, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₂.

Vilazodone Carboxylic Acid, CAS: 163521-19-5, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆N₄O₃.

Vilazodone Carboxylic Acid-d4, CAS: 163521-12-8, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂D₄N₄O₃.

Vilazodone Ethyl Ester Dihydrochloride, CAS: /, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂Cl₂N₄O₃.

Vilazodone Ethyl Ester Dihydrochloride-D4, CAS: /, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈D₄Cl₂N₄O₃.

Vilazodone Hydrochloride, CAS: 163521-08-2, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₂ .HCl.

Vilazodone N-Oxide, CAS: 1622425-52-8, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₃.

Vilazodone N-Oxide-d4, CAS: /, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃D₄N₅O₃.

Vilazodone-d4, CAS: /, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃D₄N₅O₂.

WAY 170523, CAS: 307002-73-9, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁N₃O₇S.

Z-Butylidenephthalide, CAS: 72917-31-8, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

Zinpyr-1, CAS: 288574-78-7, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₃₆Cl₂N₆O₅.

Zinpyr-4, CAS: 502467-23-4, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₁ClN₄O₅.

ZnAF-1, CAS: 321859-09-0, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈N₄O₅.

ZnAF-1F, CAS: 443302-08-7, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₆F₂N₄O₅.

ZnAF-2, CAS: 321859-11-4, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₈N₄O₅.

ZnAF-2 DA, CAS: 357339-96-9, stock: 4.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₂N₄O₇.

ZnAF-2F, CAS: 443302-09-8, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₆F₂N₄O₅.

[(2-Butyl-1-benzofuran-3-yl)methyl](methyl)amine Hydrochloride, CAS: 1052552-43-8, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO • HCl.

[(2-Ethyl-1-benzofuran-3-yl)methyl](methyl)amine Hydrochloride, CAS: 1052545-07-9, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO • HCl.

[1-(1-Benzofuran-2-yl)ethyl](ethyl)amine, CAS: 105340-56-5, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO.

[1-(1-Benzofuran-2-yl)ethyl](methyl)amine, CAS: 100127-74-0, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO.

[1-(1-Benzofuran-2-yl)ethyl](propyl)amine Hydrochloride, CAS: 1197742-01-0, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO  •  HCl.

[1-(5-bromo-7-methyl-1-benzofuran-2-yl)-2-methylpropyl](methyl)amine hydrochloride, CAS: 1432681-78-1, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NOBr .HCl.

[4-(1-Benzofuran-2-yl)-1,3-thiazol-2-yl]methanamine, CAS: 1017156-27-2, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂OS.

[4-(2,3-Dihydro-1-benzofuran-5-yl)phenyl]methanamine, CAS: 1183374-14-2, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO.

[4-(2-methyl-2,3-dihydro-1-benzofuran-5-yl)phenyl]methanamine, CAS: 1184592-17-3, stock: 9.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO.

[6-Methoxy-2-(4-methoxyphenyl)benzo[b]furan-3-yl](4-cyanophenyl)methanone, CAS: 176977-56-3, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇NO₄.

{6-[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]hexan-2-yl}(ethyl)amine, CAS: 1303889-68-0, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₂.

(+)-Biotin 4-Amidobenzoic Acid, Sodium Salt, CAS: 102418-74-6, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₃NaO₄S.

(+)-Catechin Gallate-13C3, CAS: /, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³C₃H₁₈O₁₀.

(+)-Gallocatechin Gallate-13C3, CAS: /, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³C₃H₁₈O₁₁.

(-)-Catechin Gallate, CAS: 130405-40-2, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O₁₀.

(-)-Epicatechin Gallate, CAS: 1257-08-5, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O₁₀.

(-)-Epicatechin Gallate-13C3, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³C₃H₁₈O₁₀.

(-)-Gallocatechin Gallate, CAS: 4233-96-9, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O₁₁.

(2R)-3-Chloro-2-[[4-(trifluoromethoxy)phenyl]methoxy]propyl ester 4-Methoxybenzoic Acid, CAS: 1253202-35-5, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈ClF₃O₅.

(2R,2’R,3R,3’R,4R)-2,2’-Bis[3,4-bis(phenylmethoxy)phenyl]-3,3’,4,4’-tetrahydro-5,5’,7,7’-tetrakis(phenylmethoxy)[4,8’-bi-2H-1-benzopyran]-3,3’-diyl Ester 3,4,5-Tris(phenylmethoxy)-benzoic Acid, CAS: 223387-33-5, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄₂H₁₁₈O₂₀.

(2S)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-4-methoxybenzoic Acid 2-[[4-(Trifluoromethoxy)phenyl]methoxy]propyl Ester, CAS: 1253202-36-6, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClF₃N₃O₇.

(2S)-cis-3-[[(4-Mercapto-2-pyrrolidinyl)carbonyl]amino]benzoic Acid Disulfide Dihydrochloride, CAS: 444057-64-1, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈Cl₂N₄O₆S₂.

(2Z)-2-(1-Hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene) Hydrazide Benzoic Acid, CAS: 1048973-47-2, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₂.

(3-Aminophenyl)(morpholino)methanone, CAS: 104775-65-7, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₂.

(4-Bromo-3,5-dimethoxyphenyl)benzoic Acid-d9 Methyl Ester, CAS: /, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂D₉BrO₄.

(4-Methoxycarbonylbenzoyl)trifluoroacetone, CAS: 1076198-42-9, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉F₃O₄.

(Chlorosulfonyl)benzoic Acid, CAS: 10130-89-9, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClO₄S.

(E)-2-((6-Hydroxy-[1,1’-biphenyl]-3-yl)((6-hydroxy-[1,1’-biphenyl]-3-yl)imino)methyl)benzoic Acid, CAS: /, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₃NO₄.

(E)-2-Hydroxy-5-((4-sulfinophenyl)diazenyl)benzoic Acid, CAS: 1912438-05-1, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₅S.

(E)-2-[[3-(3-Methoxy-4-propargyloxyphenyl)-1-oxo-2-propenyl]amino]benzoic Acid, CAS: 1001288-58-9, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₅.

(E)-4-((4-Hydroxyphenyl)diazenyl)benzoic Acid, CAS: 2497-38-3, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₃ • xH ₂O.

(E)-4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic Acid, CAS: 328998-25-0, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈N₂O₆.

(E)-5-[2-(Beznyloxy)2-[2,5-bis(benzyloxy)phenyl]ethenyl]-benzoic Acid, CAS: 150258-61-0, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀O₅.

(E)-Fenpyroximate, CAS: 134098-61-6, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇N₃O₄.

(E)​-​3,​5-​Dichloro-​4-​(3-​ethoxy-​2-​methyl-​3-​oxoprop-​1-​en-​1-​yl)​benzoic Acid, CAS: 1110767-89-9, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂Cl₂O₄.

(p-Salicylic Acid-d4) 4-Glucuronide Potassium Salt, CAS: /, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₄KO₉.

(R)-(-)-Repaglinide (Repaglinide Impurity), CAS: 147852-26-4, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆N₂O₄.

(R)-2-(1-Amino-ethyl)-benzoic acid hydrochloride, CAS: 1391433-88-7, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.HCl.

(R)-4-((3-Hydroxypyrrolidin-1-yl)methyl)benzoic Acid, CAS: 1187932-84-8, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

(R)-4-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic Acid, CAS: 1134776-30-9, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

(R)-4-(1-Amino-ethyl)-benzoic Acid Methyl Ester Hydrochloride, CAS: 1097196-96-7, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂ • HCl.

(R)-4-(3-Hydroxy-pyrrolidin-1-ylmethyl)-benzoic Acid Hydrochloride, CAS: 1187931-68-5, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃ • HCl.

(R)-Idelalisib, CAS: /, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈FN₇O.

(R)-Repaglinide Ethyl Ester, CAS: 147770-08-9, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₀N₂O₄.

(R,R)-Eluxadoline Hydrochloride, CAS: /, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅N₅O₅ • 2(HCl).

(R,S)-Eluxadoline Hydrochloride, CAS: /, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅N₅O₅ • 2(HCl).

(S)-4-(1-Boc-amino-ethyl)benzoic Acid, CAS: 1014644-95-1, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

(S)-4-(1-Hydrazinylethyl)benzoic Acid Ethyl Ester Benzenesulfonate, CAS: 934495-38-2, stock: 7.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₅S.

(S)-4-Chloro-3-(4-((tetrahydrofuran-3-yl)oxy)benzyl)benzoic acid, CAS: /, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClO₅.

(S)-Cloperastine Fendizoate, CAS: 220329-19-1, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₈ClNO₅.

(S)-Duloxetine Phthalamide, CAS: 199191-67-8, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃NO₄S.

(S)-Duloxetine Phthalamide-d4, CAS: /, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉D₄NO₄S.

(S)-N,N-Diisopropyl-3-[(5-methoxycarbonyl)-2-hydroxy)phenyl]-3-phenyl-propylamine, CAS: 1294517-17-1, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₃.

(S)-Repaglinide Ethyl Ester (Repaglinide Impurity), CAS: 147770-06-7, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₀N₂O₄.

(S)-Repaglinide Ethyl Ester-d10 (Repaglinide Impurity), CAS: /, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀D₁₀N₂O₄.

(S)​-3-​[[[2-​hydroxy-​1-​(hydroxymethyl)​ethyl]​amino]​carbonyl]​-​5-​[(2-​hydroxy-​1-​oxopropyl)​amino]​-​2,​4,​6-​triiodobenzoic Acid(Iopamidol EP Impurity D), CAS: 87932-11-4, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅I₃N₂O₇.

(S,E)-2-(3-((tert-Butyldimethylsilyl)oxy)-3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)propyl)benzoic Acid Methyl Ester, CAS: 1772578-77-4, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈ClNO₃Si.

(S,R)-Eluxadoline Hydrochloride, CAS: /, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅N₅O₅ • 2(HCl).

1,2-Benzenedicarboxylic Acid 1-(9-carboxynonyl) Ester, CAS: 2042194-73-8, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₆.

1,2-Bis[(O-carboxyphenylacetyl)hydrazine, CAS: 1088425-79-9, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₆.

1,2-Dibenzoyl-1-(tert-butyl)hydrazine, CAS: 112225-87-3, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₂.

1,3,5-Trichloro-2-methylbenzene, CAS: 23749-65-7, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₃.

1,3,6,8-Tetra(4’-carboxyphenyl)pyrene, CAS: 933047-52-0, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₂₆O₈.

1,3-Dibromo-5,5-dimethyl-2,4-imidazolidinedione, CAS: 77-48-5, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆Br₂N₂O₂.

1,3-Difluorobenzene, CAS: 372-18-9, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄F₂.

1,3-Difluorobenzene-d4, CAS: 1173022-08-6, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₄F₂.

1,4-Butanediol Terephthalate, CAS: 29278-69-1, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈O₈.

1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-1H-pyrimidin-2-one, CAS: 126128-40-3, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₂N₆O₉.

1-(3-Fluoro-4-nitrobenzoyl)-2-imidazolidinone, CAS: 1283965-40-1, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈FN₃O₄.

1-(4-Ethoxycarbonylphenyl)piperazine, CAS: 80518-57-6, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

1-(4-Ethoxycarbonylphenyl)piperazine-d8, CAS: 1330052-64-6, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀D₈N₂O₂.

1-(Difluoromethyl)-methyl Ester Benzoic Acid, CAS: 1018678-48-2, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₂F₂.

1-Methyl Ethyl Ester4-amino-3-methoxy-benzoic Acid, CAS: 1215980-81-6, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃.

1-tert-Butylamino-3-(2-chloro-5-carboxyphenoxy)-2-propanol Hydrochloride, CAS: /, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁Cl₂NO₄.

1-tert-Butylamino-3-(2-chloro-5-carboxyphenoxy)-2-propanol-d9, CAS: /, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₉ClNO₄.

1-[(4-Hydroxy-3,5-dimethylbenzoyl)oxy]-2,5-pyrrolidinedione, CAS: 158788-56-8, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₅.

10-Propargyl-4-deoxy-4-amino-10-deazapteroic Acid, CAS: 146464-93-9, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₆O₂.

2,2,2-Trifluoroethyl 2,5-Bis(2,2,2-trifluoroethoxy)benzoate-d4, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₅D₄F₉O₄.

2,2’-Dithiobisbenzoic Acid, CAS: 119-80-2, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₄S₂.

2,2’-Dithiobisbenzoic-13C12 Acid, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₁₂H₁₀O₄S₂.

2,3,4,5-Tetrabromobenzoic Acid, CAS: 27581-13-1, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂Br₄O₂.

2,3,4,5-Tetrabromobenzoic Acid-13C6, CAS: /, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₆H₂Br₄O₂.

2,3,4,5-Tetrafluoro-6-nitrobenzoic Acid, CAS: 16583-08-7, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HNO₄F₄.

2,3,4,5-Tetrafluorobenzoic Acid, CAS: 1201-31-6, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂F₄O₂.

2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl Salicylate, CAS: 33019-34-0, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄O₁₂.

2,3,4-Trifluoro-5-methoxybenzoic Acid, CAS: 38233-47-5, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅F₃O₃.

2,3,4-Trifluoro-5-nitrobenzoic Acid, CAS: 197520-71-1, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂NO₄F₃.

2,3,4-Trihydroxybenzoic Acid, CAS: 610-02-6, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₅.

2,3,4-Trimethoxybenzoic Acid, CAS: 573-11-5, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₅.

2,3,5,6-Tetrafluoro-4-(trifluoromethyl)benzoic Acid, CAS: 5216-22-8, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BrNO₃.

2,3,5,6-Tetrafluoro-4-hydroxybenzoic Acid, CAS: 652-34-6, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂O₃F₄.

2,3,5,6-Tetrafluoro-4-mercaptobenzoic Acid, CAS: 5211-44-9, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂F₄O₂S.

2,3,5,6-Tetrafluoro-4-methylbenzoic Acid, CAS: 652-32-4, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₂F₄.

2,3,5,6-Tetrafluorobenzoic Acid, CAS: 652-18-6, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂O₂F₄.

2,3,5-Tribromobenzoic Acid, CAS: 15396-38-0, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Br₃O₂.

2,3,5-Trichlorobenzoic Acid, CAS: 50-73-7, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Cl₃O₂.

2,3,5-Trifluoro-4-methylbenzoic Acid, CAS: 773869-50-4, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂F₃.

2,3,5-Trifluorobenzoic Acid, CAS: 654-87-5, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂F₃.

2,3,5-Triiodobenzoic Acid, CAS: 88-82-4, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃I₃O₂.

2,3,5-Tris(2,2,2-trifluoroethoxy)benzoic Acid, CAS: /, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₉O₅.

2,3,6-Trichlorobenzoic acid, CAS: 50-31-7, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Cl₃O₂.

2,3,6-Trifluorobenzoic Acid, CAS: 2358-29-4, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃F₃O₂.

2,3,6-Trimethoxybenzoic Acid, CAS: 60241-74-9, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₅.

2,3-Diaminobenzoic Acid, CAS: 603-81-6, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

2,3-Diaminobenzoic Acid Methyl Ester Hydrochloride, CAS: 1189942-66-2, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁ClN₂O₂.

2,3-Dibenzyl-5-bromobenzoic Acid Methyl Ester, CAS: 182676-91-1, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉BrO₄.

2,3-Dibromobenzoic Acid, CAS: 603-78-1, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄O₂Br₂.

2,3-Dichloro-4-fluorobenzoic acid, CAS: 154257-76-8, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Cl₂FO₂.

2,3-Dichloro-4-methylbenzoic acid, CAS: 1254073-62-5, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂Cl₂.

2,3-dichloro-5-nitrobenzoic acid, CAS: 13300-61-3, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₄Cl₂.

2,3-Dichloro-6-(trifluoromethyl)benzoic Acid, CAS: 25922-43-4, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃O₂F₃Cl₂.

2,3-Dichloro-6-fluorobenzoic Acid, CAS: 32890-91-8, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂FCl₂.

2,3-Dichlorobenzamidyl Guanidine-13C2, CAS: 1185047-08-8, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₈Cl₂N₄O.

2,3-Dichlorobenzoic Acid, CAS: 50-45-3, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₂O₂.

2,3-Dichlorobenzoic Acid-13C, CAS: 1184971-82-1, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₄Cl₂O₂.

2,3-Dichlorobenzoic Acid-13C,d3, CAS: /, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CHD₃Cl₂O₂.

2,3-Difluoro-4-(trifluoromethyl)benzoic Acid, CAS: 237424-17-8, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃O₂F₅.

2,3-Difluoro-4-hydroxybenzoic Acid, CAS: 175968-39-5, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄O₃F₂.

2,3-Difluoro-4-methoxybenzoic acid, CAS: 329014-60-0, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆F₂O₃.

2,3-Difluoro-4-methylbenzoic acid, CAS: 261763-37-5, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆F₂O₂.

2,3-Difluoro-4-methylbenzoic Acid Ethyl Ester, CAS: 773135-56-1, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂F₂.

2,3-Difluoro-4-nitrobenzoic Acid, CAS: 1806370-35-3, stock: 5.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₄F₂.

2,3-Difluoro-5-iodobenzoic acid, CAS: 333780-74-8, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃F₂IO₂.

2,3-Difluoro-5-methylbenzoic Acid, CAS: 1003709-96-3, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₂F₂.

2,3-Difluoro-6-methoxybenzoic Acid, CAS: 773873-26-0, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃F₂.

2,3-Difluorobenzoic Acid, CAS: 4519-39-5, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄F₂O₂.

2,3-Dihydro-1H-isoindole-4-carboxylic Acid, CAS: 658683-13-7, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

2,3-Dihydroxy-4-methoxybenzoic Acid, CAS: 3934-81-4, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₅.

2,3-Dihydroxybenzoic Acid, CAS: 303-38-8, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₄.

2,3-Dimethoxy-5-sulfamoylbenzoic acid, CAS: 66644-80-2, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₆S.

2,3-Dimethoxybenzoic acid, CAS: 1521-38-6, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₄.

2,3-dimethyl-5-sulfamoylbenzoic acid, CAS: 1342568-17-5, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄S.

2,3-Dimethylbenzoic Acid Methyl Ester, CAS: 15012-36-9, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2,4,5-Trichlorobenzoic Acid, CAS: 50-82-8, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂Cl₃.

2,4,5-Trifluoro-3-hydroxybenzoic Acid, CAS: 116751-24-7, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃F₃O₃.

2,4,5-Trifluoro-3-methyl-6-nitrobenzoic Acid, CAS: 167887-95-8, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄NO₄F₃.

2,4,5-Trifluoro-3-nitrobenzoic Acid, CAS: 115549-15-0, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂NO₄F₃.

2,4,5-Trifluorobenzoic Acid, CAS: 446-17-3, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃F₃O₂.

2,4,5-Trimethoxybenzoic Acid, CAS: 490-64-2, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₅.

2,4,5-Trimethylbenzoic Acid, CAS: 528-90-5, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2,4,6-Tribromo-3-hydroxybenzoic Acid, CAS: 14348-40-4, stock: 6.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₃Br₃.

2,4,6-Tribromobenzoic Acid, CAS: 633-12-5, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂Br₃.

2,4,6-Trichlorobenzoic Acid, CAS: 50-43-1, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃Cl₃O₂.

2,4,6-Trichlorobenzyl Alcohol, CAS: 217479-60-2, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₃O.

2,4,6-Trifluorobenzoic Acid, CAS: 28314-80-9, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂F₃.

2,4,6-Trihydroxybenzoic Acid, CAS: 83-30-7, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₅.

2,4,6-Trihydroxybenzoic Acid Ethyl Ester, CAS: 90536-74-6, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₅.

2,4,6-Trihydroxybenzoic acid hydrate, CAS: 71989-93-0, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₅ • H ₂O.

2,4,6-Triiodo-3-(N-hydroxyethylcarbamoyl)-5-aminobenzoic Acid, CAS: 22871-58-5, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉I₃N₂O₄.

2,4,6-Triiodo-3-(N-methylcarbamoyl)-5-(N-methylacetylamino)benzoic Acid, CAS: 21656-26-8, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁I₃N₂O₄.

2,4,6-Trimethyl-3-nitrobenzoic Acid, CAS: 106567-41-3, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.

2,4,6-Trimethylbenzoic Acid, CAS: 480-63-7, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2,4,6-Tris(trifluoromethyl)benzoic Acid, CAS: 25753-26-8, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃F₉O₂.

2,4-Bis(phenylmethoxy)-6-propylbenzoic Acid, CAS: 104847-69-0, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄O₄.

2,4-Bis(propan-2-yl)benzoic Acid, CAS: 108961-55-3, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₂.

2,4-Bis(trifluoromethyl)benzoic Acid, CAS: 32890-87-2, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄O₂F₆.

2,4-Diaminobenzoic Acid, CAS: 611-03-0, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

2,4-dibromo-5-(chlorosulfonyl)benzoic acid, CAS: 1432679-77-0, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₄SClBr₂.

2,4-Dibromobenzoic acid, CAS: 611-00-7, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Br₂O₂.

2,4-Dibromobenzoic Acid Methyl Ester, CAS: 54335-33-0, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆Br₂O₂.

2,4-Dichloro-3-cyano-5-fluorobenzoic Acid, CAS: 117528-58-2, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂Cl₂FNO₂.

2,4-Dichloro-3-fluorobenzoic Acid, CAS: 915145-05-0, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂FCl₂.

2,4-Dichloro-3-methoxybenzoic acid, CAS: 115382-33-7, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆Cl₂O₃.

2,4-Dichloro-5-chlorosulfonyl-benzoic Acid, CAS: 3740-18-9, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₄SCl₃.

2,4-Dichloro-5-fluoro-3-nitrobenzoic Acid, CAS: 106809-14-7, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂NO₄FCl₂.

2,4-Dichloro-5-fluorobenzoic Acid, CAS: 86522-89-6, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂FCl₂.

2,4-Dichloro-5-sulfamoylbenzoic Acid, CAS: 2736-23-4, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NO₄S.

2,4-Dichloro-6-fluorobenzoic Acid, CAS: 904285-09-2, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃O₂FCl₂.

2,4-Dichlorobenzoic Acid, CAS: 50-84-0, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₂O₂.

2,4-Diethylbenzoic Acid, CAS: 104175-23-7, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₂.

2,4-Difluoro-3,5-dimethoxybenzoic Acid, CAS: 1003709-80-5, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈F₂O₄.

2,4-Difluoro-3,5-dimethoxybenzoic Acid-d6, CAS: /, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₆F₂O₄.

2,4-Difluoro-3-(trifluoromethyl)benzoic Acid, CAS: 157337-81-0, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃F₅O₂.

2,4-Difluoro-3-chlorobenzoic Acid, CAS: 154257-75-7, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃ClF₂O₂.

2,4-Difluoro-3-formyl-benzoic Acid, CAS: 1203662-27-4, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₃F₂.

2,4-Difluoro-3-hydroxybenzoic Acid Methyl Ester, CAS: 194804-80-3, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃F₂.

2,4-Difluoro-3-methoxybenzoic Acid, CAS: 178974-97-5, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃F₂.

2,4-Difluoro-3-methylbenzoic acid, CAS: 112857-68-8, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆F₂O₂.

2,4-Difluoro-5-(2-methylpropanamido)benzoic Acid, CAS: 1183740-54-6, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃F₂.

2,4-Difluoro-5-(2-oxoimidazolidin-1-yl)benzoic Acid, CAS: 1178351-23-9, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₃F₂.

2,4-Difluoro-5-formylbenzoic Acid, CAS: 1162674-68-1, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄O₃F₂.

2,4-Difluoro-5-iodo-benzoic Acid Methyl Ester, CAS: 1113050-16-0, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅O₂F₂I.

2,4-Difluoro-5-methoxybenzoic acid, CAS: 1266114-05-9, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₃F₂.

2,4-Difluoro-5-methylbenzoic acid, CAS: 367954-99-2, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆F₂O₂.

2,4-Difluoro-5-nitrobenzoic acid, CAS: 153775-33-8, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃F₂NO₄.

2,4-Difluorobenzoic Acid, CAS: 1583-58-0, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄F₂O₂.

2,4-Difluorobenzoic acid hydrazide, CAS: 118737-62-5, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆F₂N₂O.

2,4-Difluorobenzoic Acid-d3, CAS: 1219804-63-3, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₃F₂O₂.

2,4-Dihydroxy-3-methylbenzoic Acid, CAS: 4707-49-7, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

2,4-Dihydroxy-5-methylbenzoic Acid, CAS: 4780-64-7, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

2,4-Dihydroxy-5-nitrobenzoic Acid, CAS: 13722-96-8, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₆.

2,4-Dihydroxy-6-tridecylbenzoic Acid, CAS: 62071-09-4, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₄.

2,4-Dihydroxybenzoic acid, CAS: 89-86-1, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₄.

2,4-Dimethoxybenzoic acid, CAS: 91-52-1, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₄.